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Regulation and effector functions of IFNγ-induced immunity to intracellular pathogens 
 
Abstract 
Macrophages are  professional phagocytes that efficiently clear microbes, dying cells, and 
debris. Nonetheless,  some pathogenic  bacteria and parasites can subvert the macrophage phagosome 
into a  vacuolar replicative niche. Exogenous macrophage activation by the  cytokine interferon 
gamma (IFNγ) tips the equilibrium  toward pathogen restriction,  host survival,  and subsequent 
adaptive immune  responses. The relevance of IFNγ-induced immunity to human health has been 
demonstrated  in patients with genetic defects in IFNγ signaling, who  are  profoundly susceptible to 
vacuolar pathogens such as  Mycobacterium tuberculosis. Still, much remains to  be discovered about 
IFNγ effector functions,  and about their co-regulation by  signaling  downstream of the many innate 
immune  sensors in macrophages.  
First, we asked whether IFNγ-induced  vesicle trafficking  mechanisms affect the maturation 
of phagosomes containing  the bacterium  Legionella pneumophila, the causative agent of 
Legionnaire’s disease. We used functional  genetic screening  to discover candidate  genes involved. 
From 380 genes in a curated vesicle trafficking-related  set, 15 were selected  as candidate  IFNγ 
pathway members by RNAi screening in cell line and primary mouse macrophages. Functional 
validation  of top candidates was inconclusive,  but revealed potential roles for membrane tetraspanins 
and the AP3 complex in IFNγ-induced  microbial restriction.   
Our second goal was to determine whether innate  immune  sensing  affects IFNγ-induced 
bacterial restriction.  Using macrophages from mice deficient  in key elements of innate immune 
sensing pathways, we discovered that the antiviral  transcription  factor IRF3, which functions 
downstream of many nucleic acid sensing pathways, suppresses IFNγ-induced  restriction of L. 
iii 
 pneumophila and the protozoan  parasite Trypanosoma cruzi. While activated IRF3 localizes to the 
nuclei in resting macrophages infected with L. pneumophila, it is mostly  excluded  from nuclei in 
macrophages activated with IFNγ prior to infection. This suggests a cascade  of suppression  in which 
IFNγ responses inhibit  IRF3 activation,  but residual IRF3 activity antagonizes  IFNγ effectors. IRF3-
mediated  inhibition  of IFNγ-inducible nitric oxide synthase was partially,  but incompletely 
responsible  for the phenotype  observed; further candidate effectors were identified  by gene 
expression profiling.  We speculate that antagonism  between IFNγ and IRF3-mediated mechanisms 
may facilitate  a balance of vacuolar pathogen immunity  with viral defense, or with protection  of 
tissue damage by nitric  oxide and other IFNγ-dependent  responses.    
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 INTRODUCTORY NOTE 
 
This thesis is focused on two independent  studies on the restriction  of L. pneumophila in 
interferon gamma (IFNγ)-activated murine  macrophages. The first study investigated  the role of 
vesicle trafficking  genes in the IFNγ-induced restriction of this bacterium, while the  second was 
directed toward understanding  the effect of innate immune  sensing on the IFNγ-activated state. 
Chapter 1 provides  an overview of macrophages, their interactions with vacuolar pathogens, 
and the effects of IFNγ on these interactions. The role of macrophages in phagocytic  clearance of 
debris and non-subverting  bacteria is discussed first, followed  by an overview of vacuolar pathogens 
that subvert the macrophage phagosome.  Next, IFNγ and its effectors in the activation  of 
macrophage-intrinsic  resistance to vacuolar pathogens is described. This is followed  by an overview 
of the innate immune  sensors that macrophages use to detect infection,  as well as a discussion  of the 
known and potential  interactions  between innate sensing and macrophage activation  by IFNγ. 
Finally, the model macrophage pathogen L. pneumophila is introduced  as a tool to investigate  IFNγ 
effector mechanisms as well as to study potential  interactions  between innate immune  sensor 
pathways and the IFNγ-activated  state.  
A genetic screening approach to investigating  vesicle trafficking  in IFNγ-induced restriction 
of L. pneumophila is discussed in Chapter 2. This includes  a description  of the pipeline  used for the 
analysis of high-throughput screening data. The follow-up studies on  individual hits  using  functional 
characterization assays are presented. 
Chapter 3 describes experiments  that investigate  whether pathogen sensing affects  IFNγ-
induced microbial  restriction in the context of L. pneumophila infection.  Building  upon the 
observation  that IRF3 enhances bacterial growth in IFNγ-activated cells, potential  ligands sensed 
upstream of IRF3 and effector mechanisms  downstream of IRF3 are investigated.  Relevance to 
parasitic infection with Trypanosoma cruzi are discussed as well.  
xiv 
 Chapter 4 provides  a perspective on the studies presented in Chapters 2 and 3. The 
hypotheses  suggested in Chapter 3 are discussed in detail. Suggestions  for further study are 
presented. 
. 
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 Macrophage-intrinsic defense against vacuolar  pathogens 
Macrophages are efficient “vacuum cleaners” found in nearly all tissues of  the body. These 
professional phagocytes  ingest and break down debris such as apoptotic  cells and foreign matter. 
They also engulf, kill,  and degrade potential  pathogens such as bacteria, parasites, and fungi.  
Phagocytosis  and phagosome maturation  culminate in fusion with lysosomes  and breakdown of 
cargo into units of constituent  proteins, lipids, sugars, and nucleic acids, though  orchestration  of the 
process is highly  variable depending  on the nature of the cargo and the state of the macrophage. 
Macrophages play a wide range of roles beyond phagocytic  clearance as well. In the context of tissue 
damage, these cells function in wound repair by secreting tissue repair factors, as well  as by clearing 
damaged tissue. Macrophages figure prominently  in the stroma of many tumors, where have been 
shown to either contribute  to or suppress tumorigenesis  and metastasis in a highly  context-dependent 
manner [1]. Because macrophages can be skewed toward different functions  in response to a range of 
stimuli,  an understanding  of how these cells are regulated and how their effector functions  are 
deployed provides insight into a  range of pathogenic  processes that involve  macrophages that are 
underactive, overactive, or  misdirected. 
The functions  of macrophages in immune defense overlap with that of the other professional 
phagocytes,  yet they are indispensable  in a number of roles including pathogen control. Like 
neutrophils, macrophages ingest and kill microbes; like dendritic cells, they function as  a  bridge 
between innate and adaptive immunity  by releasing signaling  cytokines  and chemokines  and by 
presenting  antigens to cells of the adaptive immune  system. However, macrophage depletion in mice 
leads to increased susceptibility  to some bacterial infections  [2–5], revealing nonredundant roles in 
host immunity. 
 
Phagosome maturation modulates membrane and luminal contents.  
2 
 During phagocytosis, defined as  the internalization  of cargo over 0.5 microns in size (in 
contrast to endocytosis  of smaller particles),  plasma membrane-derived pseudopods  engulf the target. 
After internalization,  the membrane and luminal  environment  of the nascent phagosome undergo 
continuous remodeling through fusion of  incoming vesicles  and  budding of  outgoing vesicles (Fig. 1-
1). In the early stages of maturation,  the phagosome fuses with early endosomal  compartments. 
Subsequent phases  include fusion with late endosomes, multivesicular bodies, and lysosomes. 
Vesicles bearing newly synthesized  proteins  from the secretory pathway are targeted to the maturing 
phagosome  as well  [6]. Autophagy,  the de novo formation  of an enclosed compartment  by seeding, 
elongation, and enclosure of a  double membrane around cytosolic contents, destined for eventual 
fusion with lysosomes,  can also play a  role in phagosome maturation [7,8], in one of several ways:  
by engulfment  of the entire phagosome  by an autophagosome,  by contributions  of autophagic 
vesicles to the phagosome,  or by participation  of individual  autophagy-related  proteins in the  process 
of phagosome maturation. 
The luminal  contents of donor vesicles contribute  to microbial  restriction.  These include 
lipases, nucleases, glycosidases,  cathepsins and other proteases, phosphatases,  and antimicrobial 
peptides, including cationic defensins  and cathelicidins,  which form pores in bacterial membranes, as 
well as ubiquicidin,  hepcidin,  and ubiquitin-derived peptides [9–11].  
The phagosome is further modulated by the acquisition of  membrane-embedded  enzymes 
including  the NADPH phagocyte oxidase  complex, comprised of  cytosolic  subunits  (p21, p40, p47, 
and p67) that are  activated upon binding the  flavocytochrome b558 complex (p22, p91 also known as 
NOX2) at the phagosomal  membrane [11,12]. This complex produces highly  reactive superoxide and 
peroxide  species (reactive oxygen species, or ROS) that damage microbes in the phagosome  [13–15]. 
Ion channels  from incoming  vesicles  function  in bacterial restriction  as well. Vacuolar ATPase 
acidifies  the compartment,  contributing  to microbial  degradation  directly  as well as indirectly,  by 
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 activating lysosomal hydrolases  [12]. NRAMP1 channels deplete the phagosome  of iron, zinc,  and 
manganese, metals needed for microbial  growth [16].  
 
 
Figure 1-1. Mechanisms of vacuolar  pathogen restriction in macrophages 
Macrophages restrict and kill phagocytosed microbes by a  number of effector mechanisms including 
phagosome  acidification and  maturation,  autophagy, antimicrobial peptide delivery, nutrient 
restriction,  damage by reactive oxygen species and nitrogen  intermediates  (ROS/RNI), and cell 
death. Mechanisms  known to be dependent on or enhanced by macrophage activation  by exogenous 
IFNγ.are underlined  (Adapted from [11,17]).   
Abbreviations  used: EE, early endosome; MVB, multivesicular body; LE, late endosome; Ly, 
lysosome; iNOS, inducible nitric oxide synthase; NO,  nitric oxide; RNI, reactive nitrogen 
intermediates;  ROS, reactive oxygen species; AMPs, antimicrobial  peptides; IDO, indoleamine 2,3-
dioxygenase;  IRG, immunity-related  GTPase; ATG, autophagy  related proteins 
 
Phagosome maturation is highly regulated 
Membrane-integral  and associated proteins and lipids,  especially  of the Rab guanosine 
triphosphate hydrolase  (GTPase) protein family, establish vacuolar identity and confer selectivity for 
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 interactions with other cellular components  [6]. The early phagosome  is marked by Rab5 and its 
effectors vacuolar protein sorting 34 (VPS34), early endosome antigen 1  (EEA1), and syntaxin 13. 
Rab5 facilitates homotypic  fusion with other Rab5-positive  compartments (phagosomes  and early 
endosomes),  and with Rab4-positive recycling endosomes. Activity of  the  phosphatidylinositide 
(PI3) kinase VPS34 enriches the membrane in phosphatidylinositide(3) phosphate (PI3P), a lipid  that 
recruits elements of the NADPH oxidase complex [18] and anchors EEA1 [19]. EEA1, in turn, 
serves as a docking  and activating  protein for syntaxin  13, a  target- soluble N-ethylmaleimide-
sensitive factor  attachment protein receptor (t-SNARE) on early endosomes  [10]. The class C VPS/ 
homotypic fusion and vacuole protein sorting (HOPS)  complex mediates the conversion  of  Rab5 to 
Rab7, a hallmark  of phagosome maturation  [20]. In late phagosomes,  cholesterol  and PI(4,5)P2 
membrane lipids  predominate.  Rab7 activates the Rab7-interacting lysosomal  protein (RILP), which 
may induce fusion with lysosomes. The lysosomal-associated  membrane proteins LAMP1 and 
LAMP2 are necessary for phagolysosomal  fusion,  though  a precise mechanism  is unknown [6].  
 
Subversion of macrophages by intracellular pathogens 
While macrophages ingest and then digest many microbes readily, certain pathogens subvert 
the inhospitable  environment  of the macrophage phagosome into a niche amenable for survival  and 
replication.  These vacuolar pathogens  include  the bacterial agents of Legionnaire’s disease 
(Legionella pneumophila), salmonellosis (Salmonella enterica),  melioidosis (Burkholderia 
pseudomallei), Q fever (Coxiella burnetii), pneumonic  plague (Yersinia pestis), and tuberculosis 
(Mycobacterium tuberculosis), and the parasitic agents of Chagas disease (Trypanosoma cruzi), 
toxoplasmosis (Toxoplasma gondii), and leishmaniasis  (Leishmania spp.), each of which  deploys  a 
range of effectors and virulence  factors to evade and disable the antimicrobial  mechanisms  of the 
host macrophage. Some of the adaptive  strategies used by intracellular  pathogens include latency, 
acid resistance, and metal ion scavenging [11,12]. Any host antimicrobial mechanism could 
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 potentially  be targeted by intracellular  pathogens directly  as well.  For example, ROS are converted to 
less toxic byproducts by bacterial catalase and superoxide  dismutase  [12]. Some bacteria arrest 
phagosome maturation by modifying  phagosomal lipids [21] or proteins [22], and others remodel  the 
phagosome  into a compartment  with an altogether different identity  by secreting effector proteins and 
selectively recruiting  vesicles or membrane fragments [22]. 
 
Activation by IFNγ can overcome macrophage subversion by intracellular pathogens 
While resting macrophages are  susceptible to subversion by phagosomal-resident microbes, 
macrophages  activated by interferon gamma (IFNγ) produced by NK, NKT, Th1, and Treg cells gain 
the capacity to restrict many of these pathogens  [23–25]. The central role of IFNγ in many bacterial 
and parasitic intracellular pathogens has been demonstrated in both humans and in model organisms 
[26]. In mice, IFNγ is required for resistance to several intracellular  pathogens,  including  vacuolar  M. 
tuberculosis [27], L. pneumophila [28], and T. gondii [29], as well as  the bacteria Listeria 
monocytogenes [30], which are phagocytosed  but escape to the cytosol. In humans, deficiency in 
IFNγ, its receptor, related downstream adaptors, or relevant signaling  genes is strongly  associated 
with susceptibility  to mycobacterial  diseases and other intracellular  bacterial [31] and parasitic  
infections.  In vitro, IFNγ activates both human and mouse macrophages to  overcome bacterial 
evasion strategies and kill or  restrict the growth of these intracellular  pathogens  [23,32,33]. 
 
IFNγ-mediated antimicrobial  effectors 
IFNγ stimulation  activates several macrophage-intrinsic  antimicrobial  mechanisms that are 
not observed or that play a minimal  role in resting cells. Among these  mechanisms, outlined below, 
few mechanisms  are induced exclusively  by IFNγ; other cytokines,  such as tumor  necrosis factor α 
(TNFα), interleukin-12 (IL-12), interleukin-2 (IL-2), or lymphotoxin  α (LTα), or microbial  products 
such as lipopolysaccharide  (LPS) can induce these effectors as well. However, activation  by other 
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 stimuli  generally  requires a combination  of signals,  or require concurrent IFNγ stimulation  in order 
for  significant activation to  occur. 
 
Inducible nitric oxide synthase restricts intracellular microbes  
A chief IFNγ-mediated effector function in murine macrophages is the production  of nitric 
oxide (NO)  by inducible nitric oxide synthase (iNOS),  also called NOS2. In mice, iNOS is a 
powerful antimicrobial  effector required for restriction  of intracellular  bacteria including  M. 
tuberculosis, S. enterica, C. burnetti, L. monocytogenes and of intracellular  parasites including  T. 
cruzi, T. gondii, Leishmania spp., certain Plasmodia species, and Schistosoma mansonii, as well as of 
certain viruses and fungi  [34,35]. 
NO is produced in virtually  all nucleated cells by the constitutive  NO synthases NOS1 and 
NOS3, with roles ranging from the regulation  of blood pressure to signaling  in the central nervous 
system. However, its toxic microbicidal potential  is revealed when NO builds  up to critical 
concentrations.  While the enzymatic activity of  NOS1 and NOS3 is regulated by cellular calcium ion 
flux and is therefore short-lived,  NOS2 is able to produce NO continuously.  As a result, levels of NO 
produced  by NOS2 in activated macrophages are orders of magnitude  higher than in other cells. At 
high concentrations,  NO reacts with elemental  oxygen  or thiols  to form highly cytotoxic unstable 
intermediates  in amounts that approach millimolar  concentrations.  Like ROS, these reactive nitrogen 
intermediates (RNI) can  damage proteins, lipids, and nucleic acids. In addition,  the reaction of NO 
with ROS produces dual ROS/RNI entities that are highly  cytotoxic  as well [36]. 
Beyond its roles in direct antimicrobial  action, recent work has uncovered additional 
functions  of NO in macrophages. A regulatory  role for NO has been implicated  in paracrine 
modulation  of T cell function [37] as well  in cell-intrinsic  regulation  of gene expression   by 
modification  of histone demethylases [38]. In addition,  loss of iNOS has profound  effects on  the 
transcriptome of  IFNγ-activated or  M. tuberculosis-infected macrophages  [39].  NO-dependent 
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 apoptosis has been observed in macrophages infected with M. tuberculosis as well, resulting in 
enhanced pathogen clearance  [40]. In addition,  NO-dependent nitrosylation of  cGMP leads to the 
production  of a mediator,  9-nitro-cGMP,  that induces autophagy  and clearance of cytosolic  bacteria 
in activated macrophages [41].  
Notably,  NO is a diffusible  gas that can spread throughout  as well as outside the host cell. 
The indiscriminate  oxidizing  and nitrosylating properties of  RNI can lead to substantial  bystander 
damage at  the cell and tissue levels in the host [42]. In addition,  the vasodilatory  actions of NO can 
affect pathology  in tissues when diffusion  outside of macrophages is high,  contributing  to sepsis in 
extreme cases [43]. Therefore, like many immune effectors, iNOS can be a double-edged sword. In 
primary mouse macrophages, post-translational  modification  of iNOS led to association  of ~50% of 
the enzyme with phagosomal membranes, thereby partially targeting the  cytotoxic effects  of RNI 
[44]. However, the effect  is partial, and may be specific to certain macrophage types; in macrophage 
cell lines,  phagosomal  localization  of iNOS was not observed [45].  
The role of iNOS in human macrophages remains poorly defined,  due to the inability to 
induce its expression  in human monocytes and macrophages in vitro. However, NO levels in patient 
samples are consistent with robust iNOS activity. Furthermore, macrophages from blood or tissue 
samples from patients with chronic inflammatory  or infectious  diseases readily induce iNOS upon 
stimulation with  IFNγ or combinations  of other macrophage-activating stimuli. These studies have 
revealed that the regulation  of NOS2 expression in humans is more complex  than it is in the mouse. 
In the absence of a robust experimental  system to assay the role and function  of iNOS in human 
infection,  this area remains poorly understood [34,46].   
 
IFNγ-mediated mechanisms limit  the availability of nutrients in the microbial vacuole 
A different strategy to restrict intracellular  pathogens involves  limiting  the supply  of nutrients 
in the phagosome  or microbial  vacuole. The IFNγ-induced  ion pump natural resistance-associated 
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 macrophage protein 1 (NRAMP1) decreases  intraphagosomal  concentrations  of Mg++ and Fe++ by 
localizing  to phagosomal  membranes and actively transporting  these cations into the cytosol  [11]. 
The Fe++ transporter ferroportin-1  is upregulated  in response to IFNγ in some macrophage types and 
exports iron through both the phagosomal [47] and the plasma membrane [48]. Meanwhile, IFNγ 
signaling decreases  macrophage iron uptake from the environment by downregulating  the iron 
receptor ferritin  [48].  
Amino acid deprivation  in the phagosome  is accomplished  by the cytosolic  enzyme 
indoleamine 2,3-dioxygenase (IDO), which depletes cytosolic  stores of tryptophan  by conversion  to 
the metabolite  N‑formylkynurenine  [48]. Together, the nutrient-depleting mechanisms of  IFNγ-
activated macrophages have been demonstrated to play a nonredundant  role in the restriction  of 
bacterial (Chlamydia spp., Francisella tularensis) and parasitic (Leishmania spp., T. gondii) 
infections  [48]. 
 
IRG proteins, induced by IFNγ in mice, influence phagosome maturation in mice and humans  
Phagosomes in IFNγ-stimulated  macrophages may be induced to mature due to p47 GTPases, 
also known as immunity-related  GTPases (IRGs).  In mice, there are 23 IRGs, many transcriptionally 
regulated by IFNγ. Upon infection,  the IRGs relocalize  from the ER or Golgi  apparatus to 
phagosome membranes [49]. Different GTPases
 have been implicated  in resistance to different 
pathogens in mouse models [50]. However in human cells, only three IRGs are conserved; two are 
pseudogenes,  and the remaining  gene, IRGM, is not transcriptionally  responsive to IFNγ [51]. 
However, siRNA inhibition  has confirmed  the role of IRGM in IFNγ or rapamycin-induced 
autophagy  as well  as IFNγ-induced mycobacterial  growth restriction in human cells [52]; 
furthermore,  IRGM genetic variation  has been linked  to human susceptibility  to MTb [53].  
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 Four hypotheses for the role of IRGs in phagosome  maturation  have been proposed; they are 
not incompatible,  and may be tailored to cellular  conditions  or specific pathogens [54]. First, the IRG 
proteins may drive phagosome maturation upon their recruitment to the pathogen-containing 
phagosome  [55]. Second, they may induce vesiculation  of the pathogen-bearing phagosome, 
effectively destroying  its protective  vacuolar niche and depositing  it into the cytosol for subsequent 
autophagic degradation [56]. Third, the bacterial phagosome itself may be  autophagocytosed, 
perhaps as a result of damage or modification  by its resident bacterium [52]. Finally,  IRG proteins 
may also help recruit Golgi-derived lipids to  the  phagosome [57]. More work is needed to elucidate 
and differentiate  the IRG-dependent and  independent mechanisms of  IFNγ-activated phagosome 
maturation in macrophages. 
 
Other effects of IFNγ on the phagosomal environment 
There is limited  evidence for the effects of IFNγ on the intraphagosomal environment. For 
example, the  antimicrobial peptide hepcidin is upregulated in IFNγ-activated,  M. tuberculosis-
infected macrophages,  localizes  to the phagosome,  and damages mycobacteria [10]  
The regulatory  effect of IFNγ on many of the proteins and lipids  classically  associated with 
phagosome maturation, however is still unknown. Notably, previous experiments with mouse 
macrophages have shown that contrary to expectation, IFNγ stimulation  decelerates fusion events 
between phagosomes  and lysosomes early after phagocytosis  [17], although older experiments  have 
shown the opposite  result [58]. Instead, IFNγ appears to extend the  time window in which 
phagosomes acquire lysosomal  elements, from 0-2h after  phagocytosis in resting macrophages to 0-
10h in IFNγ-activated macrophages,  perhaps to enhance antigen presentation. Therefore, IFNγ 
modulates  the duration, selectivity, targeting of  vesicle  trafficking events  [17]. 
 
IFNγ-induced cell death 
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 “Sacrificial”  cell death by infected macrophages represents another class of responses that 
can restrict intracellular  pathogens. Recent work has shown that IFNγ-mediated  induction  of caspase-
11 and the GBP proteins  (GBP1-3, GBP5, GBP7) facilitates  the rapid,  pyroptotic  death of BMMs 
infected with L. pneumophila [59]. Other modes of sacrificial  cell death have been described in the 
control of vacuolar pathogens  as  well. At high moieties of infection (MOI), macrophages infected 
with M. tuberculosis undergo IFNg-mediated  cell death that displays  properties of both apoptosis  and 
necrosis [60]; evidence suggests that M. tuberculosis actively subverts the antibacterial  apoptotic 
response to instead stimulate necrotic death, which facilitates opportunistic spreading of the bacteria 
[61]. At lower MOIs, apoptosis followed by efferocytosis is an  efficient restriction mechanism in 
macrophages infected with M. tuberculosis [62,63]. The contribution  of IFNγ to efferocytotic 
restriction of  M. tuberculosis, however, was not investigated.   
IFNγ has been shown to enhance phagocytic  clearance of  apoptotic cells in macrophages 
derived from patients deficient  in a key subunit  of phagocyte oxidase subunit [64], but the relevance 
to infected macrophages in other genetic backgrounds  remains to be determined. Likewise, the 
contribution of  IFNγ to a variety of modes of inflammasome-mediated pyroptosis remains  unknown. 
Current research is focused on determining  the regulation  of each mechanism,  delineating  the scope 
of pathogens to which each is applicable,  and determining  what other potential  pathways of 
sacrificial death may play a role in infected cells [65].  
   
Macrophage pathogen sensing 
In addition  to possessing receptors for cytokines like IFNγ, macrophages have an array of 
innate immune sensors that alert the cell to infection and facilitate the tailoring  of immune responses 
(Fig. 1-2). These sensors are located both in the cytosol and on vacuolar or the cell plasma membrane, 
and transduce direct and indirect signals to immune  effectors toward the goals of pathogen 
degradation or suicidal  host cell death. Innate immune sensors are also called pattern recognition 
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 receptors (PRRs) to reflect the fact that they detect classes of ligands  that match a particular template 
(called a pathogen-associated molecular  patterns, or PAMP), such as lipopolysaccharide  (LPS) 
bacterial cell wall components  or hypomethylated  DNA, and to distinguish  them from the exquisitely 
specific antigen receptors of the adaptive immune system.  The chief families  of PRRs, as classified 
by structure and function, are Toll-like  receptors (TLRs), phagocytic receptors,  cytosolic  nucleic acid 
sensors, Nod-like receptors (NLRs), and inflammasomes  [66]. 
 
 
Fig. 1-2. Innate immune sensing of vacuolar pathogens 
A partial collection  of known sensors and pathways that respond to microbial  ligands  in the 
phagosome or  translocated into the cytosol.  TLRs drive inflammatory  and antiviral  gene expression 
programs through MYD88 and TRIF. NLRs and some nucleic acid sensors promote inflammatory 
IL-1β production  and/or pyroptosis; NLRs may affect phagosome maturation. Cytosolic nucleic acid 
sensors drive inflammatory  and antiviral  gene expression, primarily  through MAVS and STING. 
Phagocytic receptors induce cytoskeletal rearrangements, and may promote other responses as well. 
(Adapted from [66–68]) 
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 Recognition and signaling by TLRs 
  The Toll-like family of PRRs  is a  diverse and ancient array of sensors for a variety of 
microbial threats [69,70].  At the plasma membrane, bacterial components  are sensed by TLRs 1 and 
6 (lipoproteins),  TLR2 (Gram-positive  peptidoglycans, mycobacterial glycolipids, porins,  atypical 
LPS), TLR4 (Gram-negative  LPS), and TLRs 5 and 11 (flagellin)  [66,71,72].  Also at the plasma 
membrane,  parasites  are sensed by TLR2 (mucins),  viruses by TLR2 (hemagglutinin)  and TLR4 
(some viral fusion proteins),  and fungi by TLR2, 4, and 6 (zymosan  and mannans) [66,71].  TLR4 is 
internalized into endocytic and phagocytic vesicles and participates in sensing and signaling  from 
these compartments  as well as from the plasma membrane [72]. In addition,  within endolysosomal or 
phagosomal compartments, unmethylated CpG  DNA  from  all categories  of  microbes is sensed by 
TLR9 (though  in humans, only in plasmacytoid  dendritic cells and B cells), bacteria are sensed by 
mouse TLR13 (23S rRNA), parasites are sensed by TLR9 (hemozoin-coated DNA) and mouse TLRs 
11 and 12 (profilin),  and viruses are sensed by TLR3 (dsRNA) and mouse TLR7/human  TLR8 
(ssRNA) [66,71–73].   
All of the TLRs except TLR3 transduce signals to the adaptor protein myeloid differentiation 
primary response gene 88 (MYD88) via the localizing  adaptor MYD88 adapter-like/toll-interleukin 1 
receptor domain  containing  adaptor protein1  (Mal/TIRAP).  TLR3,  as well  as the bimodal  TLR4, 
signal to the adaptor TIR-domain-containing  adaptor inducing  IFNβ (TRIF) via the localizing 
adaptor TRIF-related adaptor molecule (TRAM). MYD88 and TRIF activate transcription  factors 
and kinases in a  context-dependent manner, informed  by further signals from TLR co-receptors 
[70,74].   
In general, both  MYD88 and TRIF activate the canonical IKK kinases IKKα/β to promote 
inflammatory  gene expression  driven  by the transcription  factor NFκB,  due to the phosphorylation 
and subsequent  degradation  of its inhibitory  subunit  IκBα [67]. In addition,  MYD88 activation 
engages MAP kinases, resulting in  activation of  inflammatory gene  expression via  the  transcription 
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 factor activator protein 1 (AP1) [67]. Meanwhile,  TRIF activates the noncanonical  IκB kinases IKKε 
and TBK1 to promote the expression  of antiviral  genes, including  Type I interferons,  due to the 
phosphorylation  and subsequent nuclear translocation  of the transcription  factors IRF3 and IRF7  
[67,70,73,75].  Studies in mice deficient  in individual  or combinations  of TLRs and/or adapters have 
begun to decipher the role of each TLR for different pathogens,  showing that TLR deficiency  can 
profoundly  affect resistance to bacteria [76,77], parasites [78], fungi  [79], and viruses [80] both in 
vivo and in vitro.  
 
Recognition and signaling by phagocytic receptors 
  Intracellular  bacteria, parasites, and fungi enter  macrophages through passive or induced 
phagocytosis.  Both modes are facilitated  by phagocytic  receptors on the macrophage surface, 
including  scavenger receptors, C-type lectins,  the mannose receptor, and crystallizable fragment 
receptor (FcR) or complement  receptors for antibody-  or complement-opsonized microbes, 
respectively  [66]. The signaling  roles of phagocytic  receptors upon infection  are difficult  to separate 
from their roles in phagocytosis; in some cases, however,  structure can provide  a clue to function. 
For instance, the fungal-binding lectin Dectin-1 contains immunoreceptor  tyrosine-based activation 
motif-like  sequences (ITAMs) that stimulate  the expression of inflammatory  cytokines [66]. 
 
Recognition and signaling by cytosolic RNA sensors 
  While cytosolic  DNA and non-host  RNA are a hallmark  of viral infection,  nucleic acids 
derived from vacuolar pathogens can  translocate to  the host cell cytosol as well due to phagosomal 
permeabilization  or transport through bacterial specialized  secretion systems. While most of the 
evidence demonstrating  the relevance of nucleic acid sensors in innate immunity  focuses on the 
response to viral pathogens or cytosolic  bacteria such as L. monocytogenes, several  have been shown 
to either play a  role in the protection against bacterial and parasitic vacuolar pathogens. 
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 The RNA sensor retinoic  acid-inducible  gene I (RIG-I) detects ssRNA lacking  5’ 
triphosphate caps  characteristic of host mRNA, while the RNA sensor melanoma  differentiation-
associated gene 5 (MDA5) detects long dsRNA forms present in some viral replication  cycles [75]. 
Both contain a DExD/H box RNA helicase domain  to bind the ligand  and a caspase activation  and 
recruitment domain (CARD) to interact with a  common downstream adaptor, mitochondrial  antiviral 
signaling protein (MAVS, also  known  as IPS-1, VISA, and Cardif). Activated MAVS forms 
multimeric aggregates of MAVS units and adaptor proteins that serve as a platform  to activate the 
noncanonical  IκB kinases, leading  to the induction  of antiviral  genes as described above [73,75]. 
RIG-I is also capable of activating  a different adaptor, stimulator  of type I IFN gene (STING) which, 
similarly  to TRIF, activates both the canonical  and noncanonical  IκB kinases to initiate  inflammatory 
(NFκB-driven) and  antiviral (IRF3/7-driven) programs of gene expression [67,75],  and activates the 
transcription factor  STAT6 as well  [81]. Data have implicated  RIG-I and MDA5 in sensing of RNA 
translocated to the host cytosol  by the vacuolar bacteria L. pneumophila [82], while  another study has 
demonstrated MAVS-dependent  responses to L. pneumophila that are independent  of RIG-I and 
MDA5 [83]. Curiously, RIG-I has also been linked  to L. pneumophila sensing  in  a roundabout 
manner, by binding  to RNA transcribed by host RNA  polymerase III  using translocated bacterial 
DNA as a template [84]. 
In addition  to RIG-I and MDA5, several other RNA helicases have been linked  to MAVS 
activation and  the downstream  activation  of noncanonical  IκB kinases and the antiviral  transcription 
factors IRF3 and IRF7, including  DDX3 (ssRNA), DHX9 (dsRNA), and DDX60 (both ssRNA and 
dsRNA) [67]. Another group of dsRNA helicases, comprised  of DDX1, DDX21,  and DHX36, 
interact with the adaptor protein  TRIF previously described in the context TLR3/4 signaling, leading 
to the activation  of both canonical  (NFκB –activating)  and noncanonical  IκB kinases as described 
above [67,73,85].  In addition,  upon binding  dsRNA, the leucine-rich  repeat in flightless-I interacting 
protein 1 (LRRFIP1) interacts with β-catenin,  which translocates to the nucleus and acts as a 
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 potentiator  of IRF3-driven transcription [67,86].  IRF3 has been shown to facilitate  Type I interferon 
gene expression in response to infection  with the vacuolar parasite T. cruzi independently  of MAVS, 
possibly  through  the RNA sensors described above or through  sensing of DNA, described below 
[87]. 
While  the signaling  mechanisms downstream from RNA sensing described above depend on 
the activation  of transcription  factors, the MAVS and STING-activating  dsRNA sensor RIG-I also 
triggers an  entirely different, post-transcriptionally regulated cellular machinery: the  inflammasome. 
Upon binding  dsRNA, RIG-I is thought  to facilitate  the assembly of multimeric complexes of 
apoptosis-associated speck-like  protein containing  a CARD (ASC) and caspase-1, called ASC 
inflammasomes  [67,88]. Inflammasome assembly results in activation of caspase-1, which cleaves 
cytosolic  reserves of pro-IL-1β to active, proinflammatory  IL-1β. The response to microbial  RNA is 
therefore diverse, and follows  several nonredundant  pathways. 
 
Recognition and signaling by cytosolic DNA sensors 
Several redundant sensors recognize microbial  or aberrantly localized  host DNA in the 
cytosol.  DDX60, DHX36, and LRRFIP are thought  to recognize  cytosolic  DNA as well as RNA. In 
the case of DDX60,  activation  leads to formation  of MAVS complexes  and IRF3/7-driven expression 
of antiviral  genes due to activation  of noncanonical  IκB kinases [67]. In the case of DHX36,  DNA 
binding  leads to interaction  with STING,  which  activates both the canonical  and noncanonical  IκB 
kinases to initiate  inflammatory  (NFκB-driven) and antiviral (IRF3/7-driven)  programs of gene 
expression  [67,73,85].  Notably,  data from M. tuberculosis-infected macrophages deficient  in the 
cytosolic  DNase Trex1 suggest a role for STING in detection of mycobacterial  DNA secreted into 
the cytosol [89], though the identity  of the DNA sensor is unknown. DNA-bound  LRRFIP, 
meanwhile,  activates β-catenin to enhance the transcriptional  activity  of IRF3 [67]. 
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 The dedicated DNA helicases  IFI16 and DDX41  also interact with STING to initiate 
inflammatory  (NFκB-driven)  and antiviral  (IRF3/7-driven)  programs of gene expression  [67,73,85]. 
In plasmacytoid  dendritic  cells, the DNA helicases DHX36 and DHX9 activate TRIF and MYD88, 
respectively,  leading  to the induction  of gene expression  programs  driven  by IRF3 and NFκB or by 
IRF7 [67].  
The dedicated DNA sensor absent in melanoma-2  (AIM2) assembles caspase-1-activating 
inflammasome complexes with ASC to produce mature, inflammatory  IL-1β [67,73,85].  AIM2 plays 
a major role in recognition of bacteria that escape the phagosome to reach the cytosol [90], but is also 
activated in infection by the non-pathogenic vacuolar Mycobacterium bovis [91]. Evidence from 
macrophages  infected with pathogenic  M. tuberculosis and L. pneumophila is consistent with a 
model in which bacterial effector proteins counter-evolved  to thwart sensing mechanisms,  such as 
AIM2, by minimizing  the cytosolic  release of nucleic acids [92,93]. 
The DNA-dependent activator of IRFs (DAI), also called Z-DNA–binding protein (ZBP), is 
hypothesized  to activate the STING-dependent antiviral and  inflammatory signaling pathways  [67]. 
However, DAI is also thought to form interactions  with three other branches of innate immune 
signaling  [94]. First, DAI interacts with TBK1 directly  to activate IRF3. Second, DAI activates the 
receptor-interacting  protein 1 (RIP1), which signals to NFκB via the canonical  IκB  kinases. Finally, 
interactions  of DAI with receptor-interacting  protein 3 (RIP3) lead to caspase-independent necrosis 
[94]. 
Several DNA damage response elements have been implicated  in cytosolic  DNA sensing, in 
a cell type-dependent manner. In mouse dendritic  cells, as well as some human cell types, evidence 
links the meiotic  recombination  11 (MRE11), a key player in recognition and initiation  of double-
stranded breaks in nuclear DNA, to the activation  of STING and IRF3 [85,95].     
Finally, recent  evidence is consistent with a  major role for the cyclic GMP-AMP synthase 
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 (cGAS) as a cytosolic  DNA sensor [85]. Upon binding  dsDNA, cGAS synthesizes the second 
messenger molecule cyclic GMP-AMP (cGAMP). This small molecule binds directly to STING to 
initiate  IRF3 and NFkB-dependent transcription [85].  
 
Recognition and signaling by sensors of bacterial cyclic dinucleotides 
  It has recently been appreciated that the DNA sensor DDX41 as well as the DNA sensing 
adaptor protein STING also function as  sensors of cyclic dinucleotides.  As mentioned above, STING 
binds to cGAMP produced by host cGAS upon sensing of cytosolic  DNA. In contrast to sensing 
second messengers produced by the host, however, both STING and DDX41 are able  to sense the 
bacterial cyclic dinucleotide  c-di-GMP and initiate  a signaling  response [96,97]. Furthermore, 
DDX41 recognizes bacterial c-di-AMP, a second type of cyclic dinucleotide,  as well [97]. In 
macrophage cell lines infected with modified  strains of L. pneumophila, the induction  of Type I 
interferon in response to infection  directly correlated with the levels of  c-diGMP or c-diAMP 
secreted by each strain [98]. The response was partially  dependent on TBK1 and IRF3,  as well  as the 
Type I interferon  receptor IFNAR and Type I/II interferon-activated  signal  transducer and activator 
of transcription  1 (STAT1)  [98]. Candidate sensors of these bacterial ligands  identified  by mass 
spectrometry included  the phagosomal  protein coronin  1A, mRNA cap guanine-N7 
methyltransferase, and  cyclophilin H  [98]. Consistent with other mechanisms of pathogen sensing, 
macrophages likely  use redundant mechanisms  to detect bacterial cyclic dinucleotides;  however, 
STING is thought  to be the major signaling  adaptor for these diverse receptors [99,100]   
 
Recognition and signaling by NODs and NLRs 
Another important  arm of the cytosolic  surveillance  machinery is made up of the nucleotide-
binding  and oligomerization  domain  (NOD) proteins and the NOD-like receptors (NLRs), which 
detect a variety of microbial  ligands.  There are 23 known NODs and NLRs in human cells, and 34 in 
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 mouse cells [72], classified  into five categories by their N-terminal  effector domains:  NLRA (acidic 
activation  domain),  NLRB (baculoviral  inhibitory  repeat, or BIR-like domain,  also called NLR 
family, apoptosis inhibitory protein 5  [NAIP]), NLRC (caspase activating  and recruitment domain, or 
CARD), NLRP (pyrin  domain),  and NLRX (no domain  homology)  [101]. Several NODs and NLRs 
that have been implicated  in responses to vacuolar pathogens  are mentioned  below.  
The NLRC receptors NOD1 and NOD2, known to be activated by bacterial peptidoglycan, 
facilitate an inflammatory  NFκB-driven  response to S. typhimurium in a manner dependent on 
bacterial secretion through the phagosomal membrane [102] and are critical  to control  of infection 
with L. pneumophila [103],  T. cruzi (via NOD1) [104], and T. gondii (via NOD2) [105] in vivo. 
NOD1/2,  as well as the orphan receptor NLRP4 (also known as NACHT-LRR-PYD-containing 
protein-4 or  NALP4, and as pyrin-containing APAF-1-like  protein 4 or PYPAF4), are also involved 
with the recruitment  and modulation  of autophagic machinery at newly formed bacterial phagosomes 
of the cytosolic  bacteria L. monocytogenes, Shigella flexneri, and the extracellular  bacteria 
Staphylococcus aureus  [106,107], though  it is not known whether they fulfill similar functions in the 
context of vacuolar pathogens.   
NLRC4 (also  known  as interleukin-converting enzyme protease-activating  factor, or IPAF) is 
a sensor for the flagellins  and/or secretion system “needle” proteins of some vacuolar  bacteria, 
including  Salmonella spp. and L. pneumophila, in tandem with NAIP1 (human NLRB)  or mouse 
NAIP5 [108–114].  In concert with cytokine signaling, NLRC4/NAIP5 trigger inflammasome 
assembly  and rapid programmed death, termed pyroptosis, in the host macrophage  following  L. 
pneumophila infection,  thus restricting intracellular  bacterial restriction [115].  
NLRP1, also called NACHT leucine-rich-repeat  protein 1 (NALP1), and NLRP3 sense and 
trigger  an inflammasome-mediated  response to the vacuolar parasite T. gondii [116]. NLRP3 also 
facilitates an inflammatory,  IL-1β response to a virulence  factor secreted into  the cytosol  by M. 
tuberculosis [117]. NLRP3 was also found to be recruited to the maturing  phagosomes  of 
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 phagocytosed Gram-positive  bacteria and to facilitate phagosome  acidification,  though  it is unknown 
whether the effect extends to vacuolar pathogens [118]. NLRP12 (also called Monarch-1)  facilitate 
inflammasome-mediated IL-1β and IL-12 production  in  vacuolar  Y. pestis [119]. However, NLR 
sensors that are inflammatory  in certain contexts can play an inhibitory  role as well, illustrated  by 
modulation of the macrophage response to M. tuberculosis and S. typhimurium by NLRP12 [90,120].   
 
Effects of pathogen sensing on IFNγ-mediated effectors 
Studies  have begun to reveal mechanisms  by which cell-autonomous innate immune sensing 
affects IFNγ activation in macrophages. Several interactions are known to occur at the level of 
signaling  and transcription [121–123].  Little remains known, however, about the effects of innate 
sensing on pathogen restriction in IFNγ-activated cells. 
 
The IFNγ signaling cascade 
IFNγ responses  are facilitated  by the transcriptional activity of homodimers  of the 
transcription factor  STAT1, also known as  gamma-activated  factor (GAF). Ligation  of the IFNγ 
receptor (a heterodimer  of subunits  IFNGR1 and IFNGR2) on the cell surface leads to receptor 
crosslinking,  creating cytosolic  domains  that recruit adaptor proteins  [26]. The canonical sequence of 
macrophage activation by IFNγ involves  the recruitment  of Janus kinases 1 and 2 (JAK1-2), 
autophosphorylation of  JAK2, and phosphorylation  of JAK1 by JAK2 [26]. Jak1 then phosphorylates 
the IFNGR cytoplasmic  tail to create a docking  site to recruit monomers of inactive signal transducer 
and activator of transcription  1 (STAT1) [26]. Subsequently,  JAK2 phosphorylates bound STAT1 on 
tyrosine residue 701 (Y701) [26]. This signaling  is not strictly  dependent on JAK1, due to partial 
redundancy within  the JAK family  [124]. Noncanonical JAK2-independent activation of 
STAT1pY701 homodimers in  response  to  IFNγ signaling  have been described  as well,  dependent  on 
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 the activity of phosphatidylinositol  3-kinase  [125]. 
STAT1pY701 forms  parallel homodimers  upon dissociation  from the IFNGR/JAK  complex 
and translocates to the nucleus, where it drives gene expression from promoters containing IFNγ 
activation  site (GAS) elements  [26,126].  STAT1 homodimers  occupy DNA for only a brief time, 
especially  if they become acetylated at lysines 410 and 413, perhaps by the action of histone 
acetylase proteins [126]. As STAT1 homodimers  dissociate  from DNA, they take on an antiparallel 
configuration that expose them to nuclear phosphatases, and trigger export from the nucleus [126].  
In addition,  Jak1-dependent yet  STAT1-independent  effects of IFNγ signaling  on gene 
expression  have been described  in STAT1
-/- mice [127]. The effects of STAT1-independent  IFNγ-
mediated macrophage activation on vacuolar pathogens are not yet understood. 
IFNγ signaling  is amplified  by the effects of transcription  factors themselves induced  by 
IFNγ. Three members of the IRF family  of transcription  factors, IRF1, IRF2, and IRF9, are IFNγ 
targets themselves. Most prominently,  IRF1 seems to have a profound  facilitating  effect on GAS 
promoter-driven  gene expression, and at high  levels of IRF1, synergizes with IFNγ signals to drive 
apoptosis  [26].  
IFNγ signaling  is inhibited  by the suppressor of cytokine signaling  (SOCS) protein  SOCS1, 
which directly competes with IFNγ binding  of the IFNGR. SOCS1 is induced by IFNγ signaling  in a 
negative feedback loop, with duration  and magnitude  of expression  tied tightly  to the magnitude  of 
IFNγ activation  [123]. SOCS1 is essential to the prevention  of unchecked IFNγ responses, which are 
so damaging  that they lead to neonatal lethality  in SOCS1
-/- mice [126].  
 
Effects of TLR signaling on IFNγ-activated macrophages 
TLR activity  potentiates the cellular  response to IFNγ through  multiple  mechanisms  [121]. 
First, MAP kinases activated in response to TLR signaling  further phosphorylate STAT1 at serine 
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 residue 727 (S727). The capacity of STAT1 dimers phosphorylated at  both S727 and Y701 to drive 
gene expression at promoters bearing GAS elements is enhanced in comparison  with dimers 
phosphorylated  at Y701 only. Furthermore,  expression of many IFNγ-activated transcripts is 
enhanced by coordinate binding  and activity of the transcription factor NFkB, activated downstream of  
TLR signals; these genes include IRF1 and NOS2, described above, as  well as the C-X-C motif 
chemokine 10 (CXCL10),  also known as interferon gamma-induced protein 10 (IP-10), used by 
macrophages to attract and modulate other monocytic  and lymphoid  cells, and intercellular  adhesion 
molecule 1 (ICAM-1), used by leukocytes in tissue transmigration  [121]. The transcription-inducing 
activity of IRF1 has been described as a “second wave” of IFNγ-initiated signaling [26], and is an 
especially relevant potential  substrate for modulation  of the IFNγ-activated state. 
In fluorometric studies of  phagosome maturation using ligand-coated beads,  IFNγ and TLR 
signaling  produced  different  effects depending  on whether  the signals  were applied  together  or 
separately. For instance, TLR and IFNγ signals alone each  increased the duration of lysosome 
recruitment  to phagosomes,  but TLR and IFNγ signaling together also decreased its initial  rate [17]. 
TLR signals may affect also IFNγ-induced autophagy to  enhance  phagosome maturation.  TLR 
signaling  from within  the phagosome  affects the recruitment  of autophagic proteins to augment 
phagosome maturation [128].  
 
Effects of Type I IFN on IFNγ-activated macrophages 
Many TLR or nucleic acid-sensing elements in macrophages stimulate the production  of Type 
I interferons,  comprised  of over a dozen subtypes of IFNα , a single  IFNβ, and (in humans but not in 
mice) a single  IFNω.  The Type I and II interferons share a partially  overlapping  set of transcriptional 
targets [121,129].  One study has calculated a “beta-gamma mixture” for each target gene depending 
on its induction  by IFNβ and/or IFNγ, concluding  that the targets lie on a fairly continuous  spectrum 
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 between the two [129]. Therefore, signaling  by Type I and II interferons can lead to augmentation  or 
suppression  of each in  a context-dependent manner.   
Antagonism  between Type I and II responses has been described in human peripheral blood 
monocyte-derived  macrophage (MDMs),  particularly  at low concentrations  of Type I interferon 
[130]. However, another study in mouse embryonic  fibroblasts (MEFs) found evidence that tonic 
IFNAR signaling  primed cells for IFNγ signaling  [131]. The effects of interferon  cross-talk are likely 
to be exquisitely  dependent on the context,  level and duration  of activation.   
Type I IFN signaling  antagonizes  IFNγ signaling by  downregulating  of IFNγ receptor in 
mouse bone marrow-derived macrophages (BMMs) infected with cytosolic L. monocytogenes [132]. 
In human MDMs infected with Mycobacterium leprae, Type I IFNs suppress the IFNγ-activated 
expression of the antimicrobial  peptides beta-defensin  and cathelicidin  [133]. 
 
Effects of nucleic acid sensing on IFNγ-activated macrophages 
In mouse fibroblasts,  the IFNγ-mediated  restriction  of the  cytosolic  bacterial pathogen 
Shigella flexneri is dependent on elements of  the RNA sensing machinery,  including  RIG-I and 
MAVS [134]. In this study,  RIG-I and MAVS expression levels were  driven by IFNγ-activated IRF1.  
However, RIG-I and MAVS were both dispensable  for efficient restriction  of S. flexneri in response 
to IFNγ in BMMs [134]. 
 
Legionella is a model pathogen to study IFNγ-mediated macrophage-intrinsic immunity  
Legionella pneumophila is a Gram-negative facultative intracellular bacterium that  naturally 
parasitizes  amoebae, but has adapted to live in mammalian  macrophages as well. In humans, L. 
pneumophila is a significant  agent of community-acquired  pneumonia,  which can take the form of 
mild  Pontiac Fever or severe, life-threatening Legionnaire’s disease.  L. pneumophila grow in 
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 permissive  mouse and human macrophages in vitro, but its growth is restricted in cells activated by 
IFNγ [28,135]; furthermore,  IFNγ signaling  is required  for control  of L. pneumophila in vivo 
[136,137]. 
 
Membrane trafficking events in L.pneumophila-infected macrophages 
L. pneumophila remodels the phagosome within  minutes of phagocytosis,  failing  to acquire 
markers of late endosomes but instead decorating the Legionella-containing  vacuole (LCV) with ER-
derived membrane recruited from vesicular  traffic from endoplasmic reticulum  (ER) exit sites 
[138,139]  and the trans-Golgi lipid PI(4)P [140]. The LCV associates with autophagy  markers ATG7 
and ATG8 [141], but  avoids colocalization with  lysosomal markers.  Within the  LCV,  L. 
pneumophila multiply  approximately  every 2 hours, leading  to expansion  of the LCV and eventual 
lysis of the host cell after  about 14-24h,  releasing progeny bacteria to infect other host cells.  
Formation  of the protected LCV and bacterial survival  are dependent on the bacterial 
Dot/Icm Type IV secretion system, which delivers  over 100 virulence  factors so far identified  to the 
host cell cytosol;  only several have been characterized so far. While none of the Dot/Icm substrates 
are essential for the bacterium,  bacteria deficient  in Dot/Icm itself cannot form an ER-decorated 
LCV, cannot replicate in cells, and are shunted into the phagosome maturation pathway [142].  
IFNγ-activated cell-line  or primary macrophages infected with wildtype L. pneumophila are 
similar  to resting macrophages infected with Dot/Icm-deficient  bacteria, based on their kinetics of 
acquisition  of lysosomal  markers, nearly identical  growth restriction,  and lack of ER-derived 
membrane on the LCV, observed at 4 hours after phagocytosis  [143]. Whether L. pneumophila in 
IFNγ-stimulated macrophages fail to form an ER-decorated LCV at earlier time points is not clear. In 
addition,  GBP proteins contribute  to caspase-1-independent pyroptotic cell death  that  is required for  
restricts L. pneumophila in IFNγ-activated macrophages [59]. 
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 Innate immune sensing of L. pneumophila 
  A number of studies have investigated  the role of specific innate immune signaling pathways 
in L. pneumophila restriction  in vivo, or in the production  of inflammatory  signals  such as Type  I 
interferons  or IL-12 in infected cells. Bacterial clearance in mice requires signaling  through MYD88 
[144,145],  which is at least partially  explained  by the requirement  for MYD88 for the IL-12 mediated 
induction  of IFNγ production  by NK cells [146]. TLR sensing of L. pneumophila is based on largely 
redundant signaling  from TLRs2, 5, and 9 [144,145,147–150],  but not TLR4 [145,149,151],  due to a 
modified  LPS structure that isinstead sensed by TLR2 [152,153].   
In addition  to signaling  through MYD88, other sensing mechanisms responsible that facilitate 
the NFκB, IRF3, or IRF7-dependent  induction  of inflammatory  responses to L. pneumophila 
infection  include  NOD1/2 [103,154],  STING [83,155], MAVS  [84], and RIP2 [156], though the 
requirements for each are  not absolute. Notably, the studies cited above have not yielded completely 
consistent results, possibly because  of differences in experimental technique or substrains of  L. 
pneumophila used. Sensing of cytosolic  ligands  is dependent on the bacterial secretion system 
Dot/Icm [156]. The response to Dot/Icm translocated  L. pneumophila DNA relies on IRF3 but is 
independent  of NFκB [157]. Furthermore,  AIM2 is capable of triggering  a response to L. 
pneumophila DNA as well,  but its action is curtailed by secreted bacterial effectors [93]. 
  
Outlook 
Following  the discovery  of the interferons in the 1950s,  the prediction  of a macrophage 
activating  factor (MAF) lymphokine that restricts intracellular  pathogens in the late 1960s, and the 
characterization  of MAF in the 1970s and early 1980s, MAF and IFNγ were recognized  as one and 
the same in 1983 [158]. In the years since, much has been learned about the effects of IFNγ signaling 
on macrophages and its relevance to infectious  disease by vacuolar pathogens in vitro, in vivo, and in 
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 human disease.   
Despite the breadth of knowledge about the regulation and transcriptional  activation of IFNγ, 
immunologists  are still unraveling  the mechanisms  by which IFNγ-activated macrophages are better 
able to kill  or restrict intracellular  pathogens. One challenge to understanding  the system has been the 
redundancy and complexity  of the pathways involved in  microbial restriction. For example, BMMs 
derived from mice quadruply  deficient  in the IFNγ effectors NOS2, NOX2, IRGM1 and IRGM3 are 
still  capable of restricting  L. pneumophila in response to IFNγ [59]. Second, pathogens employ 
unique  strategies for immune  evasion,  which mask target host mechanisms  from investigation  and 
make it challenging  to generalize findings  across infection  models.  M. tuberculosis, for instance, 
expresses two redundant  protective reductase genes that provide  resistance killing  by ROI/RNI [159]. 
Third,  some immune  effectors are not well conserved between mice and humans. The IRG gene 
family,  for instance, a class of 23 mostly  IFNγ-regulated  murine  genes that significantly  affect 
macrophage vesicle trafficking  events at bacterial or parasitic phagosomes,  is represented by only 
one functional,  non-IFNγ-responsive  gene in human cells [51]. 
Furthermore,  despite our burgeoning  knowledge  of bacterial ligands  and the pathways 
induced when they are  sensed, relatively  little is known about whether and how these innate sensing 
pathways affect the restriction of vacuolar pathogens in macrophages activated by IFNγ. A 
reasonable a priori assumption  is that innate sensors tailor the powerful IFNγ-mediated host response 
based on the nature of the pathogen. However, immune signaling generally involves a  number of 
inhibitory feedback  loops that  make  combinatorial signal integration difficult to  predict.  The 
characterization  of the IFNγ-activated state, its effectors, and its intersection  with innate immune 
sensing remains a rich area  of investigation. 
The work described in this dissertation  undertook  two aims. First, we attempted to discover 
members of the vesicle trafficking  machinery  that facilitate bacterial restriction  in IFNγ activated 
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 macrophages, using a  functional genetic screening approach. Second, we asked whether innate 
immune  sensing  during  infection  affected IFNγ-dependent mechanisms of  microbial restriction in 
macrophage. We conclude with a roadmap for further investigation. 
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 ABSTRACT 
Vacuolar pathogens such as Legionella pneumophila are able to subvert the macrophage 
phagosome into a replicative  niche. Macrophages activated by interferon  gamma (IFNγ), however, 
are capable to overcome this subversion,  leading  to phagosome maturation, bacterial restriction, and 
macrophage survival.  Our goal is to uncover IFNγ-dependent vesicle trafficking mechanisms that 
govern the spatial distribution  and targeting  of antimicrobial  effectors to L. pneumophila vacuoles in 
macrophages,  a process which  remains  poorly understood.  We adopted a functional  genetic screening 
approach to address this topic. Using shRNA in a murine  macrophage cell line,  we systematically 
perturbed each of 380 genes in a curated set of vesicle trafficking-related genes in mouse 
macrophages,  then assessed the growth of  L. pneumophila in resting and in IFNγ-stimulated  cells. 
Candidate genes were selected from the screen using  a robust computational method that accounts 
for the effects of each shRNA on host cell survival  and proliferation,  without relying  on a priori 
assumptions  about the relationship  between host cell number and bacterial growth. The screen 
enabled  the discovery  of candidate  L pneumophila host factors as well as of factors that mediate 
IFNγ-induced bacterial restriction. Eleven of 73 candidate host factors and 26 of 84 candidate  IFNγ 
pathway members were validated  in a secondary screen in primary murine  macrophages.  Functional 
assays of candidate proteins  in wildtype  macrophages, as well as bacterial restriction  assays in 
macrophages deficient in candidate genes, further refined the list of candidate IFNγ pathway genes. 
While our results are inconclusive,  the screen identified  the tetraspanin TSPAN6 and the AP3 
complex  as possible  elements  in vesicle trafficking  processes that restrict L. pneumophila in IFNγ-
activated macrophages.  Furthermore,  our studies demonstrated that VTI1B and ARL8B, two key 
members of trafficking  between endosomal  and lysosomal  compartments,  are not required  for IFNγ-
mediated bacterial restriction. 
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 INTRODUCTION 
Interferon gamma (IFNγ) can activate macrophages to kill  or restrict the growth of 
intracellular bacterial pathogens, including some that arrest phagosome  maturation  and replicate in 
resting macrophages. Although some events and entities in vesicle transport are known to affect 
phagosome maturation, some  significant gaps in knowledge  remain. First, there is a dearth of 
experimental  evidence linking  specific vesicle trafficking  events to targeting of the bacterial 
phagosome for  fusion with lysosomes, autophagy-related  proteins,  or other proteins or compartments 
involved in phagosome  maturation.  Second, the mechanisms by which IFNγ activation orchestrates 
vesicle trafficking  events at the phagosome are poorly  understood.  Existing  data indicate that IFNγ 
activation actually decreases lysosomal  targeting to the phagosome with the first two hours after 
phagocytosis,  and only cause an augmentative  effect two hours after phagocytosis  onwards [1]. 
However, experiments  with intracellular  bacteria such as Legionella pneumophila indicate that IFNγ 
stimulation  actually results in dramatic phagosome maturation within one hour of phagocytosis  [2]. 
The mechanism by which IFNγ overcomes  phagosome  maturation  arrest by L. pneumophila within 
the first hours after phagocytosis  is not known.  
The IFNγ-dependent  vesicle trafficking mechanisms  that have been described  so far include 
the targeting of GBP and IRG proteins  to phagosomal  compartments  and several effector actions of 
GBPs, especially  at vacuoles containing  the parasitic pathogen Toxoplasma gondii [3,4]. For 
instance, IRGM1 trafficks to mycobacterial  phagosomes in IFNγ –activated cells and inhibits 
phagosome maturation vacuoles in fibroblasts  arrest [5]. IRGM5,  IRGA6, and IRGB10 are involved 
in restriction of Chlamydia spp. [6,7] due in part to restriction  of host lipids  from the pathogen 
vacuole  [8]. T. gondii vacuoles were  shown to be disrupted in a process dependent on IRG proteins in 
IFNγ –activated fibroblasts  and macrophages, exposing  the parasite to the cytosol and enhancing 
clearance [9,10]. Meanwhile,  the GBP proteins, including  mouse GBP1-11,  have been implicated  in 
the IFNγ-dependent  recruitment of  autophagic machinery and phagocyte oxidase to mycobacterial 
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 phagosomes  [11], and in the recruitment  of IRGA6 to T. gondii vacuoles  [12]. However, the mouse 
IRG gene family  is reduced to a single,  non- IFNγ –activated gene in human cells [13], while  the 
human GBP system lacks four of the mouse GBP genes, and both families are thought to be 
attenuated in humans due to decreased evolutionary  pressure from T. gondii [14]. Meanwhile, the 
canonical  elements of phagosome maturation,  such as the maturity-defining  Rab proteins Rab5 and 
Rab7, have not yet been found to have a specific role in the context of IFNγ –dependent pathogen 
restriction.   
RNAi screening  has been used successfully  in the past to investigate both host-pathogen 
interactions  and vesicle trafficking  processes in  a high-throughput fashion. Recently, a genome-wide 
shRNA screen in human macrophage-like THP-1 cells identified  and validated six effectors of IFNγ-
mediated immunity to  the vacuolar pathogen Francisella tularensis, including  two mitochondrial 
membrane trafficking  mediators in the translocase of the outer membrane (TOM) complex [15]. 
Targeted screening of 36 genes encoding  Nod-like  receptor (NLR)-related  proteins in THP-1 cells 
infected with M. tuberculosis identified  a critical role for three genes in mounting  an inflammatory 
response to the mycobacterial  virulence factor ESAT6 [16]. Genome-wide  dsRNA screening in 
Drosophila macrophage-like S2  hemocytes  identified regulators of  endogenous  resistance to 
vacuolar  Chlamydia muridarum, while shRNA validation supported the  role of two of these factors 
in a  human cell line [17]. In mosquito  macrophage-like hemocytes, targeted dsRNA screening 
identified  innate immune factors involved  in the response to purified peptidoglycan ligands  and to 
phagocytosed  E. coli [18]. A study of primary human monocyte-derived  macrophages  (MDMs) 
infected with Mycobacterium bovis strain Bacille Calmette-Guerin  combined  chemical and genetic 
screening to  locate the significant  effector function of three drug candidates within  the host cellular 
pathways of endocytosis  and autophagy [19],  demonstrating  the potential  of screening approaches in 
illuminating our  understanding of  drug  targets. Multiple  screens have probed the innate immune 
response to viruses or to purified innate immune ligands, leading among others to the discovery of 
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 novel splicing  factors for the Toll-like  receptor adaptor MYD88 [20] and novel elements of the 
cytosolic  DNA sensing machinery  [21]. 
A number of RNAi screens have identified  host factors for intracellular  pathogens. Genome-
wide screening in human THP1 macrophage-like cells  identified autophagy-related  proteins as host 
factors for M. tuberculosis [22]. Genome-wide  siRNA screening in human epithelial  cell lines 
discovered new host factors for the vacuolar pathogen Salmonella typhimurium [23] and recovered 
several known host factors for the intracellular  parasite Trypanosoma cruzi [24]. Targeted siRNA 
screening identified  candidate host factors for Chlamydia trachomatis in a  human epithelial  cell line 
[25]. Genome-wide  dsRNA screening in Drosophila S2 hemocytes identified  host factors of the 
vacuolar  Mycobacterium fortuitum [26], S. typhimurium [27], F. tularensis [28], and Chlamydia 
caviae [29], while targeted screening yielded  candidate host factors for the vacuolar pathogens L. 
pneumophila [30], Brucella abortus [31], and Pseudomonas aeruginosa [32]. Two and three of the 
candidate  host factors of C. caviae and F. tularensis, respectively,  were additionally  validated in a 
human  cell line by siRNA [11,12]. 
Vesicle trafficking mechanisms have  also been successfully  investigated  using RNAi 
screening  as well. Three of eight genes identified  as mediators of bacterial phagocytosis  in a large-
scale random dsRNA screen in Drosophila S2 cells were  validated by siRNA in mouse macrophage-
like RAW264.7 cells [33]. Targeted screening in the J774A.1 mouse macrophage-like cell line 
discovered a common role for the small  GTP-binding  protein  in both complement  and FcR-mediated 
phagocytosis  [34]. A targeted dsRNA screen in C. elegans elucidated  mechanisms  of phagosome 
maturation  after engulfment  of apoptotic cells [35].  
  The existing  RNAi screen of IFNγ-induced restriction factors or  F. tularensis identified three 
hits related to vesicle trafficking,  including  two autophagy-related proteins as  well as  pleckstrin 2, an 
actin-organizing protein that  drives membrane ruffling. The study was performed  as a genome-wide 
pooled  screen, in which shRNA constructs are recovered from cells following transduction and 
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 phenotype assay, identified  by sequencing,  and classified  based on phenotype.  After sequencing of 
cells from this screen, 3386  shRNA constructs were recovered from a total of 50 thousand tested, 
indicating  that many false negatives remain to be discovered  [15]. In particular,  we were interested 
whether any other vesicle trafficking  mediators,  aside from autophagy-related proteins, could be 
involved  in targeting the early bacterial phagosome. 
A set of 380 mouse genes, curated by a consortium of laboratories including  ours, relevant to 
vesicle transport in diverse biological  contexts has been made available  as a screening resource 
through  the RNAi Consortium  [36–38]. We therefore used this set in an arrayed screen of IFNγ-
induced macrophage-intrinsic immunity to  L. pneumophila. Phagosome composition  is a 
fundamental  fate determinant  for this  bacterial  pathogen  [39], but it is readily sensitive to IFNγ-
mediated restriction.  A better understanding  of the re-routing  of vesicles in IFNγ-activated 
macrophages  would  illuminate our understanding  of the determinants  of bacterial restriction vs host 
subversion, and inform the  development of therapeutic regimens that combine antibiotics with 
immune  activators to address drug-resistant vacuolar pathogens. 
 
 
RESULTS 
 
Primary  RNAi screen in the RAWγNO macrophage-like cell line 
Quantitation of L. pneumophila in mouse macrophages  
In order to efficiently  quantitate the restriction  of L. pneumophila in macrophages,  we used 
strain LP02 delFlaA lux, a bioluminescent, flagellin-deficient thymidine auxotroph compatible with 
both low- and high-throughput  assays. The parent strain, the thymidine  auxotroph LP02, is avirulent 
in vivo [40]. Furthermore,  it lacks flagellin,  a deficiency  which has no effect on replication  in 
“permissive,” Naip5-mutant  A/J strain mouse macrophages,  but prevents NAIP5/NLRC3-dependent 
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 inflammasome activation  and pyroptotic host cell death in macrophages derived from mice bearing 
functional  NAIP5 alleles,  including  in C57BL/6J (B6) BMMs [41]. Finally,  this strain expresses the 
lux operon of Photorhabdus luminescens, in which the enzyme, substrate, and cofactors are 
transcribed under the constitutively  active ahpC promoter. These bacteria generate a signal  which is 
proportional to colony-forming unit (CFU) counts and enables the use of a non-endpoint assay  in 
which individual  wells can be read at repeated timepoints  using  a luminescence meter [42]. 
IFNγ-induced  activity  of nitric  oxide synthase 2 (NOS2) is partially  responsible for 
restriction of L. pneumophila in RAW264.7 murine macrophage-like cells [43]. Due to its magnitude, 
the NOS2-mediated  response in these cells could obliterate potentially  more subtle phenotypic 
effects induced by our genetic perturbations.  In order to mask the significant  effect of NOS2 and 
focus on pathways of interest, we used the RAW264.7 cell line derivative RAWγNO, which is 
deficient in NOS2 induction  [44].  
Stimulation of  RAWγNO macrophages with IFNγ for 24h before infection  with LP02 
delFlaA  lux restricts bacterial growth over the next 48h in a dose-dependent manner (Fig 2-1a). Over 
one hundred-fold  reduction  in signal  was observed in bacteria grown in cells treated with 100U/ml 
IFNγ compared to mock-treated cells, a robust difference that verifies the suitability  of RAWγNO 
host cells and the LP02 delFlaA lux strain of L. pneumophila as a model  system to investigate 
intracellular  bacterial restriction  in response to IFNγ . 
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Figure 2-1. Proof of concept for primary  screen 
a.  RAWγNO cells restrict L. pneumophila in an IFNγ–dependent manner. RAWγNO cells were 
seeded in 96-well plates,pre-stimulated with  IFNγ for 24h, and infected with bioluminescent 
L. pneumophila. Bioluminescence was measured using a  plate reader. 
b.  shRNA-based depletion  of JAK2 attenuates IFNγ–dependent bacterial restriction in 
RAWγNO cells. RAWγNO cells were  seeded in 96-well plates, infected with lentivirus 
encoding  shRNA targeting JAK2 transcript or with control  pGW lentivirus, selected with 
puromycin  for 2 days, pre-stimulated with IFNγ for 24h, and infected with bioluminescent  L. 
pneumophila. Bioluminescence  was measured  using  a plate  reader. 
 
Lentiviral knockdown of vesicle trafficking genes 
A proof-of-concept  experiment  of the primary screen showed that shRNA-based knockdown 
of JAK2, a key signaling  adaptor of the IFNγ pathway,  could  attenuate the IFNγ-dependent bacterial 
restriction  phenotype  in RAWγNO cells (Fig 2-1b).  
Arrayed screening was  performed using the mouse vesicle trafficking set and control 
shRNAs, both from the RNAi Consortium  [36]. Each gene is targeted by multiple  shRNA sequences 
(on average, 5 shRNAs/gene), and each shRNA sequence is delivered  in a single  lentiviral  construct 
[37,38].  RAWγNO cells were infected with lentivirus  in 96-well plates, using two replicate wells per 
construct. Two shRNA constructs targeting the positive  control JAK2 were included  as positive 
controls in the screen. Negative control genes were targeted by multiple  shRNA constructs (green 
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 fluorescent protein [GFP], 24 constructs; red  fluorescent protein [RFP], 10 constructs; β-
galactosidase [lacZ], 13 constructs; luciferase, 23 constructs). 1985 shRNA constructs were used in 
total.  
RNAi can affect cellular  survival  and proliferation  through both on-target and off-target 
effects. Changes in cell number  affect observed bacterial growth, as host macrophages are the 
substrate for bacterial expansion.  In order to allow normalization  based on the number of host cells 
for each plate in which bacterial luminescence was measured, we quantified  cell numbers  in a 
replicate  plate using  the fluorometric Alamar Blue assay.  
Cells were seeded in 96-well plates, infected with lentivirus, and selected with puromycin. 
For the bioluminescence  assay, RAWγNO cells were in solid-bottom  white 96-well plates (Fig. 2-
2a). Cells were infected with bioluminescent L. pneumophila and washed with PBS 2h after 
infection. Bioluminescence (bacterial growth) was measured at two timepoints  using  a plate  reader. 
For the Alamar Blue assay, cells were in clear-bottom black 96-well plates cells. Cells were 
incubated  with the Alamar Blue reagent and fluorescence (host cell number) was measured once 
using a plate reader.  
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Figure 2-2. Primary  screen schematic 
RAWγNO cells were seeded in duplicate  96-well plates, infected with lentivirus,  selected with 
puromycin,  and used in bioluminescence  and Alamar Blue assays. 
a.  In the bioluminescence  assay, shRNA-transduced  cells in white, solid-bottom 96-well plates 
were stimulated  with the indicated  concentrations  of IFNγ for 24h, then infected with 
bioluminescent  L. pneumophila. Bioluminescence  was measured at 1 and 2 days post-
infection  using a plate reader. In the Alamar Blue assay, shRNA-transduced  cells in black, 
clear-bottom  plates were incubated  with the Alamar Blue reagent for 8h, and fluorescence 
was measured using a plate reader. 
b.  After normalization  to cell number,  bioluminescence  measured at each timepoint  was used to 
identify  hits in the screen. In cells that were not treated with IFNγ, shRNA constructs that 
corresponded to low relative bacterial growth were  classified as candidate host factors. In 
cells that were treated with IFNγ at both concentrations,  shRNA constructs that corresponded 
to high relative bacterial growth were classified  as candidate IFNγ mediators. The residual  of 
the observed vs expected (based on the majority  of shRNAs) normalized  bioluminescence 
was used to calculate a fit score for each experimental  shRNA at each condition  and 
timepoint. 
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Primary screen data analysis pipeline 
We developed  an analysis pipeline  to pick hits from the screen in an unbiased  manner; this 
method can be generalized  to any screen where selecting hits based on one variable (eg, bacterial 
growth) needs to be normalized  to another variable (eg, cell number).   
Data were pre-processed prior to analysis. Bacterial growth (bioluminescence)  data from 
each timepoint  and cell count (Alamar Blue fluorescence)  data were independently quality-
controlled, log-transformed  and plate-normalized.  shRNA constructs with highly  variable replicate 
data were identified  using a custom MATLAB script and excluded.  Next, data were log-transformed 
in order to approximate  a normal distribution.  The data were then plate-normalized  to adjust for 
systematic error, replacing  each raw datapoint  with a robust z-score (RZ score) using the 
bioinformatics application RNAeyes  [45]. Replicate data for each shRNA construct were then 
combined  using the geometric mean (average of log-transformed  values) using RNAeyes.  
Next, we selected shRNA constructs that have a significant  effect on bacterial growth 
(bioluminescence) independent  of their effect  on cell growth (Alamar Blue fluorescence)  (Fig. 2-2b). 
Bioluminescence  RZ scores were therefore normalized  to Alamar Blue fluorescence  RZ scores for 
each batch, timepoint,  and condition,  using a custom script written in MATLAB. In short, a best-fit 
curve (Fig. 2-3a) was calculated to correlate the two types of data, using  a robust moving  average 
that is unaffected by outlier  data, extrapolates at the edges where data are sparse, produces a smooth 
curve, and is unbiased by assumption  of any particular mathematical  model  of correlation  between 
bacterial signal and cell count. The deviation  of each datapoint  from the fit-curve represents the 
effect of the corresponding  shRNA construct on bacterial growth, independent  of cell count. This 
deviation  was quantified  as a fit-score using the residual of each data point from the fit-curve divided 
by the standard deviation  of all residuals  from the curve (Fig. 2-2b).  
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Figure 2-3. Primary  screen data analysis pipeline 
a.  Best fit curves were calculated for each batch of screening data based on robust z-scores of 
bioluminescence  and cell number. Outliers were  identified  and removed, gaps introduced  by 
outlier removal were intrapolated,  edge values were extrapolated,  and the process was 
iterated until convergence. Details are described in the Methods section. 
b.  The converged best fit curve was smoothed  using the Lowess method,  and the fit-score of 
each shRNA construct was calculated as a normalized  residual of its datapoint  from the best 
fit curve. 
 
Data regarding knockdown  efficiency of shRNA constructs in Hepa cells were available from 
the RNAi Consortium  for 51% (1953) of the experimental  set. Of these, 63% (600) were classified  as 
“good” quality  data. We eliminated  from further analysis those shRNA constructs for which “good” 
quality  knockdown  data in Hepa cells was available  and indicated  poor knockdown efficiency, 
defined as  over 69% transcript remaining.   
 
Selection of candidate IFNγ pathway mediators from the primary screen  
Candidate  regulators or effectors of the IFNγ pathway were selected  by identifying  shRNA 
that increases bacterial signal  relative to host cell counts in the presence of IFNγ at the 2dpi 
timepoint.  In order to make the selection of hits more robust, we considered  independent data 
51 
 obtained using different IFNγ treatment conditions.  The main criterion  for selection was the fit score 
calculated from cells treated with a high  concentration of  IFNγ (100U/ml), with a strict  (high) 
threshold  (fit score >1.5) applied  to identify  the best hits. The intermediate  criterion  for selection  was 
the fit score calculated from cells treated with a low concentration of  IFNγ (10U/ml), with a lower 
threshold (fit score >1.2) applied  (Fig. 2-3a). The two fit scores generally  correlated with each other, 
but the secondary criterion  eliminated  several shRNA constructs which produced  inconsistent results. 
 
 
Figure 2-4. Primary  screen hit selection criteria 
Candidate  IFNγ mediators  were  selected on the basis of fit scores at both low and high 
concentrations  of IFNγ, both measured at the 2dpi timepoint.  Candidate L. pneumophila host factors 
were selected on the basis of fit scores from the 1dpi and 2dpi timepoints  only  in cells not treated 
with IFNγ. 
 
95 shRNA constructs satisfied both criteria and were classified as hits in the IFNγ pathway 
screen (Fig. 2-4, left), corresponding  to 84 genes. These candidates included  the positive  control 
JAK2 (main criterion fit score, 1.85), though surprisingly,  39 shRNA constructs yielded  stronger 
phenotypes. Another hit known to fall into the IFNγ pathway is PIK3R4 (main criterion fit score, 
2.1), a peptide in the regulatory  subunit  of phosphatidylinositol  3 kinase (PI3K). PI3K plays an 
important role in phagosome maturation because its product, phosphatidylinositol(3)phosphate, 
tethers the Rab5 effector early endosome antigen 1 (EEA1) at the early endosomal  membrane [46]. 
PIK3 has also been implicated  in the JAK2-independent  arm of the IFNγ response, and its inhibition 
52 
 leads to decreased transcriptional  changes in response to IFNγ [47]. In addition,  both subunits  of the 
key phagosome/endosome maturation protein RAB5 were classified  as hits, and the Rab5b subunit 
was represented by two different  shRNA constructs (main criterion fit scores: Rab5a, 1.75; Rab5b, 
1.86 and 1.95).  
Several known phagosome maturation-related  genes are notably absent among the genes 
classified  as hits. False negatives may be due to incomplete  knockdown.  For instance, all five shRNA 
constructs for EEA1 yielded  >94% transcript remaining  according to knockdown validation data in 
Hepa cells from by the RNAi Consortium. Also, compensatory pathways often make it difficult or 
impossible to yield a  significant  phenotype  through the depletion of  a  single gene transcript. Finally, 
some relevant genes, most prominently  members of the interferon-induced  GTPase (IRG) and 
autophagy-related  (ATG) gene families,  were simply  not present in the vesicle trafficking  set. 
However, the primary  screen confirmed  that it is possible  to discover genes  relevant to  IFNγ-
mediated bacterial killing  in mouse cells through arrayed genetic perturbation, and yielded  an initial 
list of candidate genes for continued  testing. 
 
Selection of candidate L. pneumophila host factors from the primary screen 
We were able to identify  candidate  L. pneumophila host factors by selecting  shRNA 
constructs that decrease bacterial bioluminescence  in the absence of IFNγ (Fig. 2-4, right). In this 
arm of the screen, we also selected hits based on two criteria. The main criterion  was the fit score 
calculated from observations  at the 2dpi  timepoint;  a  strict (low) threshold (fit score < -1.4) was 
applied to identify the best hits. The intermediate  criterion  was the fit score calculated from 
observations  at the 1dpi  timepoint;  a higher threshold (fit score < -1.1) was applied. For the 
intermediate  criterion in the first batch of the screen, a relaxed threshold was applied  (fit score <0.75) 
due to the high data variability  at this timepoint.  120 shRNA constructs satisfied both criteria and 
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 were classified as candidate  host factors. After removing  shRNAs with inconsistent  data over 
replicates, 87 candidates remained, representing 73 genes. 
Three genes were classified  as both candidate  IFNγ pathway members and as candidate host 
factors, representing  either false positives  or proteins that have dual modes of action  dependent on 
the IFNγ-induced  activation  status of the cell. For example, Dynamin 2 (DNM2), one of the dual hits, 
has been found to be required for phagocytosis  of antibody  or complement-opsonized particles, but 
not apoptotic  cells, by mouse macrophages  [48]. DNM2 is therefore a host factor since it is involved 
in bacterial internalization.  After phagocytosis  of apoptotic  cells, however, DNM2 is necessary for 
phagosome maturation, possibly playing a  role  in  recruitment of  Rab5  via  VPS34 in early 
phagosomes  [35]. DNM2 therefore acts as a restriction  factor as well as a host factor for bacterial 
growth.  
Some of the candidate host factors identified  have a known role in intracellular  survival and 
growth of L. pneumophila. The small  GTPases ADP-ribosylation factor 1 (ARF1) and secretion 
associated, Ras related GTPase 1 (SAR1) are important  L. pneumophila host factors, as  shown by 
experiments  in which overexpression  of dominant  negative form of either was associated with failure 
to recruit ER-derived membrane fragments to form a replicative  Legionella-containing vacuole 
(LCV) [49,50].  ARF1 and SAR1 regulate the coat protein I (COPI) and coat protein II (COPII)-
coated vesicles, respectively,  that are involved  in ER-Golgi transport [51]. Multiple shRNA 
constructs led to the classification  of SAR1 as a hit in the host factor screen, targeting  SAR1A (main 
criterion  fit score, -2.3), and SAR1B (-3.2 and -1.8). Likewise, the ARF1-related  ARF1 (main 
criterion  fit score, -1.7) and ARF-related protein 1 (ARFRP1) (-4.4), as well as the ARF-family 
member ARF3 (-2.8) and ARF4 (-3.1) were classified  as candidate  host factors as well. SEC22B 
(main criterion fit score: -2.1), another gene classified  as a candidate host factor, is a component  of 
the vesicle-associated  soluble N-ethylmaleimide-sensitive  factor attachment protein  receptor (v-
SNARE) on ER-derived vesicles [52], associates with LCVs in an ARF1 and SAR1-dependent 
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 manner,  we can discover bacterial host factors and is functionally  important  for L. pneumophila 
replication in macrophages  [53]. Therefore, the host factor arm of the screen in RAWγNO cells 
reconstituted  known host factors as well as identifying  new candidates. 
 
Confirmation  of hits in a secondary screen using primary  mouse macrophages 
  shRNA constructs that were classified  as hits in either the IFNγ or host factor screen were 
validated  in C57BL/6J  (B6) mouse bone-marrow derived macrophages (BMMs), in order to exclude 
candidate genes that may only be relevant in the context of a cell line.  
First, we re-tested the ability  of L. pneumophila strain LP02 delFlaA lux to grow in BMMs, 
the ability of  IFNγ-stimulated  BMMs to restrict intracellular  L. pneumophila, and the potential  of 
shJak2 lentiviral  transduction  to overcome IFNγ-based growth restriction.  We found that stimulation 
of a concentration  of IFNγ (10U/ml) lower than that used in the primary screen (100U/ml)  provided 
the greatest differentiation  between cells transduced with shJak2 and those transduced with the 
shGFP control  (Fig. 2-5). There are three possible explanations  for the discrepancy in stimulation 
conditions between  RAWγNOcells and BMMs. First, the knockdown  of JAK2 transcript may be less 
complete in BMMs than in RAWγNOcells,  so that less IFNγ signaling  is required to obtain a 
threshold  level of activity.  Second, BMMs may be more sensitive to IFNγ signaling  via residual 
JAK2 protein  remaining after  incomplete  shRNA-mediated  knockdown. Third, the JAK2-
independent  IFNγ signaling  pathway may be more active in BMMs than in RAWγNOcells.  
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Fig. 2-5. Proof of concept for secondary screen 
WT BMMs cells restrict L. pneumophila in an IFNγ–dependent manner, and shRNA-based depletion 
of JAK2 attenuates IFNγ–dependent bacterial restriction  in RAWγNO cells.  
 
We tested 275 shRNA constructs in total, targeting 84 IFNγ pathway candidates and 73 L. 
pneumophila host factor candidates  from the primary screen, as well  as the negative control genes 
(GFP, RFP, lacZ, luciferase), and the positive  control Jak2. In order to account for potentially 
differing  effects of shRNA on cell survival  or proliferation  under different conditions  of stimulation, 
the Alamar Blue assay was performed for both resting and IFNγ-stimulated cells.  
In resting BMMs (Fig. 2-6a), shRNA-mediated  depletion  of many host-factor candidate gene 
transcripts (blue) decreases bacterial growth  relative to controls  (black). Interestingly,  in most cases, 
depletion  of most host factors does not decrease bacterial growth relative to controls  in IFNγ-
activated cells (Fig. 2-6b), perhaps because the strong effect of IFNγ-mediated restriction obscures 
restriction  due to depletion  of host factors. Because the number of shRNA constructs tested in the 
secondary screen was limited,  we classified candidate host factors as validated  by hand, based on 
data in resting cells (Fig. 2-6a). 
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Figure 2-6. Candidate  host factors validated in the secondary screen 
WT BMMs were lentivirally  transduced with shRNAs classified  as hits in the primary screen, as well 
as control shRNAs. Only hits classified  as candidate host factors are shown. Cells were  infected with 
bioluminescent  L. pneumophila and bioluminescence  was measured  at 2dpi. In a simultaneous  assay, 
cell counts were measured using the Alamar Blue assay. Bacterial growth (bioluminescence)  was 
log-transformed  and plotted against cell counts (Alamar Blue) for assays done in IFNγ-stimulated (a) 
or resting (b) cells. Hits classified  as validated  are labeled with gene symbols. 
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 Depletion  of most IFNγ pathway candidate gene transcripts  (red) enhances bacterial growth 
relative to controls (black) in the presence of IFNγ (Fig. 2-7b) but not in resting cells (Fig. 2-7a), 
indicating  that restriction  of L. pneumophila mediated by these candidates is IFNγ-specific.  This is 
reflected in relatively  higher ratios of log-transformed luminescence data  in  IFNγ treated vs untreated 
BMMs (Fig. 2-7c) compared to control and candidate host factor shRNA constructs.  
 
 
Figure 2-7. Candidate  IFNγ mediators validated in the secondary screen 
Screening was performed as  in Fig. 2-6. Only hits classified as candidate IFNγ mediators  are shown. 
host factors are shown. Bacterial growth (bioluminescence)  was log-transformed  and plotted  against 
cell counts (Alamar Blue) for assays done in IFNγ-stimulated (a) or resting (b) cells. In (c), the log-
transformed ratio of bioluminescence in IFNγ-stimulated  vs resting BMMs is plotted  against the ratio 
of cell count data. Hits classified  as validated  are labeled  with  gene symbols. 
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 Candidate L. pneumophila host factors validated in the secondary screen 
  Among  candidate L. pneumophila host factors (Table 2-1), none of the constructs targeting 
the ARF genes, SAR1B, or SEC22 was validated.  Redundancy in the ARF gene family  has 
previously  been implicated  in the lack of phenotypic changes in single-gene  RNAi assays, and 
double  knockdown  of any two ARFs was required to induce changes in membrane trafficking  in a 
human epithelial  cell line [54]. The classification  of ARF genes as candidate host factors in the 
primary screen with RAWγNO cells was either a false positive,  or reflects biological  differences 
between RAWγNO cells and BMMs. 
 
 
Table 2-1. Candidate host factors validated in the secondary screen 
 
Novel candidate host factors identified  in the secondary screen include  sorting nexin 12 
(SNX12),  and sorting nexin 18 (SNX18),  both members of  the sorting nexin family of endosomal 
sorting proteins [55]. Like all sorting  nexins, they contain a phox homology  (PX) domain  that binds 
membrane phosphoinositides. Like many sorting nexins, they also contain a Bin–Amphiphysin–Rvs 
(BAR) domain that can function  in both sensing and induction  of membrane curvature [56,57]  and 
mediates key functions  of endosome maturation [58]. Interestingly,  recent data are consistent with a 
role for SNX12 in endosome maturation arrest by preventing  the conversion  of these early vesicles 
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 into partially mature  multivesicular bodies [59]. SNX18  participates in the budding of  tubules at 
membranes  enriched in PI(4,5)P2, which is characteristic of late endosomes  [60]. Therefore, SNX12, 
and SNX18  are candidate  L. pneumophila host factors in murine macrophages, possibly  through 
limiting  the tubulation  and/or delivery  of late endosomes to the LCV. 
 
Candidate IFNγ effectors or pathway  members identified in the secondary screen 
Among the ~26 genes confirmed  as hits in the secondary RNAi screen (Table 2-2), we used 
literature curation to select a list of ~15 genes most likely  to satisfy the primary hypothesis:  that the 
candidate is involved in targeting vesicles to  the early bacterial phagosome downstream of IFNγ 
stimulation.  This processed involved  excluding  genes that were likely  to play a role in lysosome 
biogenesis or phagocytic  uptake of bacteria. Among the remaining  candidates,  we selected seven for 
further analysis based on consistency of phenotype  and biological interest (TSPAN6, SNAP29, 
SNAP47, HSPA8, VTI1B, ARL8B, AP3S1).  
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Table 2-2. Candidate  IFNγ mediators validated in the secondary screen. 
Proteins with described roles in endocytosis, ER-Golgi transport, secretion, or lysosomal biogenesis 
are noted; these were excluded from the final candidate list. 
 
TSPAN6 
Tetraspanin 6 (TSPAN6), a member of the poorly described tetraspanin family of membrane 
proteins,  was a significant  hit  in the IFNγ pathway  screen. Two shTspan6  constructs were associated 
with a significant  increase in bacterial growth in IFNγ-activated  cells compared to cells transduced 
with control shRNA. Inspection  of the shRNA sequences revealed that the two hit constructs overlap 
by all but one nucleotide,  and are therefore essentially  equivalent.   
We first attempted to validate the shRNA-mediated  depletion  of Tspan6 mRNA in 
RAWγNOcells. The first two sets of PCR primers tested did not detect Tspan6 transcript in these 
61 
 cells. We generated an additional  ten primer sets and tested them in BMMs, RAWγNO cells, and 
mouse organ lysates in spleen, liver, and lung. All primers tested detected Tspan6 transcript in 
primary cells (BMMs and organ lysates). Only four primer sets detected transcript in RAWγNO 
cells,  consistent with a mutation or splice variant of Tspan6 in RAWγNO cells.  
Using the four qPCR primers common to both RAWγNO cells and primary cells, expression 
of Tspan6 mRNA was quantified in shTpan6-transduced  cells. Results were highly  variable,  with 
25%-80% transcript remaining,  depending on  which primer sets were used and on whether the cells 
were resting or IFNγ-stimulated.  The low levels of signal indicating Tspan6 transcript levels detected 
by qPCR were concerning  for a low signal-to-noise  ratio, so we proceeded to Tspan6 knockdown 
validation  at the post-translational level. Western blotting  confirmed  the depletion  of TSPAN6 in 
RAWγNOcells (Fig. 2-8a). 
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Figure 2.8. Validation  of candidate IFNγ mediator TSPAN6 
a.  Western blot analysis of TSPAN6 expression in RAWγNO cells transduced with shTspan6 
constructs classified as  hits in the primary screen (shTspan6-1, shTspan6-2)  or control 
shRNAs and mock-stimulated  (left) or stimulated with IFNγ (right) for 24h. 
b.  Western blot analysis of TSPAN6 expression in WT BMMs transduced with shTspan6, 
including  seven additional  shRNAs not tested in the primary screen, or control shRNAs. 
c.   IFNγ-induced  restriction of  L. pneumophila in WT BMMs transduced with shTspan6-2  and 
positive (shStat1, shJak2) and negative control shRNA. Restriction  is calculated as the ratio 
of bioluminescence  in resting vs IFNγ-stimulated cells.  
d.  Alamar Blue assay of WT BMMs corresponding  to data in (c) 
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 Because each shRNA construct is associated with unique off-target effects, eight additional 
shRNAs targeting  Tspan6, unrelated in sequence to the original  five tested in the screen, were 
obtained  from the RNAi Consortium. Two of these constructs (shTspan6-H1, H3)  were selected 
based on TSPAN6 depletion  in  BMMs by Western blot (Fig. 2-8b). This experiment tested the two 
shRNA constructs (shTspan6-1, 2) used in the primary screen as well. Surprisingly,  despite the nearly 
complete sequence overlap between shTspan6-1 and shTspan6-2, shTspan6-1 did not reduce TSPAN6 
expression in BMMs and was not used in further studies. Transduction with shTspan-1, shTspan-H1, 
shTspan-H3 significantly  reduced the IFNγ-mediated  restriction  of L. pneumophila in BMMs when 
compared with controls (Fig. 2-8c), in cells stimulated at  either 10 U/ml or 100U/ml  of IFNγ. 
However, the new shRNA constructs shTspan6-H1 and shTspan6-H3 also led to a dramatic increase in 
cell counts (Fig. 2-8d), a phenotype observed with shTspan6-1 in the primary screen as well. 
To determine  whether TSPAN6 expression  is regulated  by IFNγ, we prepared Western blots 
using  lysates from RAWγNOcells  treated with IFNγ at a series of timepoints.  IFNγ treatment induced 
the expression of TSPAN6 within  4 hours of stimulation  (Fig. 2-9a). However, neither IFNγ 
stimulation nor  L. pneumophila infection affected the expression  of TSPAN6 in BMMs. 
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Figure 2-9. Functional characterization of candidate IFNγ mediator TSPAN6 
a.  Western blot analysis of TSPAN6 in  RAWγNO cells following  treatment with IFNγ  
b.  Immunofluorescence  analysis of TSPAN6 in RAWγNO cells stimulated  with IFNγ, infected 
with GFP-expressing  L. pneumophila, and fixed at 30min after infection  reveals colocalization 
of TSPAN6 with L. pneumophila phagosomes. LAMP1 is used as a counter-stain. 
c.  Flow cytometry analysis of the uptake of GFP-labeled  beads (left) and LAMP1 
immunofluorescence  (right) in IFNγ-stimulated  RAWγNO cells transduced with shTspan6-2 
or control shRNA.  
   
IFNγ mediator  proteins  can impact vesicle trafficking  at the LCV either directly,  by 
physically interacting with  bacterial phagosomes, or  indirectly. We used GFP-expressing  L. 
pneumophila and immunofluoresecence  microscopy  to determine  whether TSPAN6 colocalizes  with 
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 bacterial phagosomes,  and whether this localization  is dependent on IFNγ. Immunofluorescence 
staining  of TSPAN6 in RAWγNO reveals a punctate  cytosolic  pattern. RAWγNO cells infected with 
GFP-labeled,  flagellin-deficient  L. pneumophila strain LP02 delFlaA pAM239 [61] were fixed at 
0min, 30min,  1hr, 2hr, and 4hr after infection,  and stained with antibodies  to TSPAN6 and LAMP1, 
a lysosome/late endosome marker protein that accumulates on maturing  phagosomes.  Surprisingly, 
TSPAN6 colocalized with LCVs at 30min  after infection  in IFNγ-stimulated  cells (Fig. 2-9b). 
LAMP1 was not recruited to LCVs at this time. Colocalization  was not observed at other timepoints, 
nor in resting cells. We were able to confirm this result in one but not two more repetitions  of the 
experiment.  Thus, we conclude that the potential  association of  TSPAN6 with the LCV is transient 
and possibly  dependent on IFNγ stimulation. 
An alternative hypothesis to explain  the increase in bacterial growth in shTspan6-transduced, 
IFNγ-stimulated cells is that TSPAN6 enhances phagocytic  uptake in an IFNγ-dependent manner. 
We used flow cytometry to analyze IFNγ-stimulated  RAWγNOcells  that had been incubated with 
fluorescently  tagged latex beads, then washed with Trypan blue to quench fluorescence of free or 
surface-attached bacteria or beads. No significant  difference was noted among the fluorescence 
intensity distributions of cells transduced with control shRNA or shTspan6-1  (Fig. 2-9c, left). These 
results suggest that enhanced bacterial uptake was  not responsible  for increased bacterial growth in 
shTspan6-transduced,  IFNγ-stimulated cells. We note, however, that phagocytic  capability  is cargo-
dependent, and beads may not provide phagocytes with relevant activation signals.  
Another alternative hypothesis to explain the phenotype observed in TSPAN6 can explain 
decreased IFNγ-induced  bacterial restriction  was a defect in lysosomes  and other compartments  that 
phagosomes  must fuse with in order to mature, rather than a defect in proper trafficking  of these 
organelles  to the phagolysosomal  compartment. We used flow cytometry to quantify  the staining 
intensity  of LAMP1 as a proxy for lysosomal  density.  LAMP1  staining distribution was  equivalent  in 
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 cells transduced with control shRNA and with shTspan6 (Fig. 2-9c, right), which suggests (but does 
not prove) that TSPAN6 does not play a role in lysosomal  biogenesis. 
    
SNAP29 
The SNAP29 protein  is a member of the SNAREs family  of proteins  that form connections 
between the membranes of fusing intracellular  vesicles. SNAP29 plays a  role in endocytic recycling 
in fibroblasts [62] and the lipid-  loading  and membrane fusion of lamellar granules in the epidermis 
[63,64]. A recent study of SNAP29 in phagocytic immune cells (mouse BM-derived mast cells and a 
rat basophil  cell line) found that native Snap29 was transiently recruited to E. coli phagosomes 1-3 
hours after infection,  and overexpression of SNAP29 accelerated the killing  of phagocytosed bacteria 
[65]. The Snap29 gene is one of several genes disrupted in the rare neurocutaneous  syndrome  cerebral 
dysgenesis, neuropathy, ichthyosis and  keratoderma  (CEDNIK) [63,66],  but symptoms  of 
immunodeficiency  have not been observed in CEDNIK patients (E. Sprecher, personal 
communication).   
Depletion of  SNAP29 transcript in BMMs was confirmed  using qPCR (19-70% transcript 
remaining).  Analysis  of protein expression  level of SNAP29 showed that shRNA-mediated  depletion 
of SNAP29 protein  in RAWγNOcells  was transient; after a fourfold  reduction  in transcript at 5d after 
lentiviral infection, protein expression was restored 6d after lentiviral  infection  (Fig. 2-10a).  
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Figure 2-10. Validation and functional characterization of candidate IFNγ mediator SNAP29 
a.  Western blot analysis of SNAP29 levels in RAWγNO cells lysed at the timepoints  indicated 
after lentiviral  transduction  with shSnap29,  or at 5d after transduction  with control shRNAs 
(left). SNAP29 levels were normalized  to β-actin levels (right). 
b.  Growth  curves of bioluminescent  L. pneumophila in RAWγNO transduced  with shSnap29, 
the negative control  shLacZ or the lentiviral  vector pLKO, or the positive  control shStat1, 
and stimulated  with the indicated  concentration  of IFNγ prior tobacterial  infection. 
c.  Western blot analysis of SNAP29 levels in RAWγNO cells following  stimulation  with IFNγ 
and lysed at the timepoints  indicated. 
d.  Flow cytometry analysis of the uptake of GFP-labeled  beads (left) and LAMP1 
immunofluorescence  (right) in IFNγ-stimulated  RAWγNO cells transduced with shSnap29  or 
control shRNA.  
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 To determine whether SNAP29 expression  is regulated  by IFNγ, we prepared Western blots 
using  lysates from RAWγNOcells  treated with IFNγ at a series of timepoints.  IFNγ treatment induced 
the expression of SNAP29 within  4 hours of stimulation  (Fig. 2-10c),  similar to results obtained with 
TSPAN6 expression  following  stimulation.   
Also similar  to results with depletion  of TSPAN6, depletion  of SNAP29 using  shRNA did 
not affect the uptake of fluorescent  beads or the expression  of LAMP1 in IFNγ-stimulated cells 
relative to cells transduced with control shRNA (Fig. 2-10d). Based on these results, our collaborator 
pursued the study of SNAP29 using macrophage-conditional  SNAP29
-/- mice. 
  While germline  SNAP29 deficiency  is embryonic  lethal, a recently created macrophage-
conditional  SNAP29 deletion mutant  enabled the direct testing of the requirement  for SNAP29 in 
IFNγ-induced bacterial restriction.  However, growth of  L. pneumophila in resting and IFNγ-activated 
SNAP29-deficient  BMMs was equivalent  to growth in WT BMMs (J.  Coers, personal 
communication),  indicating  that SNAP29 is dispensable  in not required for this process.  
 
SNAP47 
  SNAP47 is a ubiquitously  expressed SNARE protein of unknown function  [67]. qPCR was 
used to validate SNAP47 transcript depletion  in BMMs, with 7-16% transcript remaining after 
lentiviral transduction and  selection. Western blotting  showed partial  shRNA-mediated  depletion  of 
Snap47  protein in RAWγNO cells (Figure 2-11a).  
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Figure 2-11. Validation  and functional  characterization of candidate IFNγ mediator SNAP47 
a. Western blot analysis of SNAP47 expression in RAWγNO cells transduced with shSnap47 or 
control shRNAs and mock-stimulated (left) or stimulated with  IFNγ (right) for 24h. 
b.  Flow cytometry analysis of the uptake of GFP-labeled  beads (left) and LAMP1 
immunofluorescence  (right) in IFNγ-stimulated  RAWγNO cells transduced with shSnap47  or 
control shRNA.  
 
 
  We next examined  whether alternative  hypotheses could explain the  increased bacterial 
growth in shSnap47-transduced,  IFNγ-activated macrophages. Surprisingly, depletion  of SNAP47 by 
shRNA increased the uptake of fluorescent beads  relative to two controls  and to shJak2 (Fig. 2-11b, 
left). Notably,  transduction  with the pLKO control lentivirus  similarly  increased bead phagocytosis, 
with a significantly  higher fraction of cells taking  up three or more beads than cells transduced with 
shRFP, shGFP, or shJak2. Therefore, SNAP47 is a  candidate inhibitor  of phagocytosis. 
  Furthermore, shSnap47-transduced  cells produced significantly  more LAMP1 (Fig. 2-11b, 
right) than controls, suggesting derangement of the endolysosomal  network in SNAP47-depleted 
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 cells. Together, these data suggest profound effects  of SNAP47 on vesicle trafficking throughout the 
phagolysosomal network. 
 
VTI1B 
  The SNARE protein vesicle transport through interaction  with t-SNAREs 1B (VTI1B) and its 
binding partner  syntaxin  8 (STX8),  both candidate members of the IFNγ-microbial restriction 
pathway in the screen, participate  in a SNARE complex  involved  in late endosome-lysosome fusion 
in many cells, including  macrophages  [68,69].  We hypothesize  that this complex  may be involved  in 
IFNγ-dependent targeting  of lysosomal  contents to the LCV, since LCVs acquire lysosomal  markers 
in IFNγ-stimulated,  but not resting macrophages [2].  
  Macrophages stimulated  by LPS increase VTI1B expression,  and release the cytokine  TNFα 
in a vesicle trafficking  process that requires VTI1B [70]. The requirement for VTI1B in the context 
of IFNγ stimulation  has not been studied. However, TNFα is known to synergize  with IFNγ-activated 
STAT1 homodimers  at the promoters of key IFNγ-activated sequences (GAS) in the promoters of 
innate immune  effectors such as NOS2 [71], suggesting  that proteins such as VTI1B that facilitate 
TNFα signaling  may play a positive role in the IFNγ response.  
  In addition, previous  work in human epithelial  cells has suggested a critical role for VTI1B in 
bacterial  killing, showing that siRNA-mediated depletion of  VTI1B suppressed the fusion  of 
bacterial autophagosomes with lysosomes cells infected with Group A Streptococcus [72]. 
Intriguingly,  domain analysis suggests that the VTI1B SNARE complex may be a target of the L. 
pneumophila secreted  effector protein IcmG, which contains a  cognate SNARE domain [73]. A 
previous study that tested this hypothesis  found that purified IcmG blocked  the fusion of liposomes 
bearing  VTI1B/STX7/STX8 SNARE  complexes with  liposomes bearing the cognate SNARE 
VAMP8 [73].  
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 We tested the hypothesis  that VTI1B is required for IFNγ-induced restriction of  L. 
pneumophila directly,  using  Vti1b
-/-,  Vti1b
-/+, and WT mouse BMMs [74]. IFNγ-induced  bacterial 
restriction  increased, rather than decreased in Vti1b
-/-  BMMs compared to WT and Vti1b
-/+ BMMs 
(Fig. 2-12a). Therefore, VTI1B is not required for efficient restriction  of L. pneumophila in response 
to IFNγ, contrary to what we expected from data in the primary and secondary screen.  
 
 
Figure 2-12. Validation  of candidate IFNγ mediator VTI1B 
a.  IFNγ-induced  restriction of  L. pneumophila in WT, Vti1b
-/+, and Vti1b
-/-  BMMs. Restriction 
is calculated as the ratio of bioluminescence  in resting vs IFNγ-stimulated cells.  
b.  IFNγ-induced  restriction of  L. pneumophila in WT, Vti1b
-/+, and Vti1b
-/-  BMMs transduced 
with shVti1b, or with positive (shStat1),  and negative control  shRNA, selected with 
puromycin, and  stimulated with  IFNγ at the indicated  concentrations  for 24 prior to bacterial 
infection.  Restriction  is calculated as the ratio of bioluminescence  in resting vs IFNγ-
stimulated cells, measured at 42hpi.   
 
In order to determine why transduction  with shVti1b decreases IFNγ-induced  bacterial 
restriction,  we subjected Vti1b
-/-,  Vti1b
  -/+, and WT BMMs to treatment with shVti1b or control 
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 shRNA. Following  puromycin  selection and mock-stimulation  or stimulation  with  IFNγ, BMMs were 
infected with bioluminescent L. pneumophila. IFNγ-mediated bacterial restriction was  quantified as 
the ratio of measured bioluminescence  in resting vs IFNγ-stimulated  BMMs at each condition  and 
timepoint. We found that transduction  with shVti1b decreases bacterial restriction  in BMMs of all 
genotypes  (Fig. 2-12b). Therefore, we conclude  that the phenotype observed in cells transduced with 
shRNA targeting Vti1b was caused by an off-target effect of the shRNA, rather than an effect of 
VTI1B depletion.   
 
 
ARL8B 
  ARL8B is a regulator of lysosomal  transport along microtubules [75,76],  and was recently 
found to indirectly  affect the trafficking  of phagocytosed  Escherichia coli to the lysosome  in 
RAW264.7 cells by recruiting  members of the homotypic fusion and vacuole protein sorting (HOPS) 
complex  [36]. ARL8B is thought  to be recruited by S. typhimurium, which proliferates in acidic 
phagolysosomes,  to facilitate movement  toward the cell periphery [77]. 
We obtained bone marrow from two independently derived  strains of ARL8B-deficient mice, 
Arl8b
-/-(MMRRC)  and Arl8b
-/-(RRP119),  in order to directly  test the hypothesis  that ARL8B-mediated 
vesicle trafficking  events are involved in  IFNγ-induced  restriction of  L. pneumophila. Using BMMs 
from Arl8b
-/-(RRP119)  and Arl8b
-/+(RRP119) mice,  we did  not observe  a significant  difference  in IFNγ-
dependent restriction  of L. pneumophila compared to WT BMMs stimulated with either 10U/ml or 
100U/ml IFNγ (Fig. 2-13a). We did,  however, observe a decrease in IFNγ-induced  restriction of  L. 
pneumophila by Arl8b
-/-(MMRRC)  BMMs relative to WT BMMs, especially  in BMMs stimulated  with 
10U/ml  IFNγ (Fig. 2-13b).  
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Figure 2-13. Validation  of candidate IFNγ mediator ARL8B 
Bacterial restriction  is calculated as the ratio of Alamar Blue-normalized  bioluminescence  in resting 
vs IFNγ-stimulated  cells at the concentrations  of IFNγ and timepoints  indicated. 
a.  IFNγ-induced  restriction of  L. pneumophila in WT, Arl8b
-/+(RRP119), and Arl8b
-/-(RRP119) 
BMMs.  
b.  IFNγ-induced  restriction of  L. pneumophila in WT and Arl8b
-/-(MMRRC)  BMMs.  
c.  IFNγ-induced  restriction of  L. pneumophila in WT, Arl8b
-/+(MMRRC), and Arl8b
-/-(MMRRC) 
BMMs transduced with shArl8b or negative (pLKO, shLacZ) or positive (shStat1, shJak2) 
control shRNAs, selected with puromycin, and stimulated  with IFNγ at the indicated 
concentrations  for 24 prior to infection  with L. pneumophila 
 
In a second  experiment  with Arl8b
-/-(MMRRC)  BMMs as well as with Arl8b
-/+(MMRRC) BMMs,  cells 
were transduced with shRNA targeting  ARL8B transcript or positive  or negative controls,  in order to 
assess whether the phenotype  observed in the secondary screen was a result of shRNA-specific off-
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 target effects. In this experiment,  we did not observe a significant  difference in IFNγ-induced 
restriction of  L. pneumophila among genotypes (Fig. 2-13c). The restriction  induced by stimulation 
with 100U/ml  IFNγ observed in cells transduced with shArl8b was comparable to restriction  in cells 
transduced with the positive  control  shJak2 and nearly two-fold  less than in cells transduced with 
negative control shLacZ, regardless of host genotype.  It is not clear why the initial phenotype 
obtained with Arl8b
-/-(MMRRC)  BMMs did not reproduce; one possibility  is an interaction  of lentiviral 
infection  in general that renders ARL8B redundant  for IFNγ-mediated bacterial restriction and . 
These results suggest an off-target effect of the shArl8b construct that produced a hit in the screen. 
 
AP3S1 
Finally,  we tested the candidate AP3S1 indirectly, by using BMMs derived from mice 
deficient in the essential AP3 complex member AP3B1. The AP3 complex,  thought to reside on the 
cytosolic  face of lysosomes,  plays a role in the delivery  of protein  cargo to lysosomes,  the biogenesis 
of lysosome-related organelles  [78,79]  and in the activation  of TLR4 signaling  from phagosomes  in 
dendritic cells [80]. While AP3S1 was classified  as a hit in the primary  and secondary screens, three 
distinct  shRNA constructs targeting the AP3 complex  subunit  AP3S2, as well as one shRNA 
targeting subunit AP3M2, were  selected as candidates in the primary screen, prompting  us to carry 
out a more complete investigation  of the function  of the AP3 complex  in primary  cells.  
In three independent  experiments  using three pairs of WT and KO mice, we observed  a 
significant defect in IFNγ-induced  bacterial restriction in Ap3b1
-/-  BMMs. In BMMs stimulated  with 
10 U/ml  IFNγ, AP3B1 deficiency led to a tenfold  decrease in bacterial restriction  capacity (Fig. 2-
14a), though the phenotype  was not significant  when 100 U/ml  IFNγ was used. We assume that full 
activation invokes pathways of  bacterial restriction independent of  AP3. The phenotype  did not 
change when bacteria were opsonized  by either IgG or mannose-binding  lectin (MBL) instead of the 
regular serum proteins present in culture media (Fig. 2-14a, b), suggesting  that the relevant action of 
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 AP3 was independent  of phagocytic  receptors. However, in two following  experiments using 
independent  pairs of WT and KO mice, we were surprised to  find no defect in IFNγ-induced bacterial 
restriction in Ap3b1
-/-  BMMs over a range of IFNγ concentrations. 
 
 
 
Figure 2-14. Validation  of candidate IFNγ mediator AP3B1 
a.  IFNγ-induced  restriction of  L. pneumophila opsonized in serum (regular), IgG, or  MBL in 
WT and Ap3b1
-/-  BMMs. Restriction  is calculated as the ratio of bioluminescence  in resting 
vs IFNγ-stimulated cells at 30hpi.   
b.  Growth curves of L. pneumophila corresponding  to the experiment  in (a) 
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 DISCUSSION 
Our goal was to use a targeted RNAi screen to illuminate  vesicle trafficking mechanisms that 
facilitate bacterial restriction in IFNγ-activated macrophages. We used a high-throughput screening 
protocol  to assess the effect of 1985 lentiviral  shRNA constructs on cell count and on bacterial 
growth in resting and IFNγ-stimulated  RAWγNOcells. In order to normalize  bacterial growth to cell 
counts under each condition,  we developed a  generalizable  computational  method that was robust to 
outliers,  imputed  missing  data points,  and was independent  of assumption  bias that would otherwise 
be  introduced using a  regression model. 82 shRNA constructs classified as hits in the RAWγNO 
screen were tested in a secondary screen in primary  macrophages as well.  
Because bacterial growth was measured in resting as  well as IFNγ-stimulated cells for every 
shRNA tested, analysis  of the data in resting cells alone constituted  a screen-within-a-screen that 
allowed us to predict host factors required for growth of L. pneumophila in RAWγNOcells.  
To discover gene products that may be involved,  we performed a primary screen in mouse 
RAWγNO macrophage-like  cells. Using RNAi, we perturbed each of 380 genes in a curated set of 
vesicle trafficking-related  genes, and then assessed the ability  of these cells to respond to IFNγ by 
restricting  the intracellular replication of  L. pneumophila.  Several hits from this screen were verified 
in a secondary screen in primary  mouse macrophages. Recent work has focused on identifying  1-2 
hits most likely  to satisfy the primary hypothesis  that the candidate is involved  in targeting vesicles 
to the early bacterial phagosome downstream of IFNγ stimulation.  We have also begun to rule out 
several alternative  hypotheses to explain  the observed IFNγ-dependent  effect of hit genes on the 
bacterial phagosome.  
To elucidate the relevance of these and other vesicle trafficking  proteins suggested by our 
screen to IFNγ-mediated maturation of  the bacterial phagosome in primary cells, we  performed a 
secondary screen in BMMs of B6 mice. B6 BMMs have iNOS machinery,  unlike  the RAWγNOcells 
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 used in the primary  screen. However, B6 BMMs do not require production  of NO for restriction  of L. 
pneumophila in vitro [82]. 
  TSPAN6 emerged  as a prominent  candidate. A  relatively tiny protein (27.3kD), Tspan6 – like 
the other tetraspanins – likely functions  via interactions with other proteins, likely  through 
organization  of membrane surfaces [83–85]. Therefore, it will be crucial to identify the binding 
partners of Tspan6 on the membranes of phagosomes,  endolysosomal  vesicles, or other vesicles,  and 
to identify  the dependence and nature of the  interactions on  intracellular bacterial infection and  IFNγ 
stimulation.   
  The tetraspanin CD37 interacts with the Dectin-1 PRR and regulates production  of IL-6 in 
macrophages  [86], an effect that may be relevant in intracellular  infections  with the vacuolar parasite 
Toxoplama gondii [87]. A recent paper providing  the only published  data on TSPAN6 function  so far 
suggests a role for this candidate in antiviral  innate immunity  [88]. The authors use overexpression 
and siRNA silencing  of human  Tspan6 transcript in 293T cells transfected with  IFNβ, NFκB or 
interferon-sensitive response element (ISRE) antiviral  response reporter constructs. TSPAN6 was 
found to be ubiquitinated  upon  MAVS activation,  to localize  to mitochondria,  bind  MAVS and inhibit 
its  interaction  with STING and the downstream effectors TRAF3 and IRF3. 
The relevance of these findings  to our work with TSPAN6 depends on whether the results 
extend to murine  macrophages,  and on the role of MAVS in both the macrophage-autonomous 
(IFNγ-independent)  and the IFNγ-mediated response to L. pneumophila. It is possible  that nucleic 
acid sensors are activated by bacterial infection,  as L. pneumophila has been shown  to leak 
bacterial DNA into the host cell cytosol  [89]. Interestingly,  L. pneumophila recruit mitochondria  to 
LCVs in  the early stages of infection.  However, MAVS
-/- BMMs permit only  an insignificant 
increase in L. pneumophila replication  [90], and MAVS deficiency  does not affect bacterial 
infection  in vivo. Furthermore,  while some existing  data support  a MAVS-dependent  IFNβ 
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 response to L. pneumophila infection in vivo  and in vitro  [91,92],  another study showed no effect of 
MAVS deficiency  on IFNβ production  in vitro [90]. 
Our hypothesis  is that TSPAN6 promotes the IFNγ-dependent restriction  of L. pneumophila, 
but may also inhibit  antibacterial  innate immunity  in the absence of IFNγ. It is well-established  that 
Type I IFN (stimulated  in MAVS-dependent  and most other innate immune  sensing pathways) 
restricts L. pneumophila in vitro  [42,93].  Therefore, our observation  that shTspan6 reduces L. 
pneumophila growth in resting macrophages is consistent with a role  for TSPAN6 in the inhibition 
of Type I IFN-mediated,  MAVS-dependent  responses to bacterial nucleic  acids in the  host cell 
cytosol. 
Could  TSPAN6 promote  IFNγ-dependent immunity  to L. pneumophila by inhibiting 
MAVS/Type I IFNγ signaling?  Little  is known about the interactions between Type I and Type II 
IFN responses in intracellular  bacterial infection.  In vivo,  both types of IFN  independently  play 
important  roles in restricting  L. pneumophila infection, and doubly-deficient  mice  succumb 
rapidly.  In vitro,  IFNβ-mediated L. pneumophila restriction is limited  in cells lacking  the IFNγ-
inducible  protein  IRGM [90]. Meanwhile,  RIG-I deficiency  does not affect the ability  of mouse 
embryonic fibroblasts (MEFs) to restrict L. pneumophila in response  to IFNγ [93].  In the context of 
other bacterial infections,  examples exist in which Type I IFNs have  either augmented the IFNγ 
response (S. flexneri in MEFs) [94] or detracted from it (L  monocytogenes in macrophages and 
dendritic cells) [95]. 
A molecular  basis for the impact of Type I IFN on the Type II response is based on 
competition  for STAT1.  Downstream of IFNγ receptor (IFNGR), Stat1 forms homodimers,  known as 
gamma-activation  factor (GAF) and  binds  IFNγ-activated sequences (GAS) when phosphorylated  at 
both tyrosine  701 (Y701) and serine 727 (S727).  However, phosphorylation  of S709 by IKKε in the 
context of the antiviral  response sterically  hinders  formation  of  GAF, instead favoring  the 
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 heterodimerization  of STAT1 and STAT2 [96] to form the ISGF3 transcription  complex  together 
with IRF9. 
The ability  of macrophages to restrict intracellular  bacteria in the absence of VTI1B is a 
significant  negative result. VTI1B is  a well-described  and member of SNARE bundles  involved  in 
homotypic endosome-endosome fusion,  late endosome-lysosome fusion [97] and autophagosome-
lysosome  fusion of both starvation-induced  autophagosomes  and those containing Group A 
streptococci  [72]. We hypothesized,  then, that Vti1b could be involved  in either the delivery  of late 
endosome-like  vesicles to the late phagosome,  or in fusion of the phagosome  with lysosomes.  The 
fact that Vti1b is dispensable  for killing  of L. pneumophila in IFNγ-activated cells indicates that (a) 
another SNARE or complex can substitute  for VTI1b in fusion events between phagosomes 
containing  L. pneumophila and late endosomes/lysosomes,  or that (b) phagolysosomal  fusion  is not 
necessary for efficient restriction  of L. pneumophila in response to IFNγ. 
  Lysotracker assays and acquisition  of other endosomal  (EEA1, VPS34, STX13, RILP, 
SNAPIN), autophagosomal  (LC3, IRGMs, ATG proteins) and lysosomal  markers can also be used to 
measure stages of phagosome  maturation.  Furthermore, biotin phagosome loading coupled with 
uptake of streptavidin-labeled  beads or bacteria can monitor  phagolysosome  fusion in real time. 
Acquisition  of lysosomal  functional  activities  can likewise  be measured over time using assays of 
protease, lipase, and beta-galactosidase activity.  
  Functional assays  are  readily performed to analyze bead-containing phagosomes, but  a  key 
challenge will be observing the bacterial phagosome which is not as  readily isolated.    Furthermore, 
given the potential  effects of the L. pneumophila secreted factor IcmG on TSPAN6-mediated vesicle 
fusion,  we recognize that measurement of IFNγ-mediated  vesicle trafficking  effects may be even 
more clear when live L. pneumophila are absent. 
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 MATERIALS AND METHODS 
 
Mice 
B6 mice and Ap3b1
-/-  (pearl) mice were from Jackson Laboratories.  Bone marrow derived 
from Arl8b
-/-(RRP119)  and Arl8b
-/-(MMRRC)  mice was provided by Salil  Garg (Brenner Lab). Bone marrow 
derived from Vti1b
-/-, Vti1b
-/+, and matched control WT mice was provided by Dr. Gabriele Fischer 
von Mollard. 
 
Cell lines and bacterial  strains 
  RAWγNO cells were  purchased from ATCC. L. pneumophila strain LP02 delFlaA lux was 
provided  by  Dr. Jörn Coers. L. pneumophila strain LP02 delFlaA  pAM239  was provided  by Dr. 
Ralph Isberg. 
 
BMM isolation and  culture 
Bone marrow was collected  from femurs and tibiae of 2-6 month old mice. Red blood  cells 
were lysed using TAC RBC lysis buffer (Sigma). Cells were  passed through a  70μm  cell strainer and 
plated in RPMI-1640 medium, supplemented  with 10% FBS, L-glutamine,  penicillin/streptomycin, 
MEM nonessential  amino acids, HEPES, sodium  pyruvate, β-mercaptoethanol,  and recombinant 
human  MCSF (10 ng/ml, R&D Systems). For screening, cells were  plated directly into 96-well assay 
plates. For other studies, cells were plated on non-tissue  culture treated petri dishes, differentiated for 
5d, washed with ice-cold PBS, incubated  with PBS at 4°C for 30min,  collected by repeated pipetting 
with PBS, and re-seeded at  the  densities indicated in complete supplemented media with MCSF. 
Cells were differentiated  for a total of 7d prior to stimulation  with  IFNγ (Millipore)  or infection.   
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 Bacterial infection 
L. pneumophila strains were maintained  on N-(2-acetamido)-2-aminoethanesulfonic  acid 
(ACES) buffered charcoal-yeast extract agar supplemented  with FeNO3, cysteine, and thymidine. For 
experimental  assays, L. pneumophila was grown in ACES-buffered yeast extract broth  at 37°C to a 
density  greater than 3 OD600. Bacteria were washed with PBS twice before infection. For experiments 
involving opsonization, bacteria were incubated for 1h with rotation at 37°C with 10 μg/ml 
recombinant human MBL (provided by Dr. Lynda Stuart) with 5mM CaCl2 or 0.4mg/ml  murine IgG 
(Jackson Immunoresearch).  
 
Primary  screen in RAWγNO cell line macrophages 
RAWγNOcells  were seeded in duplicate  in clear-bottom  black or solid white 96-well plates 
at 1000 cells/well,  incubated for 4h, then infected with 5ul of lentivirus  created by cloning  into the 
pLKO.1 lentiviral  vector (RNAi Consortium). 
A two-day selection process with 5μg/ml  puromycin  (Invitrogen)  was initiated  2d after viral 
infection to eliminate  cells uninfected with virus. 5d after viral infection,  cells were mock-stimulated 
or stimulated  with low (10U/ml)  or high (100U/ml)  concentrations of  IFNγ. 6d after viral infection, 
cells in black plates were incubated with Alamar Blue (Life Technologies)  for 3h, and fluorescence 
was then measured with a plate reader (Envision)  to determine cell counts. Cells in white plates were 
infected with LP02 delFlaA lux, and luminescence  was measured with the Envision  plate reader at 
24, 32, and 48h after infection.  The screening set was divided  into 4 batches, which were done in 
series. 
 
Secondary screen in primary  cells 
Large-scale viral preps of lentivirus  bearing shRNA were produced in 293T packaging  cells. 
shRNA sequences were identical  to the sequences that produced hits in the primary and secondary 
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 screens and targeted the screen-hit constructs targeting Tspan6 (3 constructs), Snap29, Snap47 and 
Vti1b. Lentivirus was  titrated in parallel with negative control virus containing shRNAs targeting 
GFP, RFP, LacZ or the empty vector. We observed that maximum  cell survival  following  puromycin 
selection varied from among viruses. Therefore, we continued to quantify cells in each  phenotypic 
assay and to normalize  assay readouts to cell density. We also chose optimal viral volumes per well 
that resulted in similar cell densities and, as  a secondary consideration, that maximized  the bacterial 
restriction phenotype. 
Bone marrow macrophage progenitor cells were prepared from B6 mice, seeded in duplicate 
in clear-bottom black or solid white 96-well plates at  1e5 cells/well, and cultured in the presence of 
MCSF for 3d before infection  with 10ul of lentivirus  (The RNAi Consortium).  A two-day selection 
process with 4μg/ml puromycin was  initiated 2d  after viral infection  to eliminate  cells uninfected 
with virus. 5d after viral  infection,  cells  were mock-stimulated or  stimulated with  IFNγ at 10U/ml. 6d 
after viral infection,  cells in black clear-bottom  plates were  incubated with Alamar Blue for 3h, and 
fluorescence was then measured with the Envision  plate reader. Cells in white plates were infected 
with LP02 delFlaA lux, and luminescence  was measured with the Envision  plate reader at 24 and 48h 
after infection.   
The bacterial restriction phenotype assay  was  performed as  follows. Murine BMMs grown in 
96 well plates were stimulated by 24h treatment in IFNγ at 10 U/ml or 100 U/ml or grown in media 
alone. Cells were then spin-infected with  L. pneumophila LP02 delFlaA lux in log-phase growth at  an 
MOI of 20. This bacterial strain expresses the lux operon  so that bacilli  are constitutively 
bioluminescent. Bioluminescence was  quantified in  an  Envision plate  reader.  Bacterial  restriction 
was calculated as the ratio of normalized  luminescence  in resting cells to that in IFNγ-treated cells.  
 
Screen Analysis: Log-transformation  and plate normalization 
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 All data were analyzed  at the level of individual  shRNA constructs, rather than genes. Data 
reflecting bacterial growth (luminescence) from each timepoint  and data reflecting cell count 
(AlamarBlue) were  independently quality-controlled, log-transformed  and plate-normalized. Data 
replicates were  first compared to identify and eliminate problematic plates and/or wells. Low-quality 
plates were  eliminated  from further analysis. Next, data were log-transformed  in order to approach a 
normal distribution.  For the purposes of log-transformation,  zero values were converted to a constant 
value below the lowest nonzero output value generated by the plate reader. The data were then plate-
normalized  to adjust for systematic error on each plate as follows.  For each plate, robust z-scores 
were  determined for each  well, using the in-house  application  RNAeyes (TRC). This program uses 
the formula:  RZ(i) = (x(i) - plateMedian)/plateMAD,  where RZ(i) is the calculated robust z-score for 
well (i), x(i) is the log-transformed  data for well (i), plateMedian  is the median of data for all non-
empty wells on the plate, and plateMAD is the median absolute deviation  (MAD) of those data, 
defined as the median of the absolute deviations  from the data's median. Next, replicate data for each 
shRNA construct were combined  using the geometric mean (average of log-transformed values), also 
within  RNAeyes. The above analysis yielded  one luminescence  RZ score and one Alamar Blue RZ 
score for each shRNA construct. Normalization  enabled us to pool data from all plates within a  batch 
together for further analysis. 
 
Normalization  to Alamar  Blue: calculation  of the fit  score 
We are interested in shRNA constructs that have a significant  effect on bacterial growth 
(luminescence)  independent  of its effect on cell growth (Alamar Blue). A strong correlation  was  seen 
between luminescence  and Alamar Blue RZ scores within  each batch, and at each timepoint. 
Luminescence RZ scores were therefore normalized  to Alamar Blue RZ scores using a custom 
MATLAB script. Normalization  to Alamar Blue was done independently  for luminescence  data from 
each batch and timepoint.  First, for each condition/timepoint,  luminescence  RZ scores (y) were 
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 plotted against Alamar Blue RZ scores (x), with each shRNA construct represented by a single point. 
A curve to best fit the correlation  between the two types of data was calculated as follows.  First, the 
moving  average was used to estimate a rough fit curve. For each point,  a window of 100 points to the 
left and right on the x-axis was used to compute a moving  average of y-values. At the edges of the x-
data, the window of the moving  average decreased accordingly  to fit within  the boundaries  of the x-
values of the dataset while taking equal numbers of points from left and right along the x-axis. The 
calculated moving  averages, when plotted  against Alamar Blue on the x-axis, define a curve that is 
roughly  fit to the data. 
The initial  fit-curve based on moving  average is prone to outlier  effects. To refine the fit-
curve,  a robust  moving  average was then computed on the basis of the initial  moving  average. The 
residual of each data point  from the moving  average was computed. Each residual was converted to a 
residual z-score by dividing  by the standard deviation  of all residuals from the curve. Points with 
statistically significant residual z-scores (with absolute value greater than 1.96) were labeled as 
“outliers.”  The moving  average was then re-calculated on the basis of all non-outlier points. Moving 
average values for  the missing outlier points were  then intrapolated using a  robust linear regression 
line through the [moving  average values vs Alamar Blue] points for 10 non-outlier  points to both left 
and right of the missing  outlier. This yielded  a refined moving  average fit-curve for the data. 
Refinement  by recalculating  residuals and removing  outliers from the calculation  of the fit-curve was 
iterated a  total of  5 times, at  which point the fit-curves were observed to converge.  
Next, the edge effect of the fit-curve was addressed. Since the span of the moving  average, or 
the number of points to left and right used to calculate moving  average for each point,  decreases at 
the low (left) and high (right) edges of the x-data – down to zero at the leftmost and rightmost  data 
point  – these calculated values were discarded. To estimate a moving  average for the leftmost 20 
points, new values were  extrapolated using a robust linear regression line through the [moving 
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 average values vs Alamar] points of the next-leftmost  20 points. The rightmost  20 points were treated 
in an analogous  fashion.  
Last, the robust, edge-corrected fit-curve was smoothed using  Lowess smoothing  with a span 
of 201, in order to eliminate  any high-frequency fluctuations without changing the  overall position of 
shape of the curve.  
To quantify the deviation  of each point from the fit-curve,  a fit score was calculated for each 
point in a manner identical  to that used to identify  outliers  (above). The residual  of each data point 
from the fit-curve was calculated. Each residual was converted to a fit-score by dividing  by the 
standard deviation  of all residuals from the curve. Negative fit scores represents points below the fit-
curve; positive  fit scores correspond to points above the curve. 
Since each residual was normalized  by the standard deviation  of the set of residuals in the 
batch, data from all batches (for each condition  and timepoint)  could be combined  and analyzed.  
 
Replicate quality 
Each RZ score was derived from data in duplicate.  It is possible  that false hits may result 
from an outlying  data point  that is not confirmed  by its replicate. To identify  shRNA constructs with 
highly variable replicate data, the residual of each data replicate (log-transformed)  to the fit-curve 
point was calculated  for each shRNA. The standard deviation  of the residuals of the replicates was 
calculated as a measure of variability  among replicates.  
 
shRNA construct quality 
Data regarding knockdown  efficiency was available  from the TRC for 51% (1953) of shRNA 
constructs in the experimental  set. Of these, 63% (600)  were classified  as “good”  quality  data. 
Knockdown efficiency experiments were  mostly in Hepa  cells. Any  shRNA constructs for which 
“good”  quality  knockdown  data indicate  a knockdown  efficiency  of less than  69% were not  eligible 
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 to be considered as hits. The threshold was set high because knockdown  efficiency may vary among 
cell types. 
 
Candidate selection 
For the IFNγ mediator  screen, fit scores from the primary  condition  and timepoint  of 
100U/ml  IFNγ, 2dpi data were used to rank hits. Fit scores from the intermediate  condition  of 
10U/ml  IFNγ, 2dpi data were used to confirm hits. Fit scores were sorted in descending order, 
because points  above the curve represent potential  hits, with bacterial survival  higher than expected 
in the presence of IFNγ.  
In order to qualify  as a hit for secondary screening, shRNA constructs were selected on the 
following criteria: primary  fit score > 1.5, intermediate  fit score > 1.2. This yielded  95 shRNA 
construct hits.  
For the host factor screen, fit scores from the primary  condition  and timepoint  of no IFNγ, 
2dpi  data were used to rank hits. Fit scores from the intermediate  condition  of no IFNγ, 1dpi-late  data 
were used to confirm  hits In Batches II-IV. Since the 1dpi-late  timepoint  was not assayed in Batch I, 
the 1dpi-early  timepoint  was used instead for this batch only. 
shRNA constructs classified as  hits for further screening in the host factor screen satisfied the 
following criteria: primary fit score  < -1.4 (all batches), intermediate fit score <-0.75 (Batch I), 
intermediate  fit score < -1.1 (Batches II-IV). 
Hits from the host factor screen were required  to satisfy the additional  criterion of replicate 
quality score <0.8, indicating  low variation  between duplicate  data. This criterion was  used because 
wells with abnormally  low bacterial luminescence  due to experimental  error were likely  to produce 
false positives.  This step yielded  77 shRNA construct hits (Batches II-IV) and 7 shRNA construct 
hits (Batch I).  
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 mRNA isolation and qPCR measurement 
For experiments  in 96-well plates,  cells  were lysed  and polyA+ RNA  was prepared  using  the 
Turbocapture mRNA kit (Qiagen); mRNA was then reverse transcribed with the Sensiscript  RT kit 
(Qiagen). For cells grown in 6-well plates, total RNA was extracted using  the RNeasy kit (Qiagen) 
following the procedure for adherent cells and reverse transcribed  with the High Capacity cDNA 
Reverse Transcription  kit (Applied Biosystems). Real time quantitative  PCR reactions were 
performed on the LightCycler 480 system (Roche) with FastStart Universal  SYBR Green Master Mix 
(Roche). Every reaction was  run in triplicate  and outliers  were excluded.  GAPDH was used as an 
endogenous  control for normalization. 
 
Western blotting 
 
  Protein was purified from lysates of RAWγNOcells  grown in six-well plates, infected with 
control or candidate-targeting  lentivirus,  and selected for puromycin  resistance. Cells were  washed 
three times in PBS and lysed in RIPA buffer (Boston Bioproducts)  with protease inhibitor  (Roche). 
Lysates were purified  by centrifugation  and suspended in SDS buffer with 10mM dithiothreitol 
(DTT). Proteins were separated by electrophoresis  on a Bis-Tris 4-12% polyacrylamide  gel (Novex), 
transferred to a nitrocellulose  membrane, blocked  with 5% milk  in Tris-buffered saline with Tween 
(TBST), and incubated  overnight at 4°C with primary  antibodies  in 5% nonfat dry milk  in TBST. 
Membranes were washed, incubated with secondary antibody  in 5% bovine serum albumin  (BSA) in 
TBST for one hour at room temperature, washed again, and incubated with for 5min with luminol 
reagent (Pierce). Antibodies  were from Abcam (β-actin, TSPAN6), Cell Signaling Technologies  (β-
tubulin, GAPDH), Jackson Immunoresearch  (HRP-conjugated secondary antibodies),  Santa Cruz 
(SNAP29), and Synaptic Systems (SNAP47). 
 
Flow cytometry analysis 
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   Bead phagocytosis  assays were performed using Dragon Green latex microsphere beads 
(Bangs Laboratories)  opsonized  in 0.4 mg/ml rabbit IgG (Jackson Immunoresearch)  for 1hr with 
rotation  at 37°C, added to macrophages at an MOI of 1, and centrifuged for 10m. LAMP1 
quantification  was performed using  an APC-conjugated  monoclonal  anti-LAMP1 antibody 
(BioLegend). Flow cytometry was  performed using a  FACSDiva (Becton-Dickinson). 
 
Immunofluorescence microscopy 
  Cells were seeded onto 8-well glass chamber slides (Nunc) at 2e4 cells/chamber,  washed three 
times with PBS, and fixed with 4% paraformaldehyde (Electron Microscopy Sciences) in PBS for ten 
minutes. Cells were  permeabilized with 0.1% saponin  and blocked  with 5% goat or donkey serum 
(Jackson Immunoresearch)  and 5% BSA (Cell Signaling  Technologies).  Primary antibody  incubation 
was done overnight  at 4°C. Cells were washed with PBS and incubated with Alexa-fluorophore 
conjugated  secondary antibody  (Life Technologies)  for 1 hour in the dark. Cells were washed, 
mounted on coverslips, and imaged using a  confocal microscope (Zeiss). 
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98   ABSTRACT 
Macrophages use an array of innate immune  sensors to detect intracellular  pathogens  and to 
tailor  effective antimicrobial  responses. During  infection  with some pathogenic  vacuolar bacteria and 
parasites, however,  extrinsic  activation  with the cytokine  interferon  gamma (IFNγ) is often required 
as well to tip the scales of the host-pathogen  balance toward host protection  and bacterial  restriction. 
Prior work has uncovered  positive  and negative  interactions  among  intersecting  signaling  pathways, 
but the effect of innate  pathogen  sensing  on the persistence and activity  of the antibacterial  IFNγ-
activated state is largely  unknown.  We show that in the absence of continued  IFNγ stimulation,  the 
key innate sensing  transcription  factor IRF3 suppresses the IFNγ-induced  antimicrobial  state in 
macrophages  infected with the intracellular  bacterium  Legionella pneumophila and the protozoan 
parasite Trypanosoma cruzi. Surprisingly,  this activity  is independent  of cytosolic  nucleic  acid 
sensors that activate IRF3 through  the signaling  adaptors STING or MAVS. Furthermore, this 
repression  is independent  of Type I IFNs usually  activated downstream of IRF3. Still, IRF3 
deficiency  profoundly  affects the transcriptional  program  of both IFNγ-activated  and bacterially-
infected macrophages.IRF3 suppresses the  expression of nitric  oxide  synthase (iNOS), yet the 
significant increase in antimicrobial nitric oxide levels observed in infected IRF3
-/- macrophages  is 
not required  for their enhanced antibacterial  capacity. Gene expression analysis suggests other innate 
immune mechanisms,  including  iron restriction  that may be involved  in enhanced IFNγ-dependent 
pathogen restriction in IRF3
-/- BMMs. Finally,  we show that IFNγ-activated but not resting 
macrophages antagonize  IRF3 effects by excluding  the active form of IRF3 from the nucleus. These 
data are consistent with a cascade  of inhibition, in which active IRF3 imperfectly  excluded from the 
nucleus of IFNγ-activated macrophages suppresses IFNγ-induced effectors. 
   
99   INTRODUCTION 
Interferon gamma (IFNγ) is a potent activator  of macrophage defense mechanisms  that restrict 
intracellular pathogens,  especially  bacteria and parasites that subvert the host phagosome into a 
replicative vacuole.  While IFNγ is produced  extrinsically  by NK, NKT, and T cells, macrophages 
also possess innate immune  sensors that detect infection  and stimulate  cell-intrinsic defense.  Previous 
studies suggest a synergy between several pathogen sensing pathways and IFNγ activation  in 
macrophages  at the level of signaling  and transcription  [1–3]. Despite our knowledge  of microbial 
ligands,  the sensors that detect them, and the pathways induced downstream,  little  is understood 
about whether and how these innate sensing pathways affect  restriction of bacteria in macrophages 
activated by IFNγ.  
Legionella pneumophila is a Gram-negative  vacuolar bacterial pathogen of protozoan 
phagocytes  that can opportunistically  colonize  mammalian  macrophages and, in humans, lead to 
Legionnaire’s  disease or Pontiac fever. Several innate sensing pathways are known  to mediate 
macrophage  responses to L. pneumophila, including  the inflammasome  [4–8], Toll-like receptor 
(TLR) [9], and cytosolic  DNA [8,10]  and RNA [11] sensing pathways. Despite the vacuolar 
localization of L. pneumophila, there is evidence that bacterial nucleic acids and other pathogen 
ligands  reach sensors throughout  the cells via the specialized  secretion system Dot/icm [12,13]. 
Infected macrophages with an intact NAIP5-NLRC4 inflammasome pathway undergo rapid 
pyroptosis upon  exposure to bacterial flagellin.  Resting macrophages  that lack elements of  the 
NAIP5 pathway or are infected  with  flagellin-deficient  L. pneumophila, are permissive  for bacterial 
growth. Macrophages activated by IFNγ, however, become restrictive.   
We tested the hypothesis that  innate sensing  pathways synergize  with the IFNγ-induced  anti-
bacterial  state. We thus quantified  IFNγ-induced restriction of intracellular  bacteria in bone-marrow 
derived  macrophages  (BMMs) from mice deficient  in key components  of pathogen  sensing 
100   pathways. In our studies, we used a bacterial strain lacking flagellin  to eliminate  NAIP5/NLRC4-
induced  pyroptosis, allowing us  to  analyze the role of the TLR, DNA- and RNA-sensing pathways in 
IFNγ -mediated restriction.   
 
RESULTS 
To determine  the effects of innate sensing  on IFNγ-activated  bacterial restriction,  we first 
considered  the roles of the Toll-like  receptors (TLRs), membrane-associated  sensors of bacterial cell 
wall components  and nucleic acids. We used mice lacking both MYD88 and TRIF to eliminate 
signaling downstream of  TLR  ligand sensing. BMMs were  pre-stimulated with IFNγ for 24hr, and 
media was completely  replaced with IFNγ-free media during  at the time of infection  in order to 
temporally  separate IFNγ signaling and  bacterial sensing events,  allowing observation of  the  effects 
of genetic perturbations  on the maintenance  of the IFNγ-activated state, IFNγ-free media was used to 
wash uninternalized  bacteria 2h after infection  (Fig 3-1a). Alternately,  resting BMMs were  infected 
with L.p. in IFNγ-free  media and only stimulated with IFNγ-at the media change 2h after infection,  a 
scenario that captures potential effects of genetic perturbations on the establishment (via signal 
transduction  from the IFNγ receptor) as well as on the maintenance  of the IFNγ-activated state (Fig. 
3-1b). 
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Figure 3-1. Schematic of the innate immune  sensor/IFNγ pathway  interaction assay 
During infection,  media is removed and replaced with media containing  bacteria. Media is changed 
again 2h after infection  to remove uninternalized  bacteria. Bacterial growth is tracked over 48h by 
measuring bacterial bioluminescence.   
a.  Pre-stimulation  of macrophages  with IFNγ, followed by removal of IFNγ prior to infection 
with bacteria, isolates the effects of sensing on the maintenance of the IFNγ-activated state 
b.  Stimulation  of macrophages  with IFNγ during infection  with bacteria involves  the effects of 
sensing on the establishment of the IFNγ-activated state 
 
TLR signaling through MYD88/TRIF synergizes with concurrent  IFNγ signaling, but does not 
affect the maintenance of the IFNγ-activated state 
BMMs were infected with LP02 delFlaA lux, a flagellin-deficient, constitutively 
bioluminescent  strain of L. pneumophila. As expected, L. pneumophila exhibits logarithmic growth 
in resting B6 BMMs, but is highly  restricted in BMMs prestimulated  with IFNγ in a dose-dependent 
manner. We found that MYD88/TRIF  deficiency  did  not significantly  affect permissivity  to L. 
pneumophila growth relative  to WT in resting  BMMs but enhanced growth in BMMs prestimulated 
with 10U/ml  or 100U/ml  IFNγ (Fig. 3-2, top), indicating  that TLR signaling  plays a nonredundant 
102   role in the macrophage-intrinsic  maintenance  or the antibacterial  activity  of the IFNγ-activated  state.  
 
 
Figure 3-2. Contribution of MYD88 and TRIF to the establishment and maintenance  of the 
IFNγ-activated state 
Intracellular growth of L. pneumophila (left) in IFNγ-stimulated  BMMs is enhanced in MyD88
-/- 
and TRIF
-/- BMMs (blue) compared to WT BMMs (black). IFNγ-dependent restriction of  L. 
pneumophila (right) is decreased roughly  twofold  in MyD88/TRIF
-/-  BMMs prestimulated with 
IFNγ prior  to infection  (top), and over fivefold  in MyD88/TRIF
-/-  BMMs stimulated  with IFNγ 
during infection (bottom). 
 
To verify the observation  that TLR and IFNγ signaling  pathways may interact synergistically 
when stimulated  at the same time (as seen in many studies,  for example [1]) we stimulated  BMMs 
with IFNγ at 2h post-infection  . Compared to WT BMMs, over fivefold  reduction in IFNγ-activated 
bacterial restriction  was observed  in MyD88
-/-TRIF
-/-  BMMs (Fig. 3-2). We conclude that the TLR 
pathway can significantly  synergize with IFNγ signaling to  establish the anti-bacterial  state of 
macrophages,  but also facilitates the maintenance  of a pre-established  IFNγ-induced anti-bacterial 
state, albeit with a  smaller effect  on bacterial restriction. 
 
The role of nucleic acid sensing in the restriction of bacteria by IFNγ-activated BMMs 
103   We next asked whether intracellular  nucleic acid sensing affects  IFNγ-activated bacterial 
restriction.  Previous work has identified  the role of MAVS [11,13]  and STING [10] in the Type I 
interferon macrophage response to  L. pneumophila RNA and DNA, respectively.  We found, 
however, that the capacity of IFNγ pre-stimulated  BMMs to restrict L. pneumophila was 
unchanged in MAVS
-/- or STING
-/-  BMMs at nearly all concentrations  of IFNγ tested, with the 
exception  of a decrease in bacterial restriction in STING
-/- BMMs at 3U/ml  (Fig. 3-3, top). 
Therefore, we found no evidence for a  role for MAVS or STING-dependent  sensing pathways in 
the maintenance of the IFNγ-activated state. In addition,  bacterial growth and restriction  in BMMs 
stimulated with  IFNγ 2h after infection  were not changed by lack of either STING or MAVS, 
indicating  that neither adaptor is necessary for establishment  of the IFNγ-activated state (Fig. 3-3, 
bottom).  
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Figure 3-3. Contribution of STING, but not MAVS to the maintenance  of the IFNγ -activated 
state  
Intracellular growth of L. pneumophila (left) in IFNγ-stimulated  BMMs is enhanced in STING
-/- 
BMMs (blue) but not MAVS
-/- BMMs (orange) compared to WT BMMs (black). IFNγ-dependent 
restriction of  L. pneumophila (right) is decreased by 25-50% in STING
-/- BMMs prestimulated with 
IFNγ (top), but not in BMMs stimulated  with IFNγ during infection (bottom). 
 
Given the possibility  that multiple  nucleic  acid (DNA or RNA) sensing pathways may have 
to be ablated in the same mouse to observe changes in capacity for IFNγ-activated  bacterial 
restriction,  we next tested BMMs deficient in the phagolysosomal  nuclease DNAse2 or the 
cytosolic DNase  TREX1, both of which harbor an excess of immunostimulatory  DNA [14–22]. L. 
pneumophila growth in resting BMMs was not significantly  altered by lack of either nuclease. In 
IFNγ pre-stimulated BMMs,  lack of DNAse2 impaired restriction (Fig. 3-4a), IFNγ while lack of 
TREX1  enhanced bacterial  restriction  compared to WT BMMs (Fig. 3-4b). Since the source (host 
or bacteria) of excess of immunostimulatory DNA  is still  not known, we cannot explain  these 
divergent results. Thus, we  conclude that while STING-independent  DNA sensing pathways may 
still impact bacterial killing, STING and MAVS are not likely  involved  in modulating  bacterial 
restriction induced by IFNγ. 
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Figure 3-4. Opposing effects of DNAse2 and TREX1 nucleases on the IFNγ-activated state 
Intracellular growth of L. pneumophila (left) in IFNγ-stimulated  BMMs is enhanced in DNase2
-/- 
BMMs (green) (a) but not TREX1
-/-  BMMs (violet)  (b) compared to WT BMMs (black).  
a.  IFNγ-dependent restriction of  L. pneumophila (right) is decreased fivefold in DNase2
-/- 
BMMs prestimulated  with IFNγ (top), as well  as in BMMs stimulated  with IFNγ during 
infection (bottom), compared to WT BMMs. 
b.  IFNγ-dependent restriction of  L. pneumophila (right) is enhanced 20-fold in TREX1
-/- 
BMMs prestimulated  with IFNγ (top), and twofold in BMMs stimulated  with IFNγ during 
infection (bottom), compared to WT BMMs. 
 
IRF3 inhibits the maintenance and not the establishment of the IFNγ-activated state 
Since loss of MYD88/TRIF,  MAVS or STING did not impact IFNγ pre-stimulated  bacterial 
restriction,  we considered two transcription  factors, IRF3 and IRF7, which are essential  elements 
106   downstream of  many innate immune sensors (including  the known non-inflammasome nucleic acid 
sensors). We found that resting IRF3
-/-IRF7
-/-  BMMs are slightly  more permissive  to L. 
pneumophila compared to WT BMMs. Surprisingly,  lack of IRF3/7  significantly  enhanced IFNγ-
mediated  restriction  of bacteria (Fig. 3-5a, top), in contrast to our original  hypothesis  of synergy 
between innate sensing  and IFNγ-mediated  host defense. 
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Figure 3-5. IRF3-mediated suppression of the IFNγ-activated state 
a.  IFNγ-dependent restriction of  L. pneumophila (right) is enhanced tenfold in IRF3
-/-IRF7
-/- 
BMMs prestimulated  with IFNγ (top), but not in BMMs stimulated  with IFNγ during 
infection (bottom), compared to WT BMMs. 
b.  Growth of  L. pneumophila in IFNγ-stimulated  BMMs is enhanced in IRF3
-/-IRF7
-/-  BMMs 
and IRF3
-/- BMMs, but not IRF7
-/- BMMs, compared to WT BMMs. 
 
We next asked whether IRF3/7  also affect the establishment  of the IFNγ-activated state by 
stimulating  BMMs with IFNγ at 2h after infection.  Under these conditions,  IFNγ-mediated bacterial 
restriction was  similar in WT and IRF3
-/-IRF7
-/-  BMMs (Fig. 3-5a, bottom), suggesting  that IRF3-
108   mediated pathways involved in sensing of L. pneumophila affect the maintenance,  but not the 
establishment  of the IFNγ-activated state. 
Further experiments  with IRF3
-/-IRF7
-/-  BMMs showed that lack of IRF3 is wholly 
responsible  for the enhanced bacterial restriction  observed  in IFNγ-activated  IRF3
-/-IRF7
-/-  BMMs 
(Fig. 3-5b), while  IRF7
-/- BMMs are phenotypically  identical  to WT BMMs in this model  of IFNγ-
mediated  bacterial  restriction.  Prolonged incubation with IFNγ was insufficient  to overcome IRF3-
dependent suppression  of the IFNγ-mediated  state (Fig. 3-6). Together,  our results suggest that 
MAVS- and STING-independent  sensing of L. pneumophila infection  is likely  to activate IRF3, 
which in turn robustly  inhibits  the maintenance  of the IFNγ-activated state.  
 
 
Figure 3-6. Relationship between the magnitude of IRF3-mediated suppression of IFNγ effector 
activity and the  magnitude of effector activity 
IFNγ-dependent restriction (y-axis) of  L. pneumophila in BMMs pre-stimulated  with IFNγ for the 
duration  of time indicated (x-axis) was calculated as the ratio of bioluminescence  in resting BMMs 
vs in BMMs stimulated  with the indicated  concentration  of IFNγ, measured at the timepoints 
indicated. 
109   IFNγ inhibits L. pneumophila-induced phosphorylation of IRF3  
To test whether IRF3 is affected by infection  of IFNγ,  we monitored  the activity  of IRF3 
based on its phosphorylation  and dimerization  in the nucleus and cytosol  [23]. Within  1hr of 
infection by L. pneumophila, Ser385-phosphorylated  IRF3 is strongly  detected in the nucleus  of 
control  BMMs not treated with IFNγ, but surprisingly,  is barely detectable in IFNγ pre-stimulated 
BMMs in either the nucleus (Fig. 3-7a) or cytosol (Fig. 3-7b). IFNγ-stimulated  or resting,  but 
uninfected  BMMs do not accumulate IRF3-p in the nucleus (Fig. 3-7c) or cytoplasm  (Fig. 3-7d). 
Thus, while  infection  can lead to phosphorylation  (likely  through  an unidentified  innate sensing 
mechanism),  IFNγ appears to inhibit  this phosphorylation,  consistent with an antagonistic 
relationship between bacterial sensing and IFNγ in regulating  the anti-bacterial state. A simple 
hypothesis is that IFNγ blocks IRF3 activation  to reduce the inhibitory  effect of IRF3, and that 
complete removal of IRF3 allows IFNγ to maximally  induce bacterial restriction. 
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Figure 3-7. Activation of IRF3 in resting, but not IFNγ-activated BMMs upon infection with 
L. pneumophila 
IRF3 phosphorylation  at serine 388 was assessed by Western blot using  lysates from resting or 
IFNγ-prestimulated  WT BMMs infected with L. pneumophila and lysed at the timepoints  indicated. 
a.  Nuclear extracts from BMMs mock-stimulated  or stimulated  with IFNγ for 24h and 
infected with L. pneumophila for the duration  of time indicated.  The nuclear protein TBP is 
used as a loading  control. 
b.  Cytoplasmic  extracts from BMMs as in (a). Total  IRF3 is quantified  as well.  β-actin is used 
as a loading  control. 
c.  Nuclear extracts from BMMs stimulated  with IFNγ for the duration  of time indicated.  The 
nuclear protein TBP is used as a loading  control. 
d.  Cytoplasmic  extracts from BMMs as in (c). Total  IRF3  is quantified  as well.  β-actin is used 
as a loading  control. 
 
TBK1 and IKKε phosphorylation  profiles are not consistent with changes in IRF3 
phosphorylation   
To determine whether the known IRF3 kinases, IKKε and TBK1, are activated upon 
infection  or modulated  by IFNγ, we monitored  their phosphorylation  in cell lysates. We found that 
111   IKKε and TBK1 are phosphorylated  in response to L. pneumophila infection in both resting and 
IFNγ pre-stimulated  BMMs. IKKε phosphorylation  was, in fact, transiently  higher  in IFNγ pre-
stimulated BMMs than in resting BMMs (Fig. 3-8). The observed exclusion  of IRF3-pS385 from 
the nucleus in BMMs containing  active forms of IKKε and TBK1 could be consistent with several 
different scenarios. First, IFNγ effectors could block the phosphorylation  of IRF3 at Ser385 by 
activated IKKε and TBK1, either directly or by separating them spatially into different locations 
within  the cell. Alternatively,  IRF3-pS385  could be rapidly  dephosphorylated  in an IFNγ-
dependent manner. Third, IFNγ-activated  BMMs could block  the translocation  of IRF3-pS385  into 
the nucleus.  
 
Figure 3-8. Activation of IKKε and TBK1 in resting and IFNγ-preactivated BMMs upon 
infection with L. pneumophila 
Western blot  analysis  of IKKε and TBK1 phosphorylation.  BMMs from resting or IFNγ-
prestimulated  WT BMMs were infected with L. pneumophila and lysed at the timepoints  indicated. 
 
To test the latter possibility,  we had probed the corresponding  cytoplasmic  extracts of each 
sample for the presence of IRF3-pS385.  Since phosphorylated  IRF3 does not accumulate in the 
cytoplasm  of IFNγ-activated BMMs (Fig. 3-7b), our evidence suggests that activated IKKε and 
TBK1 cannot stably phosphorylate  IRF3 at  Ser385 in IFNγ-activated  BMMs.  
Further supporting  the lack of connection  between IRF3 phosphorylation  and 
phosphorylation  of its known kinases, we found that deficiency  in IKKε or knockdown  of TBK1 
112   could not phenocopy  IRF3 deficiency. We note that we could not assess the ability  of IKKε
-/- 
BMMs treated with shTBK1 to phenocopy  IRF3 deficiency,  because of the confounding 
requirement for  IKKε and TBK1 for efficient bacterial growth in resting BMMs (Fig. 3-9). 
 
 
Figure 3-9. Contribution of IRF3 kinases to the maintenance of the IFNγ-activated state 
WT or IKKε
-/- BMMs were transduced with shTBK1, with control shRNA, or mock-transduced (no 
virus). Following puromycin  selection, BMMs were re-seeded into 96-well  plates at constant cell 
density and infected with L. pneumophila.  Bioluminescence is  proportional to  bacterial growth.   
 
Type I IFN does not inhibit the IFNγ-activated state during L. pneumophila infection of 
macrophages 
We next considered  how IRF3 may repress the IFNγ anti-bacterial state. We thus studied  the 
role and induction  of Type I IFNs, the most potent immune  regulators  induced  by IRF3 activation. 
Even though  we did not detect the presence of the Ser385-phosphorylated  form thought to be 
required for Type I IFN induction  in in the nuclei  of IFNγ-prestimulated  BMMs either before or 
after L. pneumophila infection,  others have demonstrated  that post-translational modifications are 
not easily correlated with the transcriptional  activity  of IRF3 [24]. Therefore, we pursued  a series of 
independent  assays to test the role of IRF3-mediated  Type I IFN in repressing the anti-bacterial 
state.  
113   While the targets of Type I and II interferons partially  overlap  [25–27], prior studies have 
shown that Type I and II IFN-stimulated  pathways can reinforce [25,28–32]  or antagonize [25,33–
35] each other in a context-dependent manner.  In the context of bacterial infection,  prior work has 
uncovered only  antagonizing  effects of Type I IFN on IFNγ-dependent  activation  through a variety of 
mechanisms, including induction of  antagonistic effectors  [35] and downregulation  of the IFNγ 
receptor [21]. We expected lack of the Type I IFN receptor, IFNAR, to phenocopy lack of IRF3, 
consistent with these reports, by enhancing  IFNγ-activated bacterial restriction. 
In resting BMMs, IFNAR deficiency  conferred a slight  increase in permissivity  to growth 
of L. pneumophila (Fig. 3-10a, top left), consistent with prior observations [36]. Contrary to our 
expectations,  and despite evidence that baseline signaling  through  IFNAR is required for a full-
fledged response to IFNγ [37], IFNAR deficiency  did not significantly  affect IFNγ-dependent  L. 
pneumophila restriction  in BMMs stimulated  prior to infection  (Fig. 3-10a, top right). This result 
suggests that endogenous  Type I IFN signaling  in BMMs treated with IFNγ and infected with L. 
pneumophila did not alter the IFNγ-activated state.  Consistent  with this hypothesis,  the ability  of 
neither IRF3
-/- nor WT IFNγ-activated  BMMs to restrict L. pneumophila were affected when 
IFNAR receptors were blocked with a neutralizing  antibody  (Fig. 3-10a, bottom). Likewise, the 
establishment  of the IFNγ-activated  state was only minimally  affected by loss or blocking  of 
IFNAR (Fig. 3-11). 
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Figure 3-10. IRF3 mediates suppression of the IFNγ-activated state in macrophages 
independently of endogenous Type I interferons 
a.  Growth of  L. pneumophila (left) in BMMs stimulated  with IFNγ prior to infection  is 
enhanced in IFNAR
-/- BMMs (magenta) compared to WT BMMs (black). IFNγ-dependent 
restriction of  L. pneumophila (right) is decreased by roughly  25-50% in IFNAR
-/- BMMs 
pre-stimulated with IFNγ (top). Blocking  IFNAR with a  neutralizing antibody  did not affect 
bacterial growth or restriction  in pre-stimulated  WT or IRF3
-/-IRF7
-/-  BMMs (bottom) 
b.  BMMs that were either resting or pre-stimulated with IFNγ produce Type I interferons in 
response to infection  with Sendai virus but not L. pneumophila, as measured  by an ISRE 
assay in p53
-/- MEFs. 
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Figure 3-11. Involvement of endogenous signaling through IFNAR in establishment of the 
IFNγ-activated state in macrophages 
Intracellular growth of L. pneumophila (left) in BMMs stimulated  with IFNγ only during bacterial 
infection  is enhanced in IFNAR
-/- BMMs (magenta) compared to WT BMMs (black). IFNγ-
dependent restriction of L. pneumophila (right) is decreased slightly  in IFNAR
-/- BMMs stimulated 
with IFNγ  during infection (top). Blocking IFNAR  with  a  neutralizing antibody did  not  affect 
bacterial growth or restriction  in WT or IRF3
-/-IRF7
-/-  BMMs stimulated with  IFNγ  during infection 
(bottom) 
 
These results suggest that IRF3-mediated  repression  of the IFNγ-activated  state proceeds 
through  a novel,  Type I IFN-independent  mechanism.  In fact, we found  that the level  of endogenous 
production  of Type I IFNs by WT BMMs during  L. pneumophila infection  is very low. 
Supernatants  from L. pneumophila-infected WT BMMs were unable  to activate ISRE-driven 
transcription  in a reporter cell line,  while  supernatants from BMMs infected with  Sendai virus  at an 
MOI of 2 robustly  activated the ISRE reporter (Fig. 3-10b). IFNβ transcript levels in L. 
pneumophila infected BMMs were less than 0.1% of those in Sendai virus-infected  BMMs, and 
were not significantly  affected by IFNγ pre-stimulation.   
Even when added exogenously  at high levels, Type I IFNs do not repress the IFNγ-activated 
state. In both  WT and IRF3
-/- BMMs prestimulated  with IFNγ and infected with L. pneumophila, 
116   stimulation with IFNβ 2 hours after infection  appeared to potentiate IFNγ-mediated  effectors, 
significantly enhancing bacterial restriction  throughout  the course of infection  (Fig. 3-12, top). 
Exogenous  IFNβ modestly enhanced bacterial restriction in resting, infected BMMs as  well, but the 
effect was only  significant  at timepoints  38h after infection.  Notably,  the relative  timing of  IFNβ 
stimulation  is critical to its effect on the IFNγ-activated state. In both WT and IRF3
-/- BMMs 
stimulated  with IFNγ 2h after L. pneumophila infection,  simultaneous stimulation with exogenous 
IFNβ significantly  restricts IFNγ-activated  bacterial  restriction  (Fig. 3-12, bottom), likely  by direct 
inhibition  of IFNγ signaling  [25] and subsequent  establishment  of the IFNγ-mediated  state. In 
summary,  while Type I and II interferons clearly interact to modulate  the anti-bacterial  state, Type I 
IFN signaling  is not required for the inhibitory  effect of IRF3 on the anti-bacterial state. 
 
Figure 3-12. Opposite effects of exogenous Type I IFN on the establishment and maintenance 
of the IFNγ-activated state 
(Top) Growth of L. pneumophila (left) in both WT and IRF3
-/-IRF7
-/-  BMMs pre-stimulated  with 
IFNγ prior to  bacterial infection  is decreased in BMMs treated with exogenous  IFNβ during 
infection  (blue) compared to mock-treated  BMMs (black), and IFNγ-dependent restriction of  L. 
pneumophila (right) is significantly increased.   
(Bottom) Treatment with exogenous IFNβ in BMMs stimulated  with IFNγ only after  bacterial 
infection  increases bacterial growth (left) and decreases restriction  (right). 
117   IRF3/7 deficiency affects the transcriptional programs of resting, IFNγ-stimulated, and L. 
pneumophila-infected BMMs 
To further investigate  potential  roles for IRF3-mediated  alteration  of gene expression,  we 
used RNA-seq transcriptome  analysis  to explore potential  targets of IRF3 responsible  for inhibition 
of the IFNγ-activated state. IRF3 could  affect IFNγ-mediated  bacterial restriction via changes in the 
transcriptome  either (a) indirectly,  by inducing  a repressor that destabilizes  the IFNγ-activated  state 
(as illustrated  in the context of hepatitis [38]) or (b) directly,  by inhibiting  a promoter element or 
transcription  factor that is necessary to maintain  the IFNγ-activated  state, a novel IRF3 function 
recently demonstrated  in T cells, where it binds  RORγT to inhibit  its nuclear translocation  and 
subsequent IL-17 induction  [39]. 
We found  a number  of genes both  repressed and induced  in IRF3
-/-IRF7
-/-  BMMs in the 
context of activation  with 10U/ml IFNγ followed  by L. pneumophila infection. Of 28,416 genes 
measured, we chose the 8,885  whose maximum expression values fell within the  50
th percentile or 
higher of all expression values. Of these, 232 genes varied by 3-fold  or more based on genotype 
within  any of the categories representing  IFNγ-stimulated and/or L.pneumophila-infected BMMs. 
Of these, the expression of 93 genes varied by 3-fold or more based on genotype in BMMs that 
were both IFNγ-stimulated  and L.pneumophila-infected (Fig. 3-13) while 162 did not (Fig. 3-14). 
43 genes were differentially expressed based on genotype in IFNγ-stimulated, infected BMMs only 
(Fig. 3-13a), including  one gene previously  identified  as a direct antibacterial  effector in 
macrophages,  Lcn2 (lipocalin  2). The list of genes uniquely  regulated by IRF3 only in IFNγ-
stimulated,  L.pneumophila-infected BMMs includes  genes that encode transcription factors 
(LYL1, EGR3,  EPAS1, BATF3, KRC, viral response and cytokine genes (OASL2, IFIT3, MX1, 
IL23a), GPCR ligands  (NPY, NIACR), the p47 GTPase GM12250,  and genes involved  in 
apoptosis (CHEK2, NPTX1, SERPINB2, FAH) as well as non-apoptotic  cell death (CD00IF). The 
118   ten genes differentially  regulated based on genotype only in infected BMMs, regardless of IFNγ 
stimulation, include the  transcription factor  PLAC8 and the IFNγ-inducible  GTPase IFGGA2 
(encoded by the gene Gm4951)  (Fig. 3-13b, top). 28 genes differ in IFNγ-activated, 
L.pneumophila-infected BMMs as well as at baseline, these include  the viral response gene 
(OASL1) as well  as secreted factors including  G-CSF (CSF3) and the acute-phase reactant SAA3 
(Fig. 3-13b).  
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Figure 3-13. Effect of IRF3/7 deficiency on the transcriptomes of IFNγ-stimulated BMMs 
infected with L. pneumophila 
Heatplots of  row-normalized  RNA-seq data from IRF3
-/-IRF7
-/-  and WT resting and IFNγ–
prestimulated  BMMs before and 12 hours after infection  with L. pneumophila. Transcripts  with 
maximum  expression above the 50th abundance percentile were further filtered to include  only 
transcripts  with  a fold-change  of 3 or more between the two genotypes (indicated  by *) in IFNγ-
prestimulated and  L. pneumophila-infected BMMs as well as (a) no other categories, (b) in infected 
BMMs, or at baseline,  or (c) in  IFNγ-stimulated  BMMs, but not at baseline.   
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Figure 3-14. Effect of IRF3/7 deficiency on the transcriptomes of resting, IFNγ-stimulated, 
and L. pneumophila-infected BMMs 
As in Fig. 3.13, except showing transcripts  with  a fold-change  less than 3 between counts in the two 
genotypes  in IFNγ-prestimulated and  L. pneumophila-infected BMMs. Transcripts shown have a 
fold-change  of 3 or greater (indicated  by *) in (a) two or three categories, (b) in infected but not 
IFNγ-prestimulated  BMMs only, and  (c) IFNγ-prestimulated  but uninfected BMMs. 
121   We have assumed that IRF3-dependent  effects result from IRF3 activity  following  infection 
with L. pneumophila, consistent  with a potential  role in bacterial  sensing pathways. However, IRF3 
deficiency  also affects the establishment  of an IFNγ-activated  state, as evidenced  by the large 
number  of genes differentially  expressed in uninfected IRF3
-/- BMMs relative to WT BMMs 
following  IFNγ stimulation  but not at baseline (Fig. 3-13c). This list includes inducible nitric oxide 
synthase (NOS2) as well as chemokines  (GDF15, CXCL11),  scavenger receptors (SCARF1), and a 
cation channel that controls macrophage activation (TRPV4). Like the genes in Fig. 3-13a-b, the 
genes listed in Fig. 3-13c are potential  elements of a transcription-mediated  pathway by which IRF3 
might  suppress the IFNγ-activated state.  However, the lack of IRF3-dependent  phenotype  in BMMs 
stimulated  with IFNγ during L. pneumophila infection  strongly  suggests that the inhibitory  effect of 
IRF3 on the IFNγ-activated  state that is relevant to restriction of L. pneumophila affects the 
maintenance  and function,  not the establishment,  of the IFNγ-activated  state. 
 
iNOS is upregulated but is not required for enhanced IFNγ-mediated restriction of bacteria in 
IRF3
-/- BMMs 
Inducible nitric oxide  synthase (iNOS, NOS2) is one of the canonical mediators  of the 
IFNγ-mediated response to  intracellular bacteria and parasites [40]. Nos2 transcription  was induced 
in macrophages synergistically by  prestimulation with 10U/ml IFNγ and by L. pneumophila 
infection.  Transcript levels in IFNγ-activated BMMs  were  approximately fivefold higher in IRF3
-/- 
BMMs compared to  WT BMMs before or after infection  (Fig. 3-13b). Therefore, we investigated 
the potential role of iNOS in the superior capacity of IRF3
-/- BMMs to restrict intracellular  bacteria.  
Consistent with the trend in transcript levels,  IRF3
-/- BMMs stimulated with 100U/ml  of 
IFNγ produced  significantly  more nitrite  metabolites  in response to bacterial infection  than 
identically  activated WT BMMs. At 10U/ml IFNγ, however, there was no significant  difference 
122   (Fig. 3-15a), likely  due to post-transcriptional  iNOS regulation, which  has  previously been 
described  in murine  macrophages [41,42].  This suggests that enhanced iNOS activity is 
dispensable  for the enhanced IFNγ-activated antibacterial response in IRF3
-/- BMMs. To 
investigate this in another way, we used both selective and nonselective  iNOS inhibitors to treat 
BMMs during  IFNγ stimulation  and infection.  Treatment with the inhibitors  L-NIL and 1400W 
suppressed nitrite  production  by both WT and IRF3
-/- BMMs, but did not affect restriction  of L. 
pneumophila in either WT or IRF3
-/- BMMs (Fig. 3-16), consistent with the existence of an iNOS-
independent  mechanism  of enhanced IFNγ-activated  bacterial restriction in BMMs lacking  IRF3. 
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Figure 3-15. IRF3 suppresses IFNγ-induced NO production  in the context of infection with 
bacterial or parasitic infection or TNFα costimulation 
a.  The Griess assay was used to detect nitric oxide byproducts  produced by IRF3
-/- and WT 
BMMs prestimulated  with IFNγ and infected with L. pneumophila in the presence of 
DMSO or iNOS inhibitors  L-NOARG, L-NIL or 1400W at concentrations  5-fold (low), 25-
fold (medium), or 125-fold  (high) above their published  IC50  
b.  The Griess assay was used to detect nitric oxide byproducts  produced by IRF3
-/- and WT 
BMMs mock-treated  (none),  stimulated  with 10U/ml  TNFα (TNF10),  infected  with T. cruzi 
Brener strain trypomastigotes  at an MOI of 5 (TCruzi5),  or co-prestimulated  with 10U/ml 
TNFα followed  by T. cruzi  infection  (TNF10_TCruzi5). 
124    
 
Figure 3-16. IRF3-mediated suppression of IFNγ-dependent restriction of L. pneumophila 
independently of iNOS inhibition 
WT or IRF3
-/-IRF7
-/-  BMMs were stimulated  with the indicated  concentrations  of IFNγ, then 
treated with the nitric oxide synthase inhibitors  L-NOARG, L-NIL, or 1400W at three different 
concentrations  before and during  infection  with L. pneumophila.  Bacterial growth was observed by 
measuring  bioluminescence.  IFNγ-dependent  bacterial restriction  was calculated as the ratio of 
growth in resting BMMs vs in IFNγ-stimulated  BMMs.  
 
The role of iNOS in pathogen restriction  varies with pathogen  species, and has been shown 
to be dispensable  for the restriction  of L. pneumophila in human monocytes  [43]. Therefore, we 
asked whether iNOS activity  was enhanced  in IRF3
-/- BMMs infected with the intracellular parasite 
Trypanosoma cruzi, which is restricted in an iNOS-dependent  manner in IFNγ−activated 
macrophages  [44]. iNOS-dependent restriction of  T. cruzi is potentiated  by co-stimulation with 
TNFα [45–47]. We found that IRF3
-/- BMMs prestimulated  with both IFNγ and TNFα produced 
significantly  more nitrites  than WT BMMs, and that infection  with T. cruzi further increased the 
125   amount of nitrites  released while maintaining  the effect of IRF3-dependent iNOS repression (Fig. 
3-15b). 
 
IRF3 suppresses IFNγ−activated defense mechanisms that delay the lysis of macrophages by 
the intracellular  parasite T. cruzi in a Type I IFN-independent manner. 
To assess the Type I interferon-independent  effect of IRF3 on the IFNγ-mediated restriction 
of T. cruzi, we infected BMMs with this parasite using media containing  IFNAR-blocking 
antibody.  IFNγ and TNFα-costimulated  IRF3
-/- BMMs released significantly  less parasites into cell 
supernatants at 5d after infection,  but not afterward (Fig. 3-17a). Restriction of  T. cruzi by 
IFNγ and TNFα-costimulated  WT and IRF3
-/- BMMs was only moderately  suppressed by addition 
of an iNOS inhibitor  before and during  infection,  indicating  the presence of both iNOS dependent 
and independent antimicrobial mechanisms induced by IFNγ in both genotypes. We used 
microscopy  to examine the fate of intracellular  parasites at 3d and 5d after infection  in BMMs that 
had been activated with 100U/ml  IFNγ and 10U/ml  TNFα and had not been treated with iNOS 
inhibitor.  At 3d, the infection  rate and average parasite burden per cell did not significantly 
different between genotypes  (Fig. 3-17b). At 5d, however, the average cellular  parasite burden was 
higher in WT than in IRF3
-/- BMMs, concomitant  with a drastic drop in cell density in WT BMMs 
only,  probably  due to the lysis of BMMs that release mature parasites as quantified  in (Fig. 3-17a). 
We conclude  that IRF3 suppresses an IFNγ-activated defense  mechanism that delays the 
maturation  and egress of T. cruzi parasites.  
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Figure 3-17. IRF3-mediated suppression of growth and lytic egress of T. cruzi from IFNγ and 
TNFα-stimulated BMMs  
a.  Trypanosomes  released into supernatant from WT or IRF3
-/- BMMs treated with IFNγ, 
TNFα and IFNAR-blocking antibody 
b.  Confocal images of fixed and stained infected BMMs were  analyzed using CellProfiler to 
identify  BMMs and parasites based on DAPI staining to quantify cell and parasite nuclei and 
Brightfield  images to demarcate cell borders. Cell survival was quantified  as the number of 
BMM nuclei  per field. 
 
127   Spatial distribution of IRF3 in L. pneumophila-infected or LPS-stimulated BMMs is 
consistent with IFNγ-mediated relocalization of IRF3 
  In order to gain insight  into the activity  of IRF3 in the context of intracellular  infection, we 
performed  immunofluorescence  analysis  of resting  or IFNγ-stimulated  WT BMMs after 
L.pneumophila infection,  or after stimulation  with LPS, which is known to drive IRF3 localization 
into the nucleus  (Fig. 3-18). Consistent with the results of Western blot analysis  in these cells (Fig. 
3-7), IRF3 was observed in the nuclei of resting BMMs 2h after infection  with L. pneumophila, as 
well as the nuclei  of BMMs stimulated  with LPS. IRF3 was partially  excluded from the nuclei of 
BMMs stimulated  with 10U/ml  of IFNγ prior to infection  or stimulation,  but mostly  localized  to 
the nuclei of LPS-stimulated  BMMs. IRF3 was more efficiently  excluded from the nuclei of 
BMMs that had been stimulated  with 10U/ml  of IFNγ prior  to infection  or stimulation. 
Surprisingly,  IRF3 staining  in IFNγ-stimulated  BMMs that had been either infected with L. 
pneumophila or stimulated with LPS displayed a  prominent cytosolic speckling pattern that was not 
detected in BMMs that had not been stimulated  with IFNγ. It it remains to be determined  whether 
the observed speckles are specific  for IRF3 or, perhaps,  an unidentified,  IFNγ-inducible cytosolic 
protein. If the staining  is specific for IRF3,  these results suggest that IRF3 is relocalized  in an 
IFNγ-induced manner. 
 
 
128    
Figure 3-18. Spatial distribution of IRF3 in L. pneumophila-infected or LPS-stimulated BMMs 
consistent with IFNγ-mediated relocalization  of IRF3 
Immunofluorescence  microscopy  analysis of IRF3 localization  in WT BMMs prestimulated  with the 
indicated  concentrations  of IFNγ for 16h,  then and fixed 2h after infection  with L. pneumophila or 
stimulation  with LPS. 
 
 
   
129   DISCUSSION 
Our studies of the role of innate sensing pathways in regulating  the IFNγ-induced anti-
bacterial state have led us to identify  a role for IRF3 as a repressor of the IFNγ-activated state. This 
novel  inhibitory pathway is not likely to depend on MYD88/TRIF,  STING,  MAVS or IFNAR for 
its effects, nor does it rely on iNOS for the enhancement of antibacterial effector activities.  Many 
genes are dysregulated  in IRF3
-/- BMMs when compared to wild type macrophages that are treated 
with IFNγ and infected with bacteria, suggesting  that IRF3 is a critical regulator  of gene expression 
during  establishment  and maintenance of anti-bacterial state. 
  Most studies showing that  IFNγ interacts with TLR sensors have identified  synergies, 
consistent with our findings  for concurrent IFNγ stimulation with  infection, but  different from the 
lack of effects in BMMs that are pre-stimulated  with IFNγ. In one study, IFNγ-mediated restriction 
of the cytosolic  bacterial pathogen S. flexneri in fibroblasts  was dependent on the transcription 
factor IRF1 that upregulated  the RIG-I RNA-sensing pathway [48], but did not suggest the 
antagonistic relationship that  we  found. On the other hand, there have been several studies showing 
that Type I IFNs can antagonize  the actions of Type II IFNs, in the same direction  as our findings. 
However, we could not find significant  production  of Type I IFNs in our system; and IFNAR 
deficiency  did not lead to an increase in IFNγ activity. 
One significant  class of genes induced in IRF3
-/- BMMs is related to iron restriction. 
Lipocalin  2 restricts iron availability  in the vacuoles of pathogenic  bacteria including  S. 
typhimurium [49–51],  M. avium [52], and C. pneumoniae [53], in some cases in an IFNγ-dependent 
manner [50], and is synergistically  induced  by IFNγ and L. pneumophila infection only in IRF3
-/-
IRF7
-/- BMMs in our experiment. Therefore, IRF3 potentially  masks an IFNγ-mediated  effect at the 
phagosome. In  addition, ferritin is strongly inhibited in IRF3
-/- BMMs, restricting the  import of iron 
from the external environment.  
130   There are several major pathways of further study to investigate the results obtained. First, 
it is essential to validate the independence  of the proposed mechanism  on Type I interferons  using 
IRF3
-/-IFNAR
-/-  mice. Then, comparison of  gene expression in BMMs from these mice and from 
IFNAR
-/- mice can elucidate which of the many genes that vary in IRF3
-/-IRF7
-/-  mice is relevant to 
the phenotype observed, and will help hone in on the proper effector functions  to prioritize  in 
further study. 
Second, our work has identified  a potential  cascade of inhibition  between IFNγ effectors 
and IRF3, visualized  by the partial exclusion  of IRF3 from the nuclei of IFNγ-stimulated  BMMs 
stimulated  by LPS or infected with L. pneumophila. This  raises  an  important question: what other 
stimuli  activate IRF3 in a manner that can be inhibited  by IFNγ effectors?  
Third,  the ligands  that activate IRF3 in the context of L. pneumophila, infection,  together 
with the investigation  of stimuli  mentioned  above, will help shed light  on the role of the IRF3-
mediated immunoregulatory mechanism. IFNγ-mediated  responses can be harmful in the context of 
tissue damage, when uncontrolled  inflammation  and necrosis can be the cause of pathology  rather 
than simply  a  bacterial defense, or in the context of infection  with most viruses, in which 
macrophages are skewed toward different effector functions.  Studies of in vivo infection  in mice 
lacking  IRF3 (and necessarily, to avoid confounding effects  of Type I  interferons, lacking IFNAR) 
will help investigate the role of IRF3-mediated suppression of  IFNγ effectors in the context of 
bacterial infection.  These mice may clear intracellular  bacteria such as L. pneumophila readily, or 
they may succumb to exuberant nitric oxide response in the lung. Furthermore,  the role of IRF3 in 
coinfection,  especially  with bacteria or parasites and viruses,  can be addressed either in vitro or in 
vivo. 
 
   
131   MATERIALS AND METHODS 
 
Mice 
IRF3
-/- mice were provided  by Dr. Meixiong  Wu with permission  from Dr. Tadatsugu 
Taniguchi. IRF7
-/- mice were  provided by Dr.  Evelyn Kurt-Jones. IRF3
-/-IRF7
-/-  and IFNAR
-/- mice 
were provided  by Dr. Kate Fitzgerald.  STING
-/- mice were provided  by Dr Glen Barber. Bone 
marrow derived from MAVS
-/- mice was  provided by Dr.  Akiko Iwasaki.  MyD88
-/-TRIF
-/-  mice 
were provided  by Dr. Ruslan Medzitov.  DNase2
-/- mice were provided  by Dr. Shigekazu  Nagata. 
TREX1
-/-  mice were  provided  by Dr. Judy Lieberman.  Age and sex-matched C57BL/6J mice were 
obtained  from Jackson laboratories. 
 
BMM isolation and  culture 
Bone marrow was collected  from femurs and tibiae of 2-6 month old mice. Red blood  cells 
were lysed using TAC RBC lysis buffer (Sigma). Cells were  passed through a  70 μm cell strainer and 
plated on non-tissue  culture treated petri dishes in RPMI-1640 medium, supplemented  with 10% 
FBS, L-glutamine, penicillin/streptomycin, MEM nonessential  amino acids, HEPES, sodium 
pyruvate,  β-mercaptoethanol,  heat-inactivated FBS,  and human MCSF (10ng/ml,  R&D Systems). 
BMMs were collected and reseeded into assay plates after 5 days of differentiation,  and stimulated  or 
infected after 7-12 days of differentiation.  BMMs were seeded in 96-well plates at 4e4-5e4 
BMM/well  unless otherwise noted. Cytokines  used to stimulate  BMMs were from Millipore  (IFNγ) 
or Peprotech (TNFα). BMMs were stimulated for 24h unless otherwise noted. iNOS inhibitors (L-
NOARG, L-NIL, 1400W) were from Sigma. 
 
Bacterial strains and parasites 
L. pneumophila strain LP02 delFlaA lux was provided  by Dr. Jörn Coers. T. cruzi strain 
132   Brener trypomastigotes were  provided by Dr.  Ricardo Gazzinelli.   
 
L. pneumophila and T. cruzi infections 
  L. pneumophila strains were maintained  on N-(2-acetamido)-2-aminoethanesulfonic  acid 
(ACES) buffered charcoal-yeast extract agar supplemented  with FeNO3, cysteine, and thymidine. For 
experimental assays,  L. pneumophila was grown in ACES-buffered yeast extract broth  at 37°C to a 
density  greater than 3 OD600. Bacteria were washed with PBS twice before infection. BMMs were 
infected at an MOI of 4 with bacteria resuspended in cell culture media. Infected BMMs were 
centrifuged  for 10 minutes  and incubated for 1.5-2 hours in a  cell culture incubator. Media was 
removed and replaced with fresh supplemented  media containing  thymidine.  Bioluminescence was 
measured over 2 days after infection  using  a plate reader (Envision).   
For T. cruzi infection, IFNAR-neutralizing antibody (Leinco) was included  in cell media 
from one day prior to infection onward. BMMs were infected with purified  trypomastigotes  at an 
MOI of 10 and incubated  for 2 hours in a cell culture incubator. BMMs were washed three times with 
warm PBS, and media was removed and replaced with fresh media at 2h after infection as well as 
daily starting at 3d after infection.  For extracellular parasite quantification,  well contents were 
agitated briefly  and 20ul of supernatant was applied  to a Neubauer hemocytometer.  Motile 
trypanosomes were  counted  manually. For  intracellular parasite  quantification, cells  were  washed 
three times with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.25% Triton-X,  stained 
with 4',6-diamidino-2-phenylindole  (DAPI), and imaged using a confocal microscope (Olympus). 
BMMs and parasites were  quantified using a  custom automated image analysis pipeline  in 
CellProfiler  [54] on the basis of Brightfield  image (BMM traces) and DAPI staining  (BMM nuclei 
and parasite nuclei/kinetoplastids). 
  For quantification  of nitrite/nitrate  byproducts  of NO synthesis in infected or stimulated 
BMMs, the Griess assay (Promega) was used according to the kit instructions. 
133   Western blotting 
Protein was purified from lysates of BMMs grown in six-well plates, infected with control or 
candidate-targeting  lentivirus,  and selected for puromycin  resistance. Cells were washed three times 
in PBS and lysed in RIPA buffer (Boston Bioproducts)  with protease inhibitor  (Roche). Lysates were 
purified  by centrifugation  and suspended in SDS buffer with 10mM dithiothreitol  (DTT). Proteins 
were separated by electrophoresis  on a Bis-Tris 4-12% polyacrylamide  gel (Novex), transferred to a 
nitrocellulose membrane, blocked with 5% milk in Tris-buffered saline with Tween  (TBST), and 
incubated overnight at  4°C with primary antibodies in 5% nonfat dry milk in TBST or, for phospho-
protein antibodies,  in 5% bovine  serum albumin  (BSA) in TBST. Membranes were washed, 
incubated with secondary antibody in 5% BSA in TBST for one hour at room temperature, washed 
again, and incubated with for 5min  with luminol  reagent (Pierce). Antibodies  were from Abcam (β-
actin),  Cell Signaling  Technologies (IRF3, IRF3pS388),  Jackson Immunoresearch  (HRP-conjugated 
secondary antibodies),  and Santa Cruz (TBP). 
 
Immunofluorescence microscopy 
  BMMs were seeded onto 8-well glass chamber slides (Nunc), washed three times with PBS, 
and fixed with 4% paraformaldehyde (Electron Microscopy Sciences) in PBS for ten minutes. Cells 
were permeabilized  with 0.25% Triton-X  and blocked  with 5% goat or donkey serum (Jackson 
Immunoresearch)  and 5% BSA (Cell Signaling  Technologies).  Primary antibody  incubation was 
done overnight  at 4°C. Cells were washed with PBS and incubated with Alexa-fluorophore 
conjugated  secondary antibody  (Life Technologies)  for 1 hour in the dark. Cells were washed, 
counterstained with DAPI, mounted on coverslips, and imaged using a  confocal microscope 
(Olympus). 
 
RNA-seq 
134     Total RNA was prepared using RNeasy columns  (Qiagen). RNA-seq libraries  were prepared 
under the supervision  of Max Mumbach  as described previously  [55]. Briefly, poly-A mRNA was 
captured using selection beads (Oligo-dT Dynabeads, Life Technologies).  mRNA was fragmented 
using zinc chloride (Ambion), and  3’ ends were dephosphorylated  prior to ligation  of RNA adapters 
(Illumina)  using T4 RNA ligase (New England  Biosciences). Reverse transcription  was performed 
using reverse transcriptase (Agilent) ,ssDNA  was  removed using ExoSap-IT (Affymetrix), and 
ssRNA was removed using acetic acid and sodium  hydroxide.  DNA adapters (Illumina)  were ligated 
using T4 RNA  ligase (New  England Biosciences). PCR  was  performed with barcoded primers 
(Illumina)  and Phusion DNA polymerase (New  England Biosciences) to identify and amplify 
libraries. Sequencing was  performed using a  HiSeq machine (Illumina) and data normalization was 
performed as  described previously [55] using the TMM method in R.  Further analysis was  performed 
using custom scripts in R. Heatmaps were generated by normalizing  each row (gene) and plotting 
using the heatmap2 function in R.  
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 SUMMARY OF FINDINGS 
 
Vesicle trafficking  screen 
In Chapter 2, we discussed  a targeted RNAi screen to find candidate L. pneumophila host 
factors and IFNγ mediators  among genes in a curated vesicle trafficking  set. Primary screening  in the 
RAWγNO murine macrophage cell line assayed 380 genes using a lentiviral  RNAi library  of 
approximately  5 shRNA constructs per gene, measuring  the effect of each construct on both bacterial 
growth and on cell survival  and proliferation.  We developed  a novel, unbiased  computational 
analysis pipeline to  identify constructs  that  significantly increased  or  decreased observed bacterial 
growth relative to the growth  expected at similar cell counts. 73 candidate  host factors and 84 
candidate  IFNγ mediators were tested in a secondary screen using bone marrow derived macrophages 
(BMMs). Of these, 9 candidate  host factors and 26 candidate IFNγ mediators  were manually 
classified  as  validated on the basis of bacterial growth in BMMs relative to cell count. We pursued 
further  validation and  functional characterization  for several of the candidate IFNγ mediators.  
Knockout mice were used where available  to validate the phenotypes observed in cells 
depleted of  candidate transcripts using shRNA. Further assays  measured the regulation of  proteins 
levels   in response to IFNγ treatment, the effects of transcript  depletion  on phagocytosis  or on the 
levels of lysosomal  marker proteins,  and the cellular  localization  of candidate proteins relative to the 
bacterial phagosome. Using knockout  mice, we discovered that ARL8B, VTI1B, and AP3B1 are not 
required  for IFNγ-mediated restriction of L. pneumophila in BMMs. The candidate TSPAN6 is a 
potential  member of this pathway, though the relevant results were not always reproducible,  and the 
hypothesis requires  further testing. In particular,  the expression  of TSPAN6 in BMMs appears to be 
low, and the specificity  of anti-TSPAN6 antibody remains to be confirmed.   
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 Effect of innate immune  sensing on IFNγ-activated restriction of intracellular  pathogens 
  In Chapter 3, we describe work investigating  the effect of innate pathogen sensing on the 
IFNγ-activated state, culminating  in the identification of the transcription  factor IRF3 as a suppressor 
of IFNγ effectors through  a mechanism independent  of Type I interferons (IFNs). Using BMMs 
derived from wildtype  (WT) and knockout  mice, we used cells that were strictly  pre-stimulated with 
IFNγ prior to, but not during  exposure to bacteria in order to assess the contribution  of sensing 
pathway members on the maintenance,  but not the establishment,  of the IFNγ-activated state. We 
found  that the TLR pathway adaptor proteins  MYD88 and/or TRIF facilitate  both the establishment 
and maintenance of the IFNγ-activated state, while  the nucleic acid sensing adaptor STING 
facilitates the maintenance  of the IFNγ-activated state, and the nucleic acid sensing adaptor MAVS 
does not have a significant  effect on either. Meanwhile, the  transcription factors IRF3 and/or IRF7, 
which are activated downstream of the nucleic acid sensing pathways that signal  through STING and 
MAVS, suppress the maintenance  of the IFNγ-activated state, unlike  these upstream adaptors. IRF3 
and IRF7 are not required for the establishment  of the IFNγ-activated state, suggesting  that the JAK-
STAT signaling  pathway downstream of IFNγ receptor (IFNGR) engagement is functionally  intact in 
IRF3
-/-IRF7
-/-  BMMs. Further work revealed that IRF3, but not IRF7 was responsible  for the 
phenotype in IRF3
-/-IRF7
-/-  macrophages. 
Our results revealed that IRF3 is activated by phosphorylation  and localizes  to the nucleus of 
L. pneumophila-infected BMMs, but that activated IRF3 is not detected in either the nucleus or 
cytoplasm  of IFNγ-activated BMMs following  infection,  despite the activation  of IRF3 kinases IKKε 
and TBK1. Meanwhile,  immunofluorescence  analysis revealed a speckled cytosolic  pattern of IRF3 
staining in IFNγ-activated,  but not resting BMMs following  infection with L. pneumophila or 
treatment with lipopolysaccharide  (LPS), suggesting  that IFNγ effectors relocalize IRF3 -- even as 
IRF3 directly  or indirectly  suppresses IFNγ effectors. 
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 Several lines of  evidence suggest that the mechanism  by which IRF3 suppresses IFNγ 
effectors is independent  of Type I interferons, a class of proteins  that make up one of the major 
transcriptional  targets of IRF3 and one of the canonical  mediators of the IRF3-dependent antiviral 
response. First, deficiency  in the Type I IFN receptor (IFNAR) does not phenocopy deficiency in 
IRF3; in fact, IFNAR appears to make a small but non-redundant  positive  contribution  to the 
maintenance of the IFNγ-mediated state. Second, ablation  of IFNAR signaling  with a neutralizing 
antibody  does not reduce the relative enhancement in IFNγ-mediated bacterial restriction observed in 
IRF3
-/- BMMs relative to WT BMMs. Third, the levels  of Type I IFNs induced by resting or IFNγ-
activated BMMs following L. pneumophila infection  are low, based on qPCR quantification  of 
transcription  of IFNβ and lack of detection of any Type I IFNs by ISRE reporter cells. 
We investigated  the mechanism by which IRF3
-/- IFNγ-activated BMMs more efficiently 
restrict L. pneumophila when compared to WT IFNγ-activated BMMs. Using  WT BMMs or BMMs 
deficient in IRF3 and IRF7, we measured gene expression before and after infection  with L. 
pneumophila in both resting and IFNγ-activated  BMMs using RNAseq. After excluding  genes with 
insignificant expression levels across  all conditions,  232 transcripts were found to be differentially 
expressed by threefold  or more as a result of IRF3/IRF7  deficiency in IFNγ-stimulated or  L. 
pneumophila-infected BMMs. The data revealed that IRF3/IRF7 profoundly  affect the transcriptome 
of BMMs following  L. pneumophila infection,  but also after IFNγ stimulation  and in the resting state, 
with both distinct  and overlapping  gene sets affected under each combination  of conditions. 
The inducible  nitric oxide (NO) synthase (iNOS, otherwise known as NOS2), a well-
described IFNγ effector, was present among  the 93 genes preferentially  induced in IRF3
-/-IRF7
-/- 
BMMs relative to WT BMMs following  both IFNγ stimulation and  L. pneumophila infection. 
Indeed, IRF3/IRF7 deficiency  resulted in roughly  five times more Nos2 transcription  under these 
conditions.  On the post-transcriptional level, following IFNγ stimulation and  L. pneumophila 
infection, the  observed concentration of nitrite byproducts of  NO production  by IRF3
-/- BMMs was 
144 
 two-fold  greater than by WT BMMs. Preferential IFNγ-dependent  nitrite production  in IRF3
-/- 
BMMs was not unique  to BMMs infected with L. pneumophila, but  was also observed  following 
stimulation  with LPS, TNFα, or after infection  with the protozoan  parasite Trypanosoma cruzi. 
However, ablation  of NOS2 activity  with chemical  inhibitors  did not change levels  of IFNγ-mediated 
bacterial restriction  in either IRF3
-/- or WT BMMs.  
NOS2 activity  is known to play a nonredundant  role in the IFNγ-mediated  restriction of 
intracellular  T. cruzi. While  IFNγ-stimulated  IRF3
-/- BMMs bear the same net parasite burden as WT 
BMMs, we found that the lysis of IRF3
-/- BMMs that accompanies  T. cruzi egress is substantially 
delayed relative to WT BMMs in a NOS2-dependent  Type I IFN-independent manner. 
 
 
ANALYSIS AND IMPLICATIONS 
 
Vesicle trafficking  screen 
RNAi screening of the vesicle trafficking  gene set in the context of L. pneumophila infection 
of BMMs did not yield any consistently  validated  and characterized IFNγ mediators.  However, 
general observations  from this RNAi screen may be relevant to the process of other screening 
experiments  as well.  Furthermore,  negative results obtained are significant in their own right. 
 
Technical issues in the RNAi screening process 
First,  both the primary  and the secondary screens exhibited  a large amount of noise, or 
variation among negative control shRNA constructs in both the cell count and bacterial growth 
observed. Still,  we were able to distinguish  strong hits above the noise by using  a large  number  of 
negative controls. However, the screen lacked a robust set of positive  controls,  which are another 
critical element of  good screen  design [1]. In fact, while the positive  control construct shJak2 was 
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 classified as  a screening hit in the primary screen, it fell beyond the cutoff in the secondary screen 
because of high overlap with negative control data. Does this fact invalidate  the hit classification 
strategy used in the secondary screen? Without  more data points,  this is difficult  to conclude,  since 
the single shJak2 construct used as a positive  control  could have unique,  idiosyncratic  off-target 
effects in BMMs. The use of more well-validated positive controls, such as multiple  shRNA 
constructs targeting both Jak2 and Stat1, would increase the statistical  power of the screen and help 
decrease false positive  hit identification.   
Second,  a majority  of the shRNA constructs classified  as hits in the primary  screen using 
RAWγNO cells were not  validated  in the secondary screen using BMMs. While this narrowing of 
candidates  is expected by design,  it is important  to note that false negatives can stem from 
experimental error or from different thresholds in hit selection, as opposed to real biological 
differences between cell line and primary macrophages. Even true biological  differences can lead to 
false negatives or positives,  if they impact significant  off-target effects of shRNA that confound  the 
data observed. Finally,  the strategy of screening in WT BMMs could have led to false negatives as 
well. One  obvious biological difference  between host cells in the two screens is that primary  BMMs 
produce NO, while  RAWγNO cells do not. Disabling  NOS2 in the secondary screen could  have 
allowed us to better replicate the conditions  in the primary screen and to lower the rate of false 
negatives. While NO  is a redundant player in IFNγ-mediated  L. pneumophila  restriction in BMMs 
[2], iNOS inhibition using a  chemical inhibitor  may have been sufficient  to reveal additional 
pathways disabled  by shRNA in the IFNγ mediator  arm of the secondary screen.  
Another issue affecting the shRNA screen was the relative lack of candidate genes for which 
more than a single  shRNA construct yielded  a hit  phenotype.  In the primary screen, 63 of 74 L. 
pneumophila host factor candidates  and 73 of 84 IFNγ mediator  candidates  were classified  as hits 
based on data obtained with only a  single shRNA construct. Of the 22 genes classified as candidates 
based on multiple  shRNA constructs in either arm of the screen, only two were also validated by 
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 multiple  constructs in the secondary screen. One of these, the candidate  L. pneumophila host factor 
choroidemia-like protein (CHML), has been studied in human phagocytic cells,  and its described 
function  does not suggest a potential  role  as a bacterial  host factor [3]. In particular,  siRNA-mediated 
depletion of  Chml transcript in human cells suppressed phagosome acidification and  maturation, and 
reduced the clearance of phagocytic  cargo [4], the opposite  of what would be expected from our 
screen. The second multiple-shRNA candidate  in the screen, the potential  IFNγ mediator  TSPAN6, 
was represented by two shRNA constructs that were later found to be redundant  at all but a single 
nucleotide. Thus,  genes classified as hits by multiple targeting constructs were largely  absent from 
this screen, which may have been  partially responsible for  the difficulty  validating  the candidates 
identified. 
Redundancy  is a hallmark  of the intracellular  life cycle of L. pneumophila. Among  270 or 
more effectors secreted through the Dot-Icm secretion system, only one (SdhA) has been shown to 
play a non-redundant  role in intracellular  survival within macrophages [5–7], and many macrophage 
host factors have been identified  as redundant as well [8,9]. However, at least two individual  host 
factors (SAR1 and ARF1) have been shown to be uniquely  required for optimal  intracellular  growth 
of L. pneumophila [9]. Notably,  several L. pneumophila effector proteins  have been shown to bind 
host factors with remarkably high binding affinity [10,11], suggesting that complete host factor 
protein ablation  rather than incomplete  shRNA-mediated depletion of  protein expression may have 
been be required in order to identify other essential host factors. 
Host defense mechanisms  are often highly  redundant as well [12]. Many parallel  pathways 
exist to deal with the large variety of bacterial and protozoan  intracellular  pathogens that infect 
macrophages,  as outlined  in Chapter 1. In addition  to NO production,  primary  BMMs may have 
other, redundant  IFNγ-inducible bacterial restriction mechanisms that cannot be discovered by a 
single-gene knockout approach. 
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 Candidate L. pneumophila host factors 
Hits in the host factor screen include  two members of the syntaxin  protein family  with roles 
in the early endocytic  system. It is possible that these proteins play a  role in phagosome modification 
by L. pneumophila. One of these candidates (SNX18),  for instance, is exploited  by the intracellular 
bacterium  S. typhimurium for the same purpose [13]. The actin regulator  WASF2, the early 
endosomal protein subunit RAB5B, and  seven other candidates were confirmed  as hits in the 
secondary screen as well. 
 
Significant negative results in the IFNγ mediator screen 
Work by our group and collaborators  using  knockout cells appeared to rule out a requirement 
for SNAP29, VTI1B, ARL8B, and AP3B1 in the IFNγ-mediated restriction of L. pneumophila. 
Results in knockout models are  considered definitive,  but with a  caveat: parallel pathways in cells 
constitutively deficient in a  target pathway could be stronger than they would be in cells in which the 
target pathway were suddenly  ablated. However, our work with VTI1B
-/- BMMs allowed us to prove 
that the phenotype observed in the screen was the result of an off-target effect of shVti1b rather than 
a result of VTI1B depletion.  This is a significant  negative result. VTI1B is a core member of the 
fusion machinery required for  homotypic fusion of late endosomes  [14] or heterotypic  fusion of late 
endosomes with lysosomes [15], or autophagosomes  with lysosomes [16]. Therefore, in IFNγ-
activated cells, this core fusion machinery  is either dispensable for bacterial restriction,  or utilizes 
other SNARE proteins in place of VTI1B.  
 
Candidate IFNγ mediators 
Preliminary  evidence  has suggested that TSPAN6 may be an IFNγ-inducible  member of the 
bacterial restriction machinery that seems  to localize to  the bacterial phagosome in macrophages. 
TM4SF4, another high-ranked  hit, was not characterized further since an antibody  was not available. 
148 
 If further work validated  a potential  role for either in the restriction  of L. pneumophila, it  would  join 
the ranks of several other tetraspanins  with known roles in immunity. In humans, loss of function  of 
the tetraspanin CD53 has been linked  to susceptibility  to bacterial, fungal,  and viral infections, 
including  the vacuolar pathogens M. tuberculosis and Salmonella [17]. This  tetraspanin is induced in 
LPS-treated macrophages,  and facilitates the activation  of iNOS [18] and the oxidative  burst [19,20]. 
Some members of the transmembrane 4 L six family  (TM4SF)  of tetraspanin proteins,  including 
CD9, CD63, CD81, CD151, and A15, play significant  roles in host defense, such as phagocytosis, 
signal transduction, and the recruitment of phosphoinositol  kinases [21]. Multiple tetraspanins, 
including  CD37, CD53, CD63, CD81, and CD82, are found on the membranes of multivesicular 
body vesicles and on exosomes released by phagocytic  cells [22]. IFNγ induces  the expression  of the 
tetraspanin CD82, which a  mediates signaling from the  phagocytic  receptor FcR [23], and suppresses 
the expression of CD9, a negative regulator of macrophage activation  [24,25]. Our data suggest that 
the tetraspanins TSPAN6 and TM4SF4  may function  in IFNγ-mediated  defense as well, but more 
work is needed to substantiate  these possibilities. 
The AP3  complex plays a  role in protein sorting and  membrane targeting in the biogenesis of 
lysosomes  and lysosome-related organelles [26,27].  The conflicting  data we obtained in our work 
with BMMs deficient  in AP3 complex member AP3B1 is still  unexplained.  shRNA-mediated 
depletion  of AP3 complex subunits  AP3S1, AP3S2,  and AP3M2 in both WT and AP3B1
-/- BMMs, 
using the same shRNA constructs classified  as  hits in the primary screen, did not reveal the influence 
of shRNA off-target effects, as they had for shVti1b.  The AP3 subunit  β3, known as AP3B1, has 
been described as an essential member of AP3. It is possible  that the requirement  for AP3B1 is 
dependent on some other variable which we did not account for in our experiments,  such as the 
precise length of time that cells were stimulated  with IFNγ. The experiments  that failed to show a 
restriction  defect relative to WT BMMs may have involved,  for example,  parallel  pathways of 
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 pathogen restriction  that obscured the role of AP3. Alternatively,  they may have involved an 
alternative,  functional  AP3 complex formed without an β3 subunit  in AP3B1
-/- BMMs.   
 
Effect of innate immune  sensing on IFNγ-activated restriction of intracellular  pathogens 
 
IRF3 
  The existence of interactions between  innate immune sensing pathways and the IFNγ 
signaling  pathway is well-known,  mediated in part by the synergy of TLR-activated NFκB with 
IFNGR-activated STAT1 homodimers  at IFNγ-activated sequences (GAS) within  the promoters of 
IFNγ target genes [28]. Our work has, in contrast, demonstrated a  significant  effect of the innate 
immune sensing pathway member IRF3 on the maintenance  of IFNγ effector mechanisms  in BMMs, 
independently  of IFNγ signaling.  We were able to separate the effects of innate sensing on signaling 
from its effects on IFNγ effector maintenance by prestimulating  BMMs with IFNγ, then removing 
this stimulus prior to infection  and therefore prior to innate immune  pathogen sensing.  
 
MYD88/TRIF 
  Notably, our  initial  work with MYD88
-/-TRIF
-/-  BMMs revealed  a significant,  though 
relatively  small contribution  of these adaptor proteins to the maintenance of the IFNγ-activated state. 
Our work also recapitulated the  known  requirement  for TLR adaptor proteins MYD88 and TRIF in 
full macrophage activation  by IFNγ signaling,  which resulted in a far more significant  positive  effect. 
While these two effects could be independent,  it is also possible  that the observed effect of 
MYD88/TRIF on pre-stimulated  BMMs was due to their effect on signaling  through IFNGR engaged 
with residual  IFNγ that remained  bound  during  infection  and media changes.  
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 STING 
  We showed that the cytosolic nucleic acid sensing pathway adaptor protein  STING, but not 
MAVS, plays a role in supporting  the maintenance  of the IFNγ-activated  state, although  the effect 
was slight.  Our ensuing  work, however, showed that the transcription  factor IRF3 that acts 
downstream of STING in macrophages suppressed, rather than supported the maintenance of the 
IFNγ-activated state.  These data are consistent with STING-mediated  maintenance of the IFNγ-
activated state through  a signaling  pathway that does not use IRF3. Two such pathways have recently 
been described, both of which can be activated by either cytosolic  dsDNA or cGAMP and which  lead 
to the nuclear translocation  of the transcription  factor NFκB. In these pathways, STING signals 
through  either TRAF6,   or through  TBK1 via TRAF3, to activate the canonical  IKK kinases (IKKα 
and/or IKKβ) which phosphorylate  the inhibitor  of NFκB [29]. It is possible  that NFκB activation,  in 
turn, directly  or indirectly  facilitates  the continued  expression  of IFNγ effectors and therefore 
enhances the maintenance of the IFNγ-activated state. 
  STING activation  has been observed as a result of sensing of excess cellular  or pathogen-
derived  DNA in BMMs deficient in either the cytosolic  nuclease TREX1 [30,31]  or the 
phagolysosomal  nuclease DNASE2 [32,33].  Based on our preliminary  results, TREX1 deficiency 
enhanced the maintenance  of the IFNγ-activated state,  consistent with increased activation of 
STING.  Surprisingly,  however, DNASE2 deficiency  had the opposite result.  A possible  unifying 
model for these data is that excess phagolysosomal  DNA in L. pneumophila-infected DNASE2
-/- 
BMMs predominantly  triggers the IRF3-activating  modality  of STING and leads to subsequent 
suppression  of the IFNγ-activated state. Meanwhile,  excess cytosolic  DNA in L. pneumophila-
infected TREX1
-/-  BMMs predominantly triggers  the NFκB-activating modality of  STING and  leads 
to subsequent  enhancement  of the IFNγ-activated state. 
 
IRF3 activation and localization 
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   IRF3 activated by Ser388 phosphorylation  was present in the nuclei of resting, but not IFNγ-
activated BMMs after  infection  with L. pneumophila, despite robust phosphorylation  of the IRF3 
kinases IKKε and TBK1 under both  conditions.  Furthermore, immunofluorescence microscopy 
revealed decreased staining  density  of IRF3 in the nucleus as well as cytosolic  speckling  in IFNγ-
activated BMMs following L. pneumophila infection  or LPS stimulation.   These findings  may be 
unrelated,  or they may represent a causal or associative relationship  between the speckled 
distribution  and the nuclear exclusion  of IRF3. For instance, the recruitment  of IRF3 to cytosolic  foci 
could  prevent its phosphorylation  by active IKKε/TBK1 kinases,  or prevent the translocation  of 
phosphorylated  IRF3 to the nucleus.  
A recent study in mouse embryonic fibroblasts  (MEFs) expressing the pestivirus  protease 
N
pro revealed formation  of cytosolic  and peroxisomal  puncta containing  N
pro and IRF3 following  cell 
stress response induction  by sodium  arsenate [34], though it is unknown  whether the localization  was 
driven by IRF3 or by the viral protein; here, N
pro led to the degradation  of IRF3 to inactivate  antiviral 
responses. Other studied have found that the IRF3 kinase TBK1 localizes  to cytosolic  speckles 
together with RIP1, RIP3, and adaptor proteins following  signaling  from TLR3, TLR4, or DAI 
[35,36], but IRF3 was thought  to be recruited to these granules transiently,  followed  by TBK1-
mediated activation  and translocation  to the nucleus. Our results so far do not distinguish  whether 
IRF3 recruitment  to speckles is related to its activation,  degradation,  or neither. We found that total 
IRF3 levels  remain constant during  IFNγ stimulation  and L. pneumophila infection,  but cannot rule 
out degradation  since IRF3 synthesis  could be concomitantly  increased to offset a degradative 
response. 
  The differential  nuclear recruitment or retention  of IRF3pSer388 in resting, infected BMMs 
but not IFNγ-stimulated  BMMs suggests that the transcriptional  activity  of IRF3 is responsible for 
the phenotype observed, with the caveat that multiple  other post-translational modifications could 
affect IRF3 activity regardless of Ser388 phosphorylation [37]. Furthermore, cytoplasmic IRF3 plays 
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 a variety of other effector roles. At levels of IRF3 activation  above a threshold  level,  for example, 
IRF3pSer388 directly activates mitochondrial  Bax to induce the intrinsic  pathway of apoptosis 
[38,39]. However, we did not detect a difference in levels of cytoplasmic  IRF3pSer388 in resting  or 
IFNγ-stimulated  BMMs,  nor did we observe a decrease in cell counts in IFNγ-activated BMMs 
relative to WT BMMs following  L. pneumophila infection. In addition, cytosolic IRF3 can act as a 
transcriptional repressor, as demonstrated  in T cells in which the transcription  factor RORγT is 
sequestered by IRF3 to prevent nuclear translocation  [40]. Therefore, the differential  nuclear 
recruitment  or retention  of IRF3 in resting  or IFNγ-stimulated  BMMs may or may not be a causative 
factor for IRF3-mediated  suppression  of the IFNγ-activated state. 
 
Type I IFNs 
  Both resting and IFNγ
-/- BMMs produced minimal amounts of Type I  IFNs  upon infection 
with L. pneumophila. Accordingly, the  blocking of  IFNAR  using neutralizing antibody did not  affect 
bacterial growth or restriction  in WT or IRF3
-/- BMMs, leading  us to conclude that IRF3-dependent 
suppression  of IFNγ-mediated  bacterial restriction  is independent  of Type I IFNs. Notably,  IRF3 also 
exerts a Type I IFN-independent  effect on in vivo infection  with the intracellular  pathogens Yersinia 
pestis[41] and Chlamydia muridarum [42], though in the case of these pathogens, IRF3 is protective. 
Interestingly, however, IFNAR
-/- BMMs had a slight  defect in both the induction  and the 
maintenance of the IFNγ-activated state. This suggests that basal signaling though IFNAR plays a 
role in enabling  BMMs for full  IFNγ-mediated defenses. Tonic IFNAR signaling  has been predicted 
to play an immunoregulatory  role [43], and examples have been described in cells exposed to 
commensal microbiota [44]. It is possible  that exposure to basal IFNAR signaling  in BMMs grown 
under sterile conditions,  perhaps in response to endogenous  ligands,  maintains  these cells in a state of 
preparedness for future activation,  and that addition  of anti-IFNAR antibody  does not displace 
existing receptor-ligand  pairs that maintain  the basal state. 
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   When high  levels of IFNβ, which are not endogenous  to infected BMMs in culture,  are 
administered  to BMMs immediately  after infection  with L. pneumophila, we observed a significant 
difference in response depending on whether BMMs had been pre-stimulated  with IFNγ or whether 
IFNγ.stimulation  was done concurrently  with infection  and IFNβ administration. While these 
findings  are not central to our results so far, they may be relevant in vivo, where macrophages may be 
exposed to Type I interferons  produced  by epithelial,  dendritic,  and other cells. Exogenous  IFNβ had 
a slight  restrictive effect on the growth of bacteria in resting BMMs, but a substantially  greater 
restrictive effect in BMMs that had been prestimulated  with IFNγ. However, IFNβ administered 
simultaneously  with IFNγ following  infection  significantly  increased bacterial  growth,  antagonizing 
IFNγ-mediated restriction. One  model consistent with these results is that IFNβ-induced transcription 
factors differentially  modulate  the expression  of IFNγ effectors depending  on the presence of IFNγ-
induced transcription  factors at their promoters. 
 
Transcriptional effects of IRF3 deficiency 
  Since IRF3 is involved  in signaling  pathways downstream of innate immune  sensing,  it was 
not surprising  that IRF3 deficiency  was  responsible for  significant transcriptional changes  in  L. 
pneumophila-infected BMMs. Differentially  expressed genes included  the IFNγ effector NOS2, as 
well as several other candidates  that could  potentially  be involved  in enhanced IFNγ-mediated 
bacterial restriction  in BMMs.  
Iron restriction  is an important  aspect of intracellular  pathogen control.  In our data, IRF3
-/- 
BMMs exhibited  differential  expression  of lipocalin  2 (LCN2),  an iron regulator with roles in 
restriction  of several vacuolar pathogens [45–47], and the  iron storage protein ferritin light chain 
(FTL2)  in response to IFNγ stimulation and  bacterial infection, suggesting that  limiting access  to 
iron be partially  responsible  for enhanced bacterial restriction  in these cells. Several other categories 
of differentially  expressed genes present other opportunities  for further exploration,  including 
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 transcription  factors (LYL1, EGR3, EPAS1, BATF3, KRC), regulators of cell death (CHEK2, 
NPTX1, SERPINB2, FAH, CD00IF),  and protease inhibitors  (SERPINB2, subunits  of SERPINA3, 
STFA3, CST7, GM5483). 
Unexpectedly,  IRF3 deficiency  also led to significant  gene expression  changes in uninfected 
BMMs. This result suggests a basal role for IRF3, potentially  due to endogenous  stimuli,  such as 
DNA from dying  macrophages. Several of these genes were uniformly  induced or repressed by IRF3 
across all conditions,  like the fatty acid binding  protein  7 (FABP7) expressed only in WT BMMs, or 
several non-coding  transcripts that were only significantly  expressed in IRF3
-/- BMMs. Interestingly, 
a subset of genes were strongly  induced  in response to IFNγ stimulation  only  in IRF3
-/- BMMs, 
though their expression  was inhibited  by bacterial infection.  These include  a GBP protein (GBP11) 
and the protease inhibitor  cystatin F (CST7), mentioned  above; the role of genes in this cluster in 
bacterial infection  is unknown.  
 
T. cruzi 
Our work with T. cruzi-infected BMMs confirmed that IRF3 can play a role in suppressing 
IFNγ-mediated  responses to intracellular parasitic as  well as  bacterial pathogens through  a 
mechanism  independent  of Type I IFNs. However, several key differences in this experimental 
system need to be considered  in interpreting  these results. First,  TNFα was used to co-stimulate 
BMMs together with  IFNγ. Second,  BMMs were stimulated  with IFNγ both before and after T. cruzi 
infection.  Therefore, the phenotype  observed could be due to suppression  of either the establishment 
or the maintenance  of either the IFNγ- or the TNFα-activated state.  Finally,  two pathogens are 
controlled  by only partially  overlapping  sets of innate defense mechanisms  due to significant 
differences between their pathogen-associated molecular patterns, virulence mechanisms,  and  
intracellular  life cycles. While  L. pneumophila thrive in a remodeled phagosome that prevents 
lysosomal fusion, for instance, the intracellular replication program  of T. cruzi requires exposure to 
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 lysosomal  contents and eventual egress into the cytosol [48]. Inside the macrophage, infectious 
trypomastigotes  convert into non-motile, replicative  amastigotes; after several rounds of replication, 
cytoplasmic  amastigotes transform back  into motile trypomastigotes  that lyse the host cell and go on 
to infect bystander host cells [49]. 
Interestingly,  it appears that the cell membranes of T. cruzi-infected WT BMMs were lysed 
more readily  than the membranes of infected, IRF3
-/- BMMs. Since the transformation  of amastigotes 
to trypomastigotes  is a prerequisite  to host cell lysis,  it is possible  that IRF3
-/- BMMs are able to 
better prevent or delay this stage transition  due to the actions of innate immune  effectors. 
Alternatively, IRF3 deficiency  could affect the process of membrane disruption  by 
trypomastigotes.  The mechanism  of parasite egress from infected cells is poorly  understood. Prior 
work has suggested that mechanical  disruption  of the cell membrane by a high burden of motile 
intracellular  trypomastigotes  contributes  to host cell lysis  [50,51], while other studies have 
implicated  the role of parasite-derived  lipases or proteases, particularly  cruzipain  [52]. The T. cruzi 
lifecycle  has been largely studied in a variety of cell types, such as  epithelial  cells, myocytes, and 
fibroblasts; meanwhile, the contribution  of macrophage innate immune  sensors and effectors to cell 
membrane breakdown in the macrophage host remains unknown.   
  
Function of IRF3-mediated suppression of IFNγ suppressors 
As demonstrated in vitro, IRF3 is a novel player in the immunomodulation  of macrophage 
microbicidal activity. Further studies will shed light on the molecular mechanism of  this antagonism 
and its role in diverse infections  in vivo. The presence of an intrinsic  suppressor mechanism  for 
IFNγ-mediated  effectors is in line with other homeostatic  processes of the immune  system. This 
suppression  may have evolved  to dampen a potentially  damaging  anti-bacterial response, and thus to 
preserve cellular  preparedness for antiviral  defenses, or to avoid  pathology  caused by over-exuberant 
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 IFNγ-mediated activation of  macrophages downstream of  bacterial sensing. Overproduction  of nitric 
oxide, in particular, has been linked with pathology  in the liver and lung due to its damaging  effects 
on host DNA, mitochondria,  lipids,  and enzymes [53] in the context of chronic inflammation, 
chemical exposure, or exogenous, therapeutic nitric oxide administration [54,55];  in the context of 
bacterial infection, it has been observed in patients with pre-existing inflammatory conditions [56]. 
 
 
FUTURE DIRECTIONS 
 
Vesicle trafficking  screen 
The vesicle trafficking  screen revealed several candidate L. pneumophila host factors, all of 
which are candidates for further validation  and functional  characterization.  Among candidate IFNγ 
mediators, meanwhile,  TSPAN6 was neither fully  characterized nor eliminated  by functional 
characterization  due to doubts about the specificity  of the anti-TSPAN6 antibody  and the low 
expression of TSPAN6 mRNA by qPCR. In order to better validate  TSPAN6 as a candidate IFNγ 
mediator, several approaches could be taken.  First, alternative methods to  deplete  gene transcripts 
could be used, such as short interfering  RNA (siRNA). We used three different siRNA constructs 
(Ambion)  targeting  murine  Tspan6 in RAWγNO cells,  and compared target gene expression as well 
as IFNγ-mediated bacterial restriction in these cells relative to cells treated with negative control 
siRNA  (Ambion, Dharmacon)  or  the  positive control siStat1.  Depletion of  Stat1  transcript was 
verified  by qPCR, and resulted in a drastic reduction  in IFNγ-mediated bacterial restriction. 
However, siTspan6 did not result in consistent depletion  of transcripts as measured by qPCR, or of 
protein,  as measured by Western blot analysis. 
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 Second, the TSPAN6 construct could be overexpressed in an attempt to rescue the shRNA 
knockdown phenotype. In our experience, however, lentiviral-mediated overexpression of  the  human 
Tspan6 ORF (which is resistant to knockdown by  shRNA constructs targeting  murine Tspan6) and of 
control  ORFs in RAWγNO cells was low and transient. In BMMs, meanwhile,  the dual rounds of 
antibiotic-based  selection required for lentiviral-mediated  overexpression  and knockdown  of human 
and murine TSPAN6, respectively,  led to unacceptable levels of cell death. A third,  more promising 
approach is the overexpression  of TSPAN6 labeled with an HA or fluorescent protein  tag in WT 
BMMs, in order to track its expression  and localization,  respectively,  after IFNγ stimulation  and L. 
pneumophila infection.  If future results confirm the recruitment of TSPAN6 to bacterial phagosomes, 
it would be  informative to correlate its presence  with markers of  phagosome maturation or  with 
known effectors, such as the oxidative  burst. Since tetraspanins  are  small proteins mostly buried 
within the phospholipid bilayer of membranes, however, a  tagging approach could be  challenging. 
Finally,  genetic deletion  of TSPAN6 using knockout  mouse models or CRISPR-CAS9 would enable 
further investigation  of the role of TSPAN6 in a clean genetic model. 
Because the machinery involved  in bacterial restriction  in BMMs is redundant,  it is possible 
that false negatives in the secondary screen could be recovered by repeating the screen in BMMs 
deficient in some of the known mechanisms.  To remove the effects of iNOS, for example, BMMs 
could  be treated with a chemical  iNOS inhibitor  before and after IFNγ stimulation  and infection. 
Furthermore, multiple  mechanisms  could be disabled  simultaneously  in order to reveal subtle effects. 
For instance, a recent study used BMMs deficient  in four different resistance mediators (IRGM1, 
IRGM3, NOS2, and NOX2) to support the conclusion  that GBP-mediated  mechanisms  play  a non-
redundant role in restriction  of L. pneumophila. 
 
Effect of innate immune  sensing on IFNγ-activated restriction of intracellular  pathogens 
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   The priority  in our follow-up  work regarding  the intersection  of innate immune  sensing and 
IFNγ-mediated pathogen restriction is the  breeding of an  IRF3
-/-IFNAR
-/-  mouse strain in order to 
conclusively rule out the role of Type I IFN in the IRF3-mediated  suppression  of IFNγ effectors in 
vitro, as well as to examine the role of IRF3 in L. pneumophila infection  in the absence of Type I 
IFNs in vivo. Here, we discuss these  priority experiments, as  well as  opportunities  for further study 
suggested by other results in this project. 
 
Contribution of MYD88/TRIF to the maintenance of the IFNγ-activated state 
  To confirm that MYD88/TRIF contributes  to the maintenance of the IFNγ-activated state by 
a mechanism  completely independent of  IFNGR signaling,  pre-stimulated MYD88
-/-TRIF
-/-  BMMs 
could  be washed extensively  and incubated  in media without  IFNγ to reduce or eliminate  the effect 
of continued signaling through residual IFNGR-IFNγ receptor-ligand pairs  that remain on the cell 
surface after the removal of IFNγ, However, the length of the incubation  period  required  is not clear, 
especially since signaling from receptor-ligand pairs  can continue even after their internalization  by 
endocytosis.  Furthermore,  attenuation  of the IFNγ-activated state during this time could affect the 
ability  to observe a MYD88/TRIF-dependent phenotype thereafter. 
   
Contribution of STING-mediated cytosolic DNA sensing to the maintenance of the IFNγ-activated 
state 
We have hypothesized  that enhancement of IFNγ-mediated bacterial restriction in TREX1
-/- 
BMMs is mediated by STING.  If this were true, shRNA or siRNA-mediated depletion of  Trex1 
transcript in STING
-/- BMMs should  strengthen the phenotype,  though it is possible  that introduction 
of foreign RNA (shRNA or siRNA) could  trigger  confounding  sensing pathways. Another approach 
is to examine whether treatment of WT BMMs with STING-specific ligands such as  3'3'-cGAMP 
leads to a similar  phenotype  as that seen in TREX
-/-  BMMs. Similarly, purified L. pneumophila DNA 
159 
 transfection into the cytosol after infection  can simulate  TREX1 deficiency  in WT and STING
-/- 
BMMs. Our hypothesis would be supported if bacterial DNA sensing enhances IFNγ-mediated  L. 
pneumophila restriction  more strongly  in WT than in STING
-/- BMMs. If it did not, however, the 
hypothesis could not be ruled out, since these exogenously delivered STING ligands may lead to 
activation of IRF3. According  to our model,  the effect of STING activation  is dependent on a balance 
of activation  of the two arms of the STING response:  the IRF3 arm, which suppresses the IFNγ-
activated state, and the IRF3-independent  arm, including  NFκB,  which enhances it. In order to 
compare the activation  of these two arms, the nuclear translocation  of IRF3 and NFκB in BMMs 
infected with L. pneumophila or stimulated  with ligand  could be compared,  and the expression  of 
genes specifically  activated by either of these transcription  factors could be quantified.   
 
Contribution of phagolysosomal DNA sensing to IRF3-mediated suppression of the IFNγ-activated 
state 
  DNASE2
-/- BMMs exhibit  lower levels of IFNγ-mediated bacterial restriction than WT 
BMMs, and these cells are also characterized by activation  of IRF3 [32]. To test the hypothesis  that 
these two phenotypes  are related, DNASE2 could be depleted in in IRF3
-/- BMMs by siRNA or 
shRNA. If the hypothesis  were true, DNASE2 knockdown  would  suppress IFNγ effectors in WT 
BMMs significantly  more than in IRF3
-/- BMMs, though noting the  caveats  regarding RNAi 
mentioned above.  Furthermore, delivery of mouse or  bacterial DNA  ligands to phagolysosomes by 
suspending  the ligands  in cell media during  L. pneumophila infection  is a way to simulate  DNASE2 
deficiency,  as well as to test whether the source of immunostimulatory  DNA (host or pathogen) is 
relevant to the outcome observed. 
 
IRF3-mediated, Type I IFN-independent suppression of IFNγ effectors  
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   To definitively  confirm  that the IRF3-mediated  suppression  of IFNγ effectors is independent 
of Type I IFNs, we are breeding mice doubly  deficient  in IRF3 and IFNAR. In vivo, we will  assess 
IFNγ-mediated  bacterial restriction and NOS2 induction  in IRF3
-/-IFNAR
-/-  and IRF3
-/- BMMs 
relative to WT and IFNAR
-/- controls. Furthermore,  RNAseq analysis of gene expression  in IRF3
-/-
IFNAR
-/- and IRF3
-/- BMMs relative to WT BMMs will  refine the list of candidate effectors, 
eliminating  genes whose transcription  is modulated  by low levels of Type I IFN or those modulated 
by IRF7 in the existing  data set, in which WT and IRF3
-/-IRF7
-/-  BMMs were used 
We have already begun investigating  alternative, known mechanisms without the  guidance of 
candidate genes, including the role of IFNγ-mediated necrosis which, according to our preliminary 
data, does not seem to play a role in enhanced bacterial restriction  in IRF3
-/- BMMs. Instead, assays 
specific to the candidates identified  by RNAseq in IRF3
-/-IFNAR
-/-  BMMs will help in the 
identification  of IFNγ effectors relevant to the restriction  of L. pneumophila and specifically 
repressed by IRF3. 
 
IRF3 localization in IFNγ-activated BMMs 
We have observed that IFNγ-activated BMMs form cytosolic speckles that stain positive  for 
IRF3. In order to confirm that these speckles actually  represent IRF3, rather than another IFNγ-
inducible  protein that cross-reacts with anti-IRF3 antibody,  we have used two different antibodies 
targeting IRF3 at different sites of the protein, but neither resulted in satisfactory IRF3-specific 
staining patterns. Another approach is to overexpress fluorescently-labeled  IRF3 in order to eliminate 
staining pattern ambiguity.  A different possibility  is that IFNγ induces  the expression  of alternative 
isoforms of IRF3, which then forms the speckles observed. In fact, an alternative isoform called 
IRF3-CL is known to inhibit  the activity  of full-length  IRF3 in human cells [57], but its regulation  by 
IFNγ has not been studied; furthermore,  it is unknown  whether a corresponding,  IRF3-inhibitory 
variant exists in mouse cells. Detailed analysis of mRNA mapping  to IRF3 from our RNAseq data in 
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 resting and IFNγ-stimulated  BMMs infected with L. pneumophila or stimulated  with LPS will  allow 
us to determine whether IRF3 is differentially  spliced under these conditions. 
 
Effect of IRF3 on bacterial infection in vivo 
Finally,  we plan to perform intranasal L. pneumophila infection of  WT, IRF3
-/-, IFNAR
-/-, and 
IRF3
-/-IFNAR
-/-  mice. We will  collect data on lung bacterial burden as well as analyze the pathology 
of lung slices for evidence of tissue damage. WT mice clear L. pneumophila infection within about a 
week. Despite the described role of Type I IFNs in L. pneumophila infection  in vitro, we expect that 
bacterial clearance in IFNAR
-/- mice will be similar  to that in WT mice, as shown previously  [58,59]. 
Meanwhile,  we expect that IRF3 deficiency  on an IFNAR
-/- background  should  enhance the capacity 
of alveolar macrophages to restrict bacteria, analogous  to what we observed in vitro. However, as 
with deficiency in IFNAR, it is not possible to predict whether phenotype in vitro will  have an effect 
in vivo. Furthermore,  the increased activity  of IFNγ effectors such as NOS2 may lead to host tissue 
damage, which could even lead to a paradoxical  increase in bacterial burden. In the latter case, the 
result would support a  beneficial role for the immunomodulatory  action of IRF3. 
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